Perfuze has announced two “significant milestones” in its mission to improve stroke care: the completion of patient enrolment in its US pivotal investigational device exemption (IDE) clinical trial, MARRS, and the appointment of medtech executive Joe Rotger as the...
The established ‘gold standard’ approach to carotid revascularisation remained enshrined as the go-to operation as far as the Charing Cross (CX; 23–25 April, London, UK) symposium audience gathered in Theatre 3 for a carotid and acute stroke challenges great...
Penumbra recently announced a significant update to its flagship large-bore reperfusion catheter, Red 72. Developed for speed and ease of navigation, the new Red 72 Silver Label features “meticulously blended” transition zones to better accommodate the natural distal anatomy of the...
Transverse Medical has announced the completion of the first series of patients under its feasibility clinical study at the Victorian Heart Hospital in Melbourne, Australia. Patients undergoing transcatheter aortic valve implantation (TAVI) procedures were treated using the company's next-generation...
Methinks AI has announced that it has been chosen as the patient selection software for the DONE SYMPLE trial—a randomised controlled trial (RCT) aimed at simplifying imaging protocols and expanding access to treatment for very-late-window (24–72 hours) stroke patients.
The...
NOTE: This video is ONLY available to watch in selected countries and geographies
Speaking to NeuroNews at the 2024 European Society of Minimally Invasive Neurological Therapy (ESMINT) congress (4–6 September, Marseille, France), Vincent Costalat (Montpellier, France) provides a number...
Q’Apel Medical has announced the voluntary recall of 1,617 units of its 072 aspiration system including the Hippo catheter and Cheetah delivery tool—a recall categorised as Class I, the most serious type of medical device recall, by the US...
Anaconda Biomed has announced that results of the ANAIS study, which evaluated the safety and performance of its Ana funnel catheter in the endovascular treatment of large vessel occlusion acute ischaemic stroke, have been published in the American Journal of...
Artedrone, a Truffle Capital medtech portfolio company, has today announced the successful completion of a set of various in vitro and animal studies demonstrating the ability of its Sasha microrobotic solution to autonomously perform mechanical thrombectomies in stroke treatment....
Hyperfine has announced the enrolment of initial patients in the NEURO PMR study assessing in-office neurological evaluation with Swoop—the company’s artificial intelligence (AI)-powered portable magnetic resonance imaging (MRI) system.
The NEURO PMR study is claimed by Hyperfine to be the first multicentre,...
Terumo Neuro has announced that its carotid stent system has received premarket approval (PMA) from the US Food and Drug Administration (FDA).
This milestone marks the first dual-layer micromesh carotid stent approved in the USA, offering physicians a clinically proven option...
Imperative Care has announced today that it will fund an investigator-initiated, multicentre randomised controlled clinical trial comparing aspiration thrombectomy with the Zoom stroke system plus best medical treatment versus best medical treatment alone. The study will examine treatments in...
Fuelled by a passion for research, and inspired by a “heartbreaking” case she encountered early on in her career, Simona Sacco (L’Aquila, Italy) has made a number of significant contributions to the neurology field—perhaps most prominently through her current...
Revalesio has announced new data from its completed Phase 2 RESCUE clinical trial of RNS60 in acute ischaemic stroke patients, demonstrating that patients were—on average—discharged 4.8 days sooner from the hospital following treatment with RNS60 plus standard-of-care endovascular therapy...
Nicolab, a provider of digital telehealth solutions for advancing stroke workflow, and Wellumio, a medical device company specialising in portable imaging technology, have announced the signing of a memorandum of understanding (MOU).
This strategic collaboration aims to explore the integration...
Kandu Health and Neurolutions announced yesterday that they have merged to form Kandu Inc—a company that “expects to set a new standard of care for stroke recovery” via a “first-in-kind”, end-to-end solution for stroke survivors that combines brain-computer interface...
NOTE: This video is ONLY available to watch in selected countries and geographies
With a list of benefits including customisability, high radiopacity and shortened procedure times, the TRUFILL n-BCA liquid embolic system (Johnson & Johnson) should be considered a...
The “world’s first” multisector advocacy movement dedicated to stroke—the Global Stroke Action Coalition—is launching today, and has issued an urgent call to action to address growing inequities in stroke. A press release notes that stroke is already a leading...
An urgent neurovascular device recall notice, new clinical data on interventional treatments for idiopathic intracranial hypertension (IIH), and landmark certifications of two stroke centres in India, all feature among NeuroNews’ most-viewed stories from March, while an in-depth interview with...
Brainomix has announced the US Food and Drug Administration (FDA) clearance of a novel and patented feature that enables physicians to assess ischaemic core volume from universally available non-contrast computed tomography (NCCT) images through the Brainomix 360 Stroke solution.
The...
A systematic review and meta-analysis published recently in the Journal of NeuroInterventional Surgery has synthesised the existing data on intracranial aneurysm treatments utilising the novel Contour neurovascular system (Stryker), ultimately finding the device to be a safe and effective...
Anaconda Biomed has announced the enrolment and treatment of the first US patient by Shahram Majidi (Mount Sinai, New York, USA) in its ATHENA clinical trial.
ATHENA is a global, randomised, 327-patient pivotal study evaluating the safety and effectiveness of...
Abbott has announced the launch of its neuromodulation business’ next-generation delivery system, which will be used to streamline the implantation process for electrodes used as part of the company’s Proclaim dorsal root ganglion (DRG) neurostimulation system.
The new system is...
Route 92 Medical has announced approval from the Australian Therapeutic Goods Administration (TGA) for its portfolio of innovative neurovascular interventional products intended to treat patients with acute ischaemic stroke.
Within this portfolio are the first 0.088-inch super bore reperfusion systems...
Viseon has announced the first clinical use of its “groundbreaking” Hubble AV system, marking what the company describes as a “major milestone” as it looks to expand into the neurosurgery market. Neurological surgery professor Gabriel Zada (University of Southern...
Brain Navi Biotechnology has announced a strategic partnership with BenQ Medical Technology to introduce and commercialise Brain Navi’s NaoTrac neurosurgical navigation robot in the Chinese market. A recent press release details that this collaboration aligns with Brain Navi's 2025 globalisation strategy, prioritising...
“Imagine if you saw construction workers building a house, and they were using a hammer or a saw, and you were like, ‘what the f*** is that?’”
This is the perspective comedian and actor T.J. Miller puts forward to explain...
Route 92 Medical has announced the results of a “first-of-its-kind” multicentre study—published recently in Stroke: Vascular and Interventional Neurology—demonstrating the utility of the company’s Monopoint system in procedures to treat idiopathic intracranial hypertension (IIH). Physicians participating in the study noted...
Highlights:
Major news from the 2025 International Stroke Conference (ISC; 5–7 February, Los Angeles, USA), including first-time data presentations on the DISTAL, ESCAPE-MeVO and DISCOUNT trials evaluating mechanical thrombectomy in distal/medium-vessel occlusion stroke
Coverage of results from the MEMBRANE...
Highlights:
Major news from the 2025 International Stroke Conference (ISC; 5–7 February, Los Angeles, USA), including first-time data presentations on the DISTAL, ESCAPE-MeVO and DISCOUNT trials evaluating mechanical thrombectomy in distal/medium-vessel occlusion stroke
Coverage of results from the MEMBRANE...
Brainomix recently announced the completion of a £14 million (US$18 million) Series C investment round co-led by prominent health technology investors, including existing investors Parkwalk Advisors and the Boehringer Ingelheim Venture Fund (BIVF), along with new investor Hostplus via...
The American Stroke Association (ASA) has awarded its first Indian comprehensive stroke centre (CSC) certifications to Apollo Hospital in Hyderabad and Aster Hospital in Calicut, in an effort to establish a coordinated system of stroke care across the country.
Launched...
XCath has announced the incorporation of artificial intelligence (AI)-driven simulation, powered by NVIDIA's Isaac for Healthcare, into XCath’s autonomous robotic system, which is intended to improve upon the current standard of care for stroke and other complex vascular conditions.
“One...
Medtronic has issued an urgent medical device recall letter recommending that its customers do not deploy unused Pipeline Vantage 027 devices due to concerns over an increased risk of incomplete wall apposition and braid deformation. The company has also...
Hyperfine, a company attempting to “redefine” brain imaging with its US Food and Drug Administration (FDA)-cleared, artificial intelligence (AI)-powered portable magnetic resonance (MR) solution—the Swoop system—recently announced a strategic collaboration with technology giant NVIDIA.
As per a Hyperfine press release,...
A prospective study has established the safety of venous sinus stenting (VSS) using a novel device in idiopathic intracranial hypertension (IIH) patients who have failed standard medical therapy, as well as suggesting the potential efficacy of this approach.
The RIVER...
Perfuze has today announced the receipt of US Food and Drug Administration (FDA) 510(k) clearance for its Zipline access catheters—a regulatory milestone that the company claims will strengthen its growing portfolio of innovative neurovascular devices, empowering physicians to treat...
MicroTransponder, a company that is attempting to transform the stroke continuum of care with its US Food and Drug Administration (FDA)-approved Vivistim paired vagus nerve stimulation (VNS) system, has announced a US$65 million Series F financing round.
The round was...
A ‘Life After Stroke’ support service—which was axed in budget cuts by the local council on the Isle of Wight, UK two years ago—is being revived thanks to a new funding agreement between National Health Service (NHS) Hampshire and...
Researchers from Carnegie Mellon University and Allegheny Health Network in Pittsburgh, USA have developed a new method for deep brain stimulation (DBS). The technique, referred to as ‘DeepFocus’, uses trans-nasal stimulation to achieve more accurate electrical stimulation in the...
The long-anticipated findings from three randomised trials evaluating mechanical thrombectomy versus the standard of care in patients with distal- or medium-vessel occlusion (D/MeVO) strokes feature prominently among our 10 most popular stories from February—occupying two spots on the list....
Genentech, a member of the Roche Group, has announced the US Food and Drug Administration (FDA) approval of the thrombolytic agent TNKase (tenecteplase) for the treatment of acute ischaemic stroke in adult patients. According to a company press release, this...
Stereotaxis has announced a US Food and Drug Administration (FDA) regulatory submission for the first robotically navigated catheter designed to expand usage of robotic magnetic navigation into the broader endovascular field.
Emagin 5F is the first in a family of...
In an interview with NeuroNews, David Volders (Toronto, Canada) gives his perspectives on some of the key trends in the world of aspiration thrombectomy, and outlines multiple technologies that he believes are set to have a positive impact on...
This advertorial, intended only for audiences outside the USA, is sponsored by Penumbra.
Recently, at the 2024 BRAIN conference (2–4 December, London, UK), David Volders (University of Toronto, Toronto, Canada) sat down with NeuroNews to discuss mechanical thrombectomy devices that...
Penumbra has launched the Access25 delivery microcatheter—a single-lumen medical device designed to aid physicians in accessing the neurovasculature for the delivery of Penumbra’s advanced 0.020-inch coil platform.
Access25 is compatible with Penumbra’s Midway intermediate catheters and Benchmark/BMX guide catheters, and was designed...
Newly commissioned research, led by Costello Medical on behalf of Hereditary Brain Aneurysm (HBA) Support, has revealed “shocking gaps” in the screening and care people receive for hereditary brain aneurysms, highlighting the need for action to ensure consistent screening...
This press release has been sponsored by Medtronic.
Brainomix, a pioneer in stroke artificial intelligence (AI) imaging software has announced a strategic partnership with Medtronic Neurovascular, a global leader in medical technology. This collaboration aims to enhance stroke care across...
Cerevasc has announced that the first patient has been randomised to and treated with the eShunt system in its STRIDE clinical trial—a head-to-head comparison of this novel system versus the standard-of-care ventriculoperitoneal (VP) shunt in patients with normal-pressure hydrocephalus (NPH)....
Medtronic has announced US Food and Drug Administration (FDA) approval of its BrainSense adaptive deep brain stimulation (aDBS) and the BrainSense electrode identifier.
Through this approval, Medtronic says it has enhanced its Percept DBS neurostimulators with exclusive BrainSense adaptive technology,...
The MIND study—presented for the first time at this year’s International Stroke Conference (ISC; 5–7 February, Los Angeles, USA)—has revealed the potential benefits of minimally invasive surgery in patients with deep and lobar intracranial haemorrhages (ICHs). Analyses of the...
Viz.ai recently announced new data supporting advancements in neurovascular care, with two studies—both presented at the 2025 International Stroke Conference (ISC; 5–7 February, Los Angeles, USA)—showing positive outcomes and the real-world impact of its stroke solutions in clinical practice...
Via computational fluid dynamics models, a recent study has offered insights into the relevance of balancing two key mechanisms of haemodynamic deterioration—plaque burden and compromised perfusion—with regard to blood pressure management in symptomatic intracranial atherosclerotic stenosis (ICAS) patients.
“This research...
Newronika has successfully closed its €13.6 million Series B funding round led by a new investor, Fondazione ENEA Tech e Biomedical, with additional participation from multiple existing investors. This news follows another recent announcement from the company of US...
Stryker announced today that it has completed the acquisition of Inari Medical. A press release notes that the addition of Inari brings an established peripheral vascular position to Stryker in the fast-growing venous thromboembolism (VTE) segment.
“The acquisition of Inari...
New findings from the DiVERT Stroke clinical study show that women spent less time in the hospital, saw fewer referrals to cardiology and were prescribed less frequent post-stroke cardiac monitoring than men when admitted to comprehensive stroke centres (CSCs)...
The clot-dissolving medication alteplase can improve stroke patients’ recovery by more than 50% when given up to 24 hours after the beginning of an ischaemic stroke, as per preliminary late-breaking science presented at the recent International Stroke Conference (ISC; 5–7...
Cerevasc announced recently that it has received approval from Argentina's National Administration of Drugs, Food and Medical Devices (ANMAT) to initiate the STRIDE trial—a clinical study evaluating the company’s eShunt system as a treatment for normal-pressure hydrocephalus (NPH).
This trial...
Hyperfine has announced the presentation of two studies at the 2025 International Stroke Conference (ISC; 5–7 February, Los Angeles, USA) that provide evidence supporting the value of artificial intelligence (AI)-powered portable magnetic resonance imaging (MRI) via its US Food and...
Microtransponder has announced that neurosurgeon Ronald Benitez (Atlantic Brain and Spine, Morristown, USA) presented safety and outcomes data from the largest, real-world cohort of stroke survivors treated with the Vivistim device to date during the 2025 International Stroke Conference...
Royal Philips—in collaboration with the World Bank and Ukraine’s Ministry of Health (MOH)—has announced a nationwide initiative to modernise stroke and cardiovascular care in Ukraine.
A company press release notes that the demand for stroke care in Ukraine is nearly...
Removing a blood clot from a large brain artery via endovascular therapy (EVT), then injecting the clot-dissolving drug tenecteplase into the artery, has resulted in ischaemic stroke survivors being more likely to experience a better 90-day functional outcome when...
Wellumio has announced enrolment of the first patient in a feasibility, safety and usability assessment of the company’s Axana 0.1T portable magnetic resonance imaging (MRI) device, which will study the ability of the Axana device to detect acute stroke...
InspireMD and North American Science Associates (NAMSA) today announced that, pursuant to a previously announced strategic outsourcing partnership, the companies are working together to conduct the CGUARDIANS II pivotal study of InspireMD’s CGuard Prime 80cm carotid stent system for use...
Johnson & Johnson (J&J) MedTech has today announced the launch of the Cereglide 92 catheter system—a next-generation 0.092-inch catheter with the Innerglide 9 delivery aid, indicated for use in facilitating the insertion and guidance of interventional devices in the neurovascular...
Two randomised trials presented at the International Stroke Conference (ISC; 5–7 February, Los Angeles, USA) have indicated that mechanical thrombectomy treatments confer no advantages over the current standard of care for acute ischaemic strokes caused by distal- or medium-vessel...
Viz.ai and RapidAI—two leading companies developing artificial intelligence (AI)-powered technologies intended to optimise stroke care—have separately announced positive study data on their AI solutions.
Earlier this week, Viz.ai announced results from a clinical study recently published in The Neurohospitalist highlighting the...
Arsenal Medical has announced the complete enrolment of an initial cohort of 10 patients in the EMBO-02 clinical study evaluating NeoCast for the treatment of chronic subdural haematomas (cSDHs) across three sites in Australia.
A company press release describes NeoCast...
Mild electrical brain stimulation—specifically, transcranial direct current stimulation (tDCS)—did not further improve motor recovery in stroke survivors in a multicentre study presented as late-breaking science at the 2025 International Stroke Conference (ISC; 5–7 February, Los Angeles, USA).
“The results are somewhat...
Revalesio has announced new analyses of the completed Phase 2 RESCUE clinical trial evaluating its drug candidate RNS60 in acute ischaemic stroke that demonstrate a nominally significant lowering of infarct growth in patients treated less than 12 hours from...
Terumo Neuro has announced that the company is showcasing its comprehensive and streamlined portfolio of stroke solutions at booth number 522 at the International Stroke Conference (ISC; 5–7 February, Los Angeles, USA).
In addition, Terumo Neuro is hosting a symposium at ISC...
Siemens Healthineers has announced in a press release that it is showcasing its new mobile solution to support stroke diagnosis, designed to speed up time-critical therapy decisions and get patients the right treatment as quickly as possible, at the...
Vena Medical has been granted Breakthrough Device designation from the US Food and Drug Administration (FDA) for its MicroAngioscope, marking what the company describes as a “historic leap forward” in neurovascular care and stroke treatment.
For the first time ever,...
Removing a clot blocking a medium- or small-sized artery in the brain via a mechanical thrombectomy procedure proved to be a safe treatment for ischaemic stroke but did not lessen disability more than the current ‘best medical treatment’ alone—including...
Saluda Medical has announced the recent presentation of new clinical data at the 2025 North American Neuromodulation Society (NANS) annual meeting (30 January–1 February, Orlando, USA). The company states that data from 11 total abstracts and four oral presentations—two...
Thirty-day results from the ROADSTER 3 study have demonstrated that transcarotid artery revascularisation (TCAR) is a safe and effective approach in patients who are deemed to be ‘standard risk’ for experiencing adverse events related to carotid endarterectomy (CEA). These...
Cerevasc has today reported initial results from its pilot US Food and Drug Administration (FDA)-approved investigational device exemption (IDE) clinical study of the eShunt system in the treatment of elderly patients with normal-pressure hydrocephalus (NPH).
This prospective, non-randomised, open-label, multicentre...
Brainomix will be unveiling a series of new studies this week at the International Stroke Conference (ISC; 5–7 February, Los Angeles, USA), further validating the impact of its Brainomix 360 system to “transform” stroke treatment rates for patients across...
RapidAI has received US Food and Drug Administration (FDA) 510(k) clearance for Lumina 3D—an “industry-first”, automated 3D imaging reconstruction solution designed to replace manual workflows with an artificial intelligence (AI)-powered approach based on the latest “groundbreaking” AI technology advances.
“Obtaining...
NeuroNews’ first top 10 of the year kicks off with exclusive interviews on two novel concepts with the potential to transform the neurovascular space—a ‘two-in-one’ approach to surgical drainage and embolisation for subdural haematoma, and a fully reversible thrombolytic...
SPR Therapeutics has announced the presentation of four featured abstracts at the 2025 North American Neuromodulation Society (NANS) annual meeting (30 January–1 February, Orlando, USA). All the abstracts contained recent clinical data and insights highlighting the utility of the Sprint...
Viz.ai has announced an expanded partnership with Softek Illuminate—an industry leader in the development of proprietary natural language processing (NLP) and artificial intelligence (AI) software that discovers at-risk patients based on electronic medical records (EMR), assesses disease severity, and...
Remedy Pharmaceuticals has announced that three speaker presentations reporting efficacy data from both the Phase 2 GAMES-RP and Phase 3 CHARM studies on its stroke drug, Cirara (intravenous glyburide), will be given at the upcoming International Stroke Conference (ISC;...
Abbott has announced new four-year data showing the long-term and sustained relief that its proprietary BurstDR spinal cord stimulation (SCS) technology provides for patients with chronic pain—particularly pain in the back and legs. The data, which Abbott says reinforce...
A blood test may have the ability to rapidly distinguish haemorrhagic strokes (brain bleeds) from ischaemic (clot-caused) strokes, even before patients with stroke symptoms reach the emergency room, according to a preliminary study set to be presented at the 2025...
Rapid Medical has announced enrolment of the first patient in its COGNITIVE study—which, according to the company, is the first study to examine a link between mechanical thrombectomy and cognitive improvement. Tigertriever—described by Rapid as “the only active stent...
The past 18 months have seen a radical shift in clinical evidence supporting the role of middle meningeal artery embolisation (MMAe) within subdural haematoma (SDH) treatment, with no fewer than four randomised controlled trials—three of which were first presented...
Biotronik Neuro will unveil new data from the BENEFIT-03 clinical study at the upcoming North American Neuromodulation Society (NANS) annual meeting (30 January–1 February 2025, Orlando, USA), with a recent press release from the company noting that these findings...
The Brain Aneurysm Foundation (BAF) has announced the appointment of Joseph P Caruso to its board of directors, with Caruso commencing a three-year term on the board this month.
A BAF press release notes that Caruso has decades of business...
Amplitude Vascular Systems (AVS) recently announced that it has completed a Series B round of financing of US$36 million. The funding will support the US peripheral commercial launch as well as US coronary and carotid investigational device exemption (IDE)...
A new scientific advisory from the American Heart Association (AHA)—published recently in the journal Stroke—has reviewed clinical data from six randomised controlled trials evaluating endovascular therapy (EVT) in the treatment of ischaemic strokes caused by large-core infarctions, and ultimately...
Imperative Care has today announced the receipt of US Food and Drug Administration (FDA) 510(k) clearance of the company’s Zoom system, making it the first comprehensive stroke thrombectomy system to include large-bore 0.088-inch catheters indicated for both access and aspiration...
According to new research led by the University of Missouri School of Medicine (Columbia, USA), the number of mechanical thrombectomies performed at a hospital is not an accurate indicator of patient outcomes. Using data from nearly 1,000 centres, researchers found...
Saluda Medical has announced the US Food and Drug Administration (FDA) approval of its biomarker-based, automated patient programming platform in spinal cord stimulation (SCS), representing a “significant advancement” for SCS therapy. The new programming platform, EVA, is compatible with all...
Lauxera Capital Partners has invested €50 million in neurovascular medical device company Acandis—a transaction that marks the firm’s first investment out of Lauxera Growth II, its second-generation healthcare growth buyout fund.
Key uses of funds from this transaction include accelerating...
A comprehensive, geospatial analysis of acute ischaemic stroke care in India has identified “critical disparities” in access to life-saving reperfusion treatments, revealing that only 26.3% of the country’s population has access to an intravenous thrombolysis (IVT)-capable centre within an...
The US Food and Drug Administration (FDA) has issued a statement outlining measures to enhance protections against medical device shortages.
According to Michelle Tarver, director of the FDA’s Center for Devices and Radiological Health (CDRH), supply chain disruptions—often caused...
Nalu Medical has announced the publication of a study in the journal Pain Management showing that the use of Nalu peripheral nerve stimulation (PNS) therapy in chronic pain patients is associated with lower healthcare resource utilisation (HCRU) and a significant...
Mainstay Medical has announced the publication of positive one-year primary assessment results from the RESTORE randomised clinical trial evaluating ReActiv8 for the treatment of intractable chronic low back pain. The data show that the addition of ReActiv8 restorative neurostimulation...
Radical Catheter Technologies, a NeuroTechnology Investors (NTI) portfolio company, has announced the Food and Drug Administration (FDA) clearance of its 8Fr neurovascular catheter, marking the company’s second 510(k) clearance from the US regulator. A press release labels this as...
Abbott and Medtronic—two leading players in the neuromodulation space—have both announced significant CE-mark approvals relating to their respective deep brain stimulation (DBS) technologies.
Abbott announced on 14 January that it has secured a CE mark for its Liberta RC DBS...
Cerevasc has announced the first enrolment of a patient in the STRIDE clinical trial evaluating the company’s eShunt system in patients with normal-pressure hydrocephalus (NPH).
The STRIDE trial is a multicentre randomised controlled study that will assess the safety and...
Laura Capoccia (Frosinone, Italy) writes about vascular surgeons’ role in acute stroke management and the importance of collaboration with other specialties in this setting.
While stroke treatment has dramatically changed in recent years, still around 795,000 people experience a new...
BRAIN.Q has announced that the CE mark has been granted for its BQ 2.0 system, which is designed to reduce disability following ischaemic stroke.
A company press release details that this regulatory approval marks the first therapy to show a...
Q'Apel Medical has announced that it has received CE-mark certification for its Armadillo SelectFlex neurovascular access system. As noted in a company press release, this “first-of-its-kind” 7Fr system features the patented SelectFlex technology and is indicated for the introduction of interventional...
Medtronic announced today that it has entered into an exclusive US distribution agreement with Contego Medical. Under the agreement, Medtronic will be the sole US distributor for Contego’s portfolio of commercially available products, which provide revascularisation treatment for carotid...
Following Basking Biosciences’ recent announcement that the first acute ischaemic stroke patients have received its novel thrombolytic therapy as part of the Phase 2 RAISE clinical trial, NeuroNews speaks to the company’s co-founder and chief medical officer—Ohio State University...
Kaneka Corporation has announced that—on 23 December 2024—it acquired 96.8% of shares in Israeli medical equipment company Endostream Medical.
By combining its own manufacturing and Endostream’s technology, Kaneka states in a press release that it will jointly develop new medical...
A retrospective study has indicated that carotid artery stenting (CAS)—when performed by fellowship‐trained neurointerventional physicians in comprehensive stroke centre (CSC) settings—was associated with a lower complication rate as compared to prior literature on CAS, carotid endarterectomy (CEA) and transcarotid...
Anaconda Biomed has announced that it has named long-time medtech executive Trent Reutiman as its new chief executive officer (CEO).
A press release details that, based in California’s San Francisco Bay Area, Reutiman will establish a “new footprint” for the company...
Palliative care—an approach that helps people manage pain and other symptoms during all stages of a serious illness, rather than simply being an ‘end-of-life’ strategy—can help improve quality of life for stroke survivors as well as their family members,...
A new Vascular Quality Initiative (VQI) data analysis, recently published in the European Journal of Vascular and Endovascular Surgery (EJVES), has found no statistically significant differences between three carotid endarterectomy (CEA) shunting strategies regarding in-hospital stroke and death rate,...
Wellumio is expanding its global footprint by launching a new subsidiary in California, USA—a strategic move that, according to the company, lays the groundwork for planned USA-based clinical trials to validate its innovative Axana device and accelerate its mission to...
The US Food and Drug Administration (FDA) has issued draft guidance that includes recommendations to support development and marketing of safe and effective artificial intelligence (AI)-enabled devices.
The guidance, if finalised, would be the first guidance to provide comprehensive...
Stryker has announced a definitive agreement to acquire all of the issued and outstanding shares of common stock of Inari Medical for US$80 per share in cash, representing a total fully diluted equity value of approximately US$4.9 billion.
A Stryker...
The North American Neuromodulation Society (NANS) has announced its 2025 award winners ahead of the NANS annual meeting (30 January–1 February, Orlando, USA), recognising “individuals who are making strides in the field of neuromodulation”.
Nagy Mekhail (Cleveland Clinic, Cleveland, USA)...
NeuroNews’ final top 10 of 2024 features a number of the biggest talking points and new data presentations from two major neurovascular events: the Society of Vascular and Interventional Neurology (SVIN) annual meeting (20–22 November, San Diego, USA) and...
Navigantis has announced the first successful neurovascular clinical cases performed with its Vasco interventional robotic platform for patients suffering from neurovascular disorders.
"This achievement marks an important milestone in our mission to introduce the advantages of robotic procedures to the...
Balt has announced that it recently secured €355 million in financing from a group of leading institutional investors and banks to refinance existing debt, accelerate product innovation, expand production capacity, and enhance development of key growth markets, as outlined...
Contego Medical has announced the successful completion of the first commercial cases with its newly US Food and Drug Administration (FDA)-approved Neuroguard IEP system.
A press release notes that John Gaughen Jr, an interventional neuroradiologist at Centra Medical Group (Lynchburg,...
TargED Biopharmaceuticals has today announced that it has commenced clinical development with the dosing of the first participant with TGD001—a “groundbreaking” thrombolytic designed to break down clots of all sizes and compositions, from large clots that cause acute ischaemic...
Leading artificial intelligence (AI)-based medical imaging companies Viz.ai and Avicenna.AI have announced the integration of Avicenna.AI’s CINA-iPE and CINA-ASPECTS tools into Viz.ai’s One platform. A press release states that the combination of Avicenna.AI’s two AI-based algorithms alongside Viz.ai’s care...
Recently presented results from the PROTECT-MT randomised controlled trial (RCT) have indicated worse functional outcomes following stroke thrombectomy with a balloon guide catheter (BGC) versus a conventional guide catheter. However, the study’s investigators believe these findings are unlikely to...
A device described as the latest addition to a growing group of ‘super-large bore’ catheter technologies has demonstrated “extremely positive” outcomes in early clinical usage.
At the recent BRAIN conference (2–4 December 2024, London, UK), Shahram Majidi (Department of...
Fluid Biomed has today announced the close of an oversubscribed US$27 million Series A equity financing co-led by Amplitude Ventures and an undisclosed major strategic partner. New participants in the investment syndicate include IAG Capital Partners and LifeArc Ventures,...
While intracranial atherosclerotic disease (ICAD) is often cited in the context of its greater prevalence among patients in China and other parts of Asia, discussions at the recent BRAIN conference (2–4 December, London, UK) emphasised its relevance as an...
In light of recently presented and generally positive findings from the COAST study, which deemed coiling to be safe in the treatment of small (<5mm) intracranial aneurysms, Victor Volovici (Rotterdam, The Netherlands) outlines existing clinical data, and weighs up...
Royal Philips has today announced the expansion of its strategic partnership with Sim&Cure—a partnership that started five years ago and is now entering into its next phase with the aim of further enhancing Philips’ position in the neurointerventional domain by...
Von Vascular has announced the first international presentation of data on its Algo smart pump at the 2024 BRAIN conference (2–4 December, London, UK). The preclinical studies—presented by Von Vascular chief executive officer (CEO) Manning Hanser on behalf of principal...
RapidPulse announced today that the US Food and Drug Administration (FDA) has agreed that the company can begin enrolment in an investigational device exemption (IDE) study of its novel and precise cyclic aspiration system. This will allow US and...
A meta-analysis of more than 4,500 patients, presented recently at the 16th World Stroke Congress (WSC; 23–26 October, Abu Dhabi, United Arab Emirates), has revealed that female sex; disease severity upon admission; presence of vasospasm; and scores on the Fisher...
Alveron Pharma has announced the closing of a €5 million series seed extension financing—worth approximately US$5.28 million—to advance the development of its innovative drug, OKL-1111, for the treatment of intracranial haemorrhage (ICH). The syndicate behind this funding is led by...
InspireMD today announced that the first patient has been enrolled in the company’s CGUARDIANS II clinical trial evaluating its CGuard Prime carotid stent system in patients undergoing carotid artery stenting (CAS) via the transcarotid artery revascularisation (TCAR) approach. The patient...
NeuroNews’ November top 10 features a number of stories reporting new data and discussions around stroke thrombectomy—not only relating to its clinical effects, but also its real-world applicability. The perennial hot topic of endovascular treatment in chronic subdural haematoma...
A novel catheter intended to improve on the tools currently available in neurosurgical external ventricular drain (EVD) placement was awarded a US$100,000 grand prize at this year’s Society of Vascular and Interventional Neurology (SVIN) annual meeting (20–22 November, San...
University Hospitals (UH) Cleveland Medical Center in Cleveland, USA has been awarded US$7 million in research funding by the Patient-Centered Outcomes Research Institute (PCORI) to evaluate endovascular thrombectomy in patients presenting more than 24 hours from time last known...
“The race is on—don’t miss the bus!”, were the words of David Liebeskind (University of California Los Angeles Health, Los Angeles, USA) as he discussed the apparent promise of cytoprotection in acute ischaemic stroke care during a session at...
RapidAI today announced the launch of its Rapid Enterprise platform—powered by Rapid Edge Cloud—which includes the addition of the Rapid Navigator Pro and third-party integration. The company has invited interested parties to visit its booth at the ongoing Radiological...
In patients with large vessel occlusion (LVO) stroke caused by intracranial atherosclerotic stenosis (ICAS), rescue stenting following mechanical thrombectomy appears to lead to higher rates of successful reperfusion and 90-day functional independence—but also an increased occurrence of procedural complications—as...
The Society of Vascular and Interventional Neurology (SVIN) recently announced the publication of a “significant” research paper in the journal Stroke, presenting the Mechanical Thrombectomy Access Score (MTAS)—a “pivotal advancement” in interventional neurology and stroke care with far-reaching global implications, according...
A lack of overall understanding regarding rupture risks is one of the most notable challenges impeding the successful treatment and management of brain aneurysms—and therefore also represents one of the most pressing unmet needs faced by these patients. In...
Viz.ai has announced new data supporting advancements in neurology and vascular care, with two studies—both set to be presented at the Radiological Society of North America (RSNA) annual meeting (1–5 December 2024, Chicago, USA)—showing positive outcomes and the real-world...
The MEMBRANE randomised controlled trial (RCT)—presented at the 2024 Society of Vascular and Interventional Neurology (SVIN) annual meeting (20–22 November, San Diego, USA) by Ansaar Rai (West Virginia University Rockefeller Neuroscience Institute, Morgantown, USA)—has produced fresh evidence on the...
EMVision has announced “exceptional results” with what the company claims is a world-first neurodiagnostic technology for identifying stroke and stroke types.
These results come from the EMView trial, in which a total of 307 participants were enrolled and successfully scanned...
Detailed results from three randomised controlled trials (RCTs) evaluating middle meningeal artery (MMA) embolisation in the treatment of chronic subdural haematoma (cSDH) have been published in the New England Journal of Medicine (NEJM). With key initial data from each...
The Society of NeuroInterventional Surgery’s (SNIS) Patient Safety Organization (PSO)—in partnership with the NeuroPoint Alliance (NPA)—has announced that the NeuroVascular Quality Initiative Quality Outcomes Database (NVQI-QOD) has recorded more than 25,000 procedures in the registry.
As stated in a...
Route 92 Medical announced today that it has obtained CE-mark approval under the EU Medical Device Regulation (MDR) 2017/745 for its innovative line of neurovascular, stroke intervention-focused products. Concurrently, the company also announced clearance under the Medical Device Single...
Endostream Medical has announced that it has officially received European Union (EU) Medical Device Regulation (MDR) certification for its Nautilus intrasaccular system—a novel device intended for the treatment of brain aneurysms.
The company revealed this news via a LinkedIn post...
FreeOx Biotech has announced that its uric acid-based leading compound, Ox-01, has been officially selected by the US National Institute of Neurological Disorders and Stroke (NINDS) to be evaluated on its new stroke-dedicated StrokeNet Thrombectomy Endovascular Platform (STEP).
A FreeOx...
“This meeting is more than just a conference—it’s a community. And it’s dedicated to pushing the boundaries of what’s possible in the neurovascular space,” says Alexandra Czap (University of Texas Health Science Center at Houston, Houston, USA), discussing the...
People with conditions or habits like high blood pressure, atrial fibrillation and smoking not only have a higher risk of stroke, but may also have more severe strokes, than people without these risk factors. That is according to a...
Last month saw the passing of esteemed surgeon and neuroendovascular pioneer Nick Hopkins. Given the seismic impact he had on the neurointerventional landscape and the enduring legacy he leaves behind, it is perhaps unsurprising that the news resonated across...
Arsenal Medical today announced the initiation of the EMBO-02 clinical study of NeoCast in the treatment of chronic subdural haematomas (cSDHs). NeoCast is a first-of-its-kind, shear-responsive, non-adhesive, solvent-free, liquid embolic material designed for deep distal penetration, according to a...
Vivolta has announced the signing of a long-term partnership with Neurochase to manufacture electrospun microcatheters for delivering advanced central nervous system (CNS) therapies to the brain.
UK-based company Neurochase is developing a scalable system to directly deliver therapies—via convection enhanced...
Zap Surgical Systems has announced the successful closing of a US$78 million Series E funding round led by Qingdao Baheal Medical, with participation from other strategic investors. The new financing will advance the commercialisation of the company’s Zap-X gyroscopic...
Branch atheromatous disease (BAD)-related stroke—a “meaningful” yet “understudied” subtype of ischaemic stroke—could be categorised as a separate disease entity, according to the findings of a prospective, multicentre study conducted across China and published recently in the journal Stroke.
The study’s...
As one of six women currently leading major neurointerventional societies across the globe, Thanh N Nguyen (Boston, USA) is proudly playing a key role in challenging the medical field’s history of underrepresentation. In addition to her present tenure as...
This advertorial, intended for readers outside the USA only, is sponsored by Johnson & Johnson MedTech Neurovascular.
“If you take all the good things about the gold-standard catheters on the market and add some improvements—better ‘pushability’, and a very good...
Gianluca Faggioli (University of Bologna, Bologna, Italy) and Gert J de Borst (UMC Utrecht, Utrecht, The Netherlands) went head-to-head at the recent European Society for Vascular Surgery (ESVS) annual meeting (24–27 September, Kraków, Poland) to debate a motion that...
Data from a registry claimed to be the first prospective registry on mechanical thrombectomy for stroke in India have revealed a number of key insights on how this treatment is being implemented across the country. High revascularisation rates and...
Hyperfine has announced the CE-mark approval of its latest generation of artificial intelligence (AI)-powered Swoop system software under the European Medical Device Regulation (MDR).
This approval marks a significant step in positioning Hyperfine for the broad European launch of its...
Hereditary Brain Aneurysm (HBA) Support—a patient-centred organisation providing support and resources for those affected by hereditary brain aneurysms—has announced its new status as a registered charity, having recently been granted charity registration number 1210213 by the Charity Commission in...
Mechanical thrombectomy has gone from strength to strength in the treatment of acute ischaemic stroke over the past decade—progressing beyond early-window large vessel occlusions (LVOs) to patients presenting >6 hours post-symptom onset and those with occlusions located in the...
People with atrial fibrillation (AF) who have a stroke could benefit from receiving blood-thinning treatments—known as direct oral anticoagulants (DOACs)—at an earlier stage than is currently recommended, as per a new study led by researchers from University College London...
Zeta Surgical has announced that its artificial intelligence (AI)-powered Zeta navigation system has received 510(k) clearance from the US Food and Drug Administration (FDA) for use with expanded instruments and enhanced hospital connectivity.
According to a company press release, the...
Two prominent figures in the field of stroke research—Lauren Sansing (Yale School of Medicine, New Haven, USA) and Virginia Howard (University of Alabama at Birmingham , Birmingham, USA)—are set to be recognised with awards at the upcoming American Heart...
Q'Apel Medical has announced the appointment of seasoned medical device executive Jay Hallinan as its new chief commercial officer. In this role, Hallinan will lead the company's global sales and marketing organisation, oversee its commercial strategy, and drive revenue growth across its...
NeuroOne Medical Technologies has announced the execution of an amendment to its existing distribution agreement with Zimmer Biomet—an update that will provide Zimmer Biomet with certain exclusive rights to distribute NeuroOne’s OneRF ablation system for use in the brain.
NeuroOne will...
Highlights:
New research finds that each hour saved between acute ischaemic stroke symptom onset and initiating a mechanical thrombectomy procedure is associated with a 22–25% increase in the odds of achieving functional independence
Neurointerventionists ‘can rarely recover payment’ for...
Highlights:
New research finds that each hour saved between acute ischaemic stroke symptom onset and initiating a mechanical thrombectomy procedure is associated with a 22–25% increase in the odds of achieving functional independence
Neurointerventionists ‘can rarely recover payment’ for...
In a guest piece for NeuroNews, Blaise Baxter (San Francisco, USA) discusses empathy and compassion in the working life of a neurointerventionist, and highlights the integral importance of maintaining positive doctor-patient relationships.
The day is off to a familiar start....
Simcere Pharmaceutical Group has announced that a new study with major clinical findings regarding Sanbexin—an edaravone-dexborneol concentrated solution for injection—was recently presented at the 16th World Stroke Congress (WSC; 23–26 October, Abu Dhabi, United Arab Emirates). According to the data,...
A systematic review and meta-analysis of five studies and more than 11,000 patient records has indicated that each hour saved between acute ischaemic stroke symptom onset and initiating a mechanical thrombectomy procedure is associated with a 22–25% increase in...
Prolong Pharmaceuticals has announced that its investigational therapy—PEGylated carboxyhemoglobin, bovine (PP-007)—has received a fast-track designation from the US Food and Drug Administration (FDA) for the treatment of acute ischaemic stroke. PP-007 is currently being evaluated for safety and efficacy...
New research, published this month in the journal Stroke, has demonstrated the key role quality improvement programmes play in ensuring hospitals can adequately tackle the public health threat of stroke in the USA.
The research in question indicates that ‘Get With...
Today, on World Stroke Day (29 October), here is a timely reminder that stroke is the second leading cause of death globally. Despite the revolution offered by mechanical thrombectomy that began over a decade ago and the evidence base...
On World Stroke Day (29 October), Terumo Neuro has announced that it has partnered with Tulane University School of Medicine (New Orleans, USA) and Kendrick Johnson—assistant professor of neurosurgery at the medical school—to release an educational video focused on raising awareness...
Today, on World Stroke Day (29 October), the World Stroke Organization (WSO) has announced the launch of a global coalition aimed at accelerating policy action on stroke—which is currently the second leading cause of death and the third leading...
Royal Philips and Medtronic Neurovascular today announced a strategic advocacy partnership that will see the two companies attempt to raise awareness around potential health and economic benefits for patients, their families, and societies, regarding improved access to timely stroke...
This year, 25 October marks a full decade since the initial presentation of results from the MR CLEAN randomised controlled trial (RCT), which—along with multiple other RCTs—instigated the rapid expansion of mechanical thrombectomy in the treatment of acute ischaemic...
Remedy Pharmaceuticals has announced that the US Food and Drug Administration (FDA) Office of Orphan Products Division (OOPD) has granted orphan drug designation to its stroke drug Cirara for the treatment of large-territory acute ischaemic stroke—which includes large hemispheric...
This advertorial is sponsored by Acandis.
While intracranial stents are among the devices most commonly used by neurointerventionists, one challenge that hampers their utilisation in routine practice is thrombogenicity. However, HEAL (Acandis)—a novel coating technology applied to the surface of...
Contego Medical today announced the US Food and Drug Administration's (FDA) premarket approval (PMA) of the Neuroguard IEP system for carotid revascularisation.
The company shares in a press release that clinical studies of the Neuroguard IEP system, including the PERFORMANCE...
Penumbra has announced the completion of enrolment in its THUNDER investigational device exemption (IDE) clinical study for patients with acute ischaemic stroke.
THUNDER is evaluating the safety and efficacy of the company’s latest computer-assisted vacuum thrombectomy (CAVT) technology—the Penumbra system...
The European Society of Minimally Invasive Neurological Therapy (ESMINT) and the European Society of Neuroradiology (ESNR) have today announced the signing of a memorandum of understanding (MoU) agreement, as the two societies look to formalise their collaboration.
The purpose of...
Borvo Medical has announced US Food and Drug Administration (FDA) 510(k) clearance of the Borvo Endoport Vacuum-Assisted Collection (EVAC) system—an advanced alternative to traditional subdural haematoma (SDH) drainage methods. In addition, Borvo recently presented its innovative technology at the...
InspireMD has announced US Food and Drug Administration (FDA) approval of the company’s investigational device exemption (IDE) application to initiate the CGUARDIANS II pivotal study of its CGuard Prime 80cm carotid stent system during transcarotid artery revascularisation (TCAR) procedures.
In...
Leo Nelson (Nick) Hopkins, a world-renowned surgeon, researcher and innovator who played a pioneering role in modern neurosurgery’s shift from open- to endovascular-first techniques, has died aged 81. Hopkins passed away on 5 October at the Gates Vascular Institute...
Significant updates from key industry players including Microvention (now Terumo Neuro), Stryker and Johnson & Johnson MedTech Neurovascular dominate the list of NeuroNews’ most popular stories from September. A new study investigating tiny ‘magnetic robot armies’ as a means...
Findings from a retrospective analysis presented at the recent European Society for Vascular Surgery (ESVS) annual meeting (24–27 September, Kraków, Poland) provide evidence that—for symptomatic carotid artery stenosis patients—endarterectomy “remains a useful and relevant intervention in the era of...
A new study has found that neurointerventionists have “essentially no financially viable access to payment recovery” through the US No Surprises Act (NSA) for professional mechanical thrombectomy out-of-network (OON) claims. The study—led by the Harvey L Neiman Health Policy...
New study data suggest that the interventional treatment of symptomatic carotid artery disease may result in an improved rate of age-adjusted overall survival compared to medical management. However, the same study—presented at this year’s European Society for Vascular Surgery...
Siemens Healthineers has announced today that it will be joining forces with more than 20 industry and public partners—including seven leading stroke hospitals—to improve stroke management for patients across Europe. With a total volume of €26.9 million, the five-year...
Synchron has announced positive results from the COMMAND study evaluating the safety and efficacy of the company’s Stentrode brain-computer interface (BCI) device in six patients over a 12-month period.
The study results were presented yesterday at the 2024 Congress of...
Viz.ai has announced clinical data validating the impact of Viz LVO in the management and outcomes of patients with large vessel occlusion (LVO) ischaemic stroke. Viz LVO—part of the Viz Neuro suite of artificial intelligence (AI)-powered solutions—automatically detects and...
The Royal London Hospital (London, UK) has become the first in Europe to use an innovative balloon guide catheter (BGC) called Emboguard (Johnson & Johnson MedTech Neurovascular) for mechanical thrombectomy procedures in clinical practice.
“Timely and effective treatment of stroke...
Inbrain Neuroelectronics has announced the “world’s first” human procedure involving its cortical brain-computer interface (BCI) in a patient undergoing brain tumour resection. According to a press release from the company, its BCI technology was able to differentiate between healthy...
The latest analysis of the Global Burden of Disease, Injuries and Risk Factors study (GBD), assessing data ranging from 1990–2021, has indicated that roughly half of all healthy years of life lost due to stroke worldwide are caused by...
Boston Scientific has announced the close of its acquisition of Silk Road Medical—a medical device company that has pioneered a new approach for stroke prevention and the treatment of carotid artery disease through the minimally invasive transcarotid artery revascularisation (TCAR) procedure.
Boston...
NOTE: This video is ONLY available to watch in selected countries and geographies
Jan-Karl Burkhardt (Penn Medicine, Philadelphia, USA) sat down with NeuroNews at this year’s Society of NeuroInterventional Surgery (SNIS) annual meeting (22–26 July, Colorado Springs, USA) to...
Nevro Corporation has announced the US Food and Drug Administration (FDA) approval and limited market release of HFX iQ with HFX AdaptivAI—a responsive, personalised pain management platform powering the HFX iQ spinal cord stimulation (SCS) system.
Building on a foundation...
Toro Neurovascular has announced the successful treatment of the first patient using its Toro 88 SuperBore aspiration catheter as part of a first-in-man clinical study. The procedure—performed by Nobuyuki Sakai and his staff at Seijinkai Shimizu Hospital in Kyoto,...
Hyperfine has announced the presentation of interim data supporting the role portable, ultra-low-field magnetic resonance imaging (MRI) can play in acute stroke workup in a hospital emergency department setting.
Findings from the study, titled “Interim analysis from single-centre observational study of ultra-low-field...
Route 92 Medical has announced a new US$50 million extension to its previously announced, oversubscribed Series F financing, bringing the total raised to US$82 million. Novo Holdings joined returning investors US Venture Partners, Norwest Venture Partners, InnovaHealth Partners, and...
Johnson & Johnson (J&J) recently shared that its medical technology businesses—including Cerenovus and Biosense Webster, as well as Abiomed, DePuy Synthes, and Ethicon—will now go by the name ‘Johnson & Johnson MedTech’.
This move “underscores J&J’s leadership in medical technology with...
An analysis presented at this year’s European Society of Minimally Invasive Neurological Therapy (ESMINT) congress (4–6 September, Marseille, France) has indicated that flow diverters are “particularly effective” in the treatment of unruptured, distal anterior cerebral artery (ACA) aneurysms, while...
Stryker has announced that it has completed the acquisition of Nico Corporation—a company attempting to provide a systematic approach to minimally invasive surgery for tumour and intracerebral haemorrhage (ICH) procedures.
As noted in a recent company press release, this acquisition...
Following her recent appointment as Q’Apel Medical’s new chief executive officer (CEO), Jodie Fam sat down with NeuroNews to discuss the current landscape of the neurovascular device space.
Speaking at the 2024 Society of NeuroInterventional Surgery (SNIS) annual meeting (22–26...
Axonics has announced that the jury has returned a unanimous verdict in the patent infringement lawsuit brought by Medtronic against the company in US District Court for the Central District of California in the USA.
The jury found that Axonics...
Sim&Cure and Siemens Healthineers have announced a strategic partnership aimed at enhancing patient care and advancing brain aneurysm treatment.
A recent press release from the two companies notes that “immediate medical intervention is crucial for ruptured aneurysms”, while “proactive management...
Patients with unruptured brain arteriovenous malformations (AVMs) who are allocated to conservative management, or ‘observation’, experience a low rate of neurological events, according to an analysis of the TOBAS registry presented recently by Jean-Christophe Gentric (Cavale Blanche Hospital, Brest,...
Interventional neuroradiologist Anne-Christine Januel (Toulouse University Hospital, Toulouse, France) has been elected as the new president of the European Society of Minimally Invasive Neurological Therapy (ESMINT).
The recent ESMINT congress (4–6 September 2024, Marseille, France) saw Januel succeed Zsolt Kulcsár (University...
Microvention, a wholly owned subsidiary of Terumo Corporation, has today announced its official rebranding to Terumo Neuro, effective immediately.
This name change signifies a new chapter in the company’s evolution while maintaining its unwavering commitment to the creation and commercialisation...
Oxford Heartbeat has today announced that the clinical impact trial of its artificial intelligence (AI)-powered PreSize Neurovascular software has successfully completed patient recruitment.
A company press release describes this as a “huge milestone” as the trial—which is funded by the UK’s National...
Researchers have created nanoscale robots that could be used to manage bleeds in the brain caused by aneurysms, potentially enabling a more precise and relatively low-risk treatment approach.
A study published recently in the journal Small “points to a future...
A number of highlights from the 2024 Society of NeuroInterventional Surgery (SNIS) annual meeting (22–26 July, Colorado Springs, USA) populate our list of most-read stories from August. In addition, an exclusive interview with a team of physicians hoping to...
Royal Philips and the World Stroke Organization (WSO) have published a joint policy paper calling for a “revolution in stroke care” to make a real difference to the lives of millions and bring significant economic benefits worldwide.
A Philips press release notes that, thanks to...
Remedy Pharmaceuticals recently announced promising new data from the Phase 3 CHARM clinical trial of Cirara (intravenous glyburide) in patients with large hemispheric infarction (LHI)—a serious form of ischaemic stroke characterised by large volume lesions that can lead to malignant...
RapidAI and the Alaska Stroke Coalition (ASC) have announced their partnership on the ‘Rapid AK’ project—a three-year initiative focused on advancing health equity for Alaskans affected by stroke. As part of the effort, six hospitals across the US state...
Mass screening for atrial fibrillation (AF) using electrocardiography (ECG) together with a heart failure biomarker does not prevent ischaemic stroke or systemic in older adults—aged 75–76 years—over five years of follow-up. However, the biomarker in question may improve the...
Hereditary Brain Aneurysm (HBA) Support—a not-for-profit organisation providing information and support for individuals and families affected by hereditary brain aneurysms—has announced the upcoming launch of multiple projects intended to improve care and support for patients with familial brain aneurysms.
In...
Evasc Neurovascular recently announced a “landmark achievement” during the 2024 European Society of Minimally Invasive Neurological Therapy (ESMINT) congress (4–6 September, Marseille, France), reporting that more than 300 patients have been successfully treated with the company’s Eclips device.
As per...
The Society for Vascular Surgery Vascular Quality Initiative (SVS VQI) clinical registry has announced the Carotid Care Quality Champion recognition programme.
The programme honours healthcare organisations across the USA dedicated to improving the safety and effectiveness of vascular care through...
Rapid Medical has announced completion of the interim safety analysis from the multicentre, pivotal DISTALS study, reporting no safety concerns in medium vessel occlusions at the ongoing European Society of Minimally Invasive Neurological Therapy (ESMINT) congress (4–6 September, Marseille,...
Among brain aneurysm patients, the risk of developing a mental health condition has been found to be higher as compared to among peers without an aneurysm—and the highest risk was seen in patients younger than 40 years of age....
In a guest piece for NeuroNews, Carmen Parra-Fariñas (Toronto, Canada) discusses some of the key considerations that distinguish the growing, dedicated field of paediatric interventional neuroradiology (INR) from the treatment of adult neurovascular disease patients.
Neurovascular pathologies are a significant...
Clearmind Biomedical has received US Food and Drug Administration (FDA) 510(k) clearance for its Neuroblade system—a novel neuroendoscopy system that enables minimally invasive procedures with integrated features like visualisation, illumination, irrigation, suction, coagulation, and powered debridement.
The company has also...
Cerevasc has announced it has received Breakthrough Device designation from the US Food and Drug Administration (FDA) for its eShunt system, which is intended for the treatment of normal-pressure hydrocephalus (NPH).
The Breakthrough Device designation was supported by data...
This advertorial is sponsored by WallabyPhenox.
Ahead of the COATING study’s much-anticipated final analyses, principal investigator Laurent Pierot (Reims University Hospitals, Reims, France) sits down with NeuroNews to outline the “tremendous impact” he feels its results will have on the...
Highlights:
First-time COAST study results as well as several other highlights from the 2024 Society of NeuroInterventional Surgery (SNIS) annual meeting (22–26 July, Colorado Springs, USA)
Insights on the emerging, specific field of paediatric interventional neuroradiology (INR) from Carmen...
Highlights:
First-time COAST study results as well as several other highlights from the 2024 Society of NeuroInterventional Surgery (SNIS) annual meeting (22–26 July, Colorado Springs, USA)
Insights on the emerging, specific field of paediatric interventional neuroradiology (INR) from Carmen...
AtriCure has received an expanded indication for the AtriClip left atrial appendage (LAA) exclusion system in CE-marked countries in Europe.
The product is now indicated for use in patients at high risk of thromboembolism for whom LAA exclusion is warranted.
The...
A UK clinical trial evaluating deep brain stimulation (DBS) in children with epilepsy recently got underway—and a teenager who was the patient to take part in the study has seen his daytime seizures reduced by 80%.
In October 2023, 12-year-old...
Throughout his life and career, Christophe Cognard (Toulouse, France) has always sought to help advance the interventional neuroradiology (INR) space, and make the management of neurovascular diseases as multidisciplinary and collaborative as possible. Notable examples include his efforts as...
Amplitude Vascular Systems (AVS), developer of the Pulse intravascular lithotripsy (IVL) platform, and the Jacobs Institute, a non-profit medical device innovation centre in Buffalo, USA, are set to partner on a study of the Pulse IVL system.
This partnership will...
While the recently presented SEGA trial and many other studies have attempted to establish which of the two prevalent methods for medically inducing a loss of consciousness during a mechanical thrombectomy procedure is best, the neurointerventional community remains divided....
A new brain-computer interface (BCI) developed at University of California (UC) Davis Health (Sacramento, USA) has allowed a man with severely impaired speech due to amyotrophic lateral sclerosis (ALS) to communicate by transforming his brain activity into text—which is...
Medtronic has received US Food and Drug Administration (FDA) approval of asleep deep brain stimulation (DBS) surgery for people with Parkinson’s disease and people with essential tremor. Medtronic claims that, in the process, it has become the first and...
Johanna T Fifi, an interventional neurologist at Mount Sinai Hospital (New York, USA), has been named the 2024–2025 president of the Society of NeuroInterventional Surgery (SNIS).
An SNIS press release notes that, as president, Fifi will lead the society in...
Arissa Medical has announced the third enrolment of patients into its Syntra study—an early feasibility pilot study evaluating the safety and efficacy of the company’s Syntra device for the treatment of irregular, wide-necked sidewall and wide-necked bifurcation cerebral aneurysms.
Third-cohort...
Industry updates—including several revealed during this year’s Society of NeuroInterventional Surgery (SNIS) annual meeting (22–26 July, Colorado Springs, USA)—garnered much of our readers’ attention throughout July. Alongside a number of news items on the latest neurovascular catheter technologies, late-breaking...
Contego Medical recently announced that Mitchell Silver, an interventional cardiologist and vascular medicine specialist, has joined the team as chief medical officer (CMO).
A press release notes that Silver will play a pivotal role in shaping the company's clinical strategy...
Magnus Medical has announced promising new clinical data on its Stanford accelerated intelligent neuromodulation therapy (SAINT) at the 2024 NYC Neuromodulation Conference (31 July–4 August, New York City, USA). The research was showcased in two poster presentations demonstrating the...
Medical Microinstruments (MMI) recently announced the completion of a preclinical study that demonstrated the feasibility of the Symani surgical system in neurosurgical procedures. Adnan Siddiqui (Jacobs Institute, Buffalo, USA) successfully repaired a blood vessel in the brain in an animal...
Synchron has announced the world’s first-ever use of Apple Vision Pro by one of the patients implanted with the Synchron brain-computer interface (BCI).
Mark, a 64-year-old man with amyotrophic lateral sclerosis (ALS), successfully used his direct thoughts to control the...
The growth of intravenous thrombolysis (IVT) coupled with the advent—and ongoing expansion—of mechanical thrombectomy has seen acute stroke transform from “a diagnosable and hardly treatable condition, to a highly treatable condition”, over the past two decades. However, significant disparities...
Potentially groundbreaking research was presented recently at the Society of NeuroInterventional Surgery (SNIS) annual meeting (22–26 July, Colorado Springs, USA), with Robert Starke (University of Miami Miller School of Medicine, Miami, USA) introducing a novel outcome metric, dubbed ‘complete...
Gravity Medical Technology has announced the launch of its next-generation stroke treatment devices: the Neutron aspiration catheter and the Supernova stent retriever. Early adoption has demonstrated the successful treatment of more than 60 patients worldwide, according to a company...
InspireMD today congratulated the lead investigators on the completion of enrolment in the CREST-2 clinical trials.
The CGuard embolic prevention stent system (EPS), utilising InspireMD's MicroNet mesh, was included as a device option for stenting in the CREST-2 trials...
Two data analyses presented at the recent Society of NeuroInterventional Surgery (SNIS) annual meeting (22–26 July, Colorado Springs, USA) have revealed new insights on the role of rescue stenting following failed mechanical thrombectomy, with one indicating parity between different...
Silk Road Medical has announced the milestone of more than 100,000 transcarotid artery revascularisation (TCAR) procedures having been performed to date.
“A growing number of patients come to us looking for a solution that is minimally invasive and requires less...
Coil embolisation of smaller intracranial aneurysms—those less than 5mm in size—has been found to be a safe approach, as per data presented for the first time at the 2024 Society of NeuroInterventional Surgery (SNIS) annual meeting (22–26 July, Colorado...
Navigantis has announced the closing of a US$12 million Series A financing led by Puma Venture Capital, with participation from Cormorant Asset Management and Mirae Asset Capital. All existing Navigantis investors participated in the financing round. In addition, Amit Hazan—founder and managing...
Despite mechanical thrombectomy’s high success rate in saving the lives of stroke patients, Medicare is paying lower rates over time for the procedure in the USA. That is according to three separate studies presented earlier this week at the...
Brainomix has announced new data from studies that were presented this week at the Society of NeuroInterventional Surgery (SNIS) annual meeting (22–26 July, Colorado Springs, USA). The research was conducted in collaboration with the Mayo Clinic (Rochester, USA), West Virginia...
Patients who undergo carotid revascularisation at the weekend have increased odds of complications and mortality, with transfemoral carotid artery stenting (TFCAS) posing the highest risk and transcarotid artery revascularisation (TCAR) the lowest, compared to carotid endarterectomy (CEA). This is...
Research presented earlier this week at the Society of NeuroInterventional Surgery (SNIS) annual meeting (22–26 July, Colorado Springs, USA) has highlighted the effect of socioeconomic variables and their role in successful recovery after stroke surgery—specifically, the impact of living...
Non-English-speaking patients are less likely to arrive by ambulance when experiencing stroke symptoms, and also less likely to receive a mechanical thrombectomy procedure, according to research released at the 2024 Society of NeuroInterventional Surgery (SNIS) annual meeting (22–26 July,...
Radical Catheter Technologies has announced 510(k) clearance by the US Food and Drug Administration (FDA) for its Radical catheter—which, the company claims in a recent press release, is “the first significant advance in catheter technology in more than three...
The modified Rankin scale (mRS) is something of a default clinical outcome metric in many contemporary stroke studies, but—as Eva Mistry and Paul Wechsler (both Cincinnati, USA) write in this NeuroNews guest article—represents an imperfect method for measuring success,...
Spryte Medical has announced that its neuro optical coherence tomography (nOCT) technology has been granted Breakthrough Device designation by the US Food and Drug Administration (FDA). This recognition underscores the “transformative potential” of nOCT in neurointervention and cerebrovascular treatment, the company...
Imperative Care has announced that late-breaking data from the Imperative trial were presented recently at the ongoing Society of NeuroInterventional Surgery (SNIS) annual meeting (22–26 July, Colorado Springs, USA). The prospective, multicentre clinical trial evaluated the clinical benefits of...
There is a potential connection between a diagnosis of certain gastrointestinal (GI) syndromes, and the formation and rupture of intracranial aneurysms, according to research presented this week at the Society of NeuroInterventional Surgery (SNIS) annual meeting (22–26 July, Colorado Springs,...
Arsenal Medical has announced that NeoCast—a first-of-its-kind, shear-responsive liquid embolic material designed for deep distal penetration—met its primary feasibility and safety endpoints in the open-label, multicentre, prospective EMBO-01 clinical trial. These data were presented earlier today at the 2024...
Microvention, a wholly owned subsidiary of Terumo Corporation, has announced the recent publication in the Journal of NeuroInterventional Surgery (JNIS) of one-year results from CLEVER—a study that sought to provide a clinical evaluation with the Woven EndoBridge (WEB) 17...
Changing standard procedures for evaluating and treating patients with suspected stroke has led to improved access to lifesaving stroke surgery across the US state of Delaware, and should inform triage and treatment nationwide, according to research released yesterday at...
Rapid Medical has announced the first procedures in the USA with the breakthrough deflectable access platform Drivewire 24, doing so at the ongoing Society of NeuroInterventional Surgery (SNIS) annual meeting (22–26 July, Colorado Springs, USA). This milestone follows the US...
Worsening air quality and temperature extremes are linked to increased stroke burden, according to a study presented at this year’s Society of NeuroInterventional Surgery (SNIS) annual meeting (22–26 July, Colorado Springs, USA). This trend was found to disproportionately impact...
Q'Apel Medical has announced the appointment of Jodie Fam as its new chief executive officer (CEO). With more than two decades in the medical device industry, Fam has held executive leadership positions at multiple medical device companies, including public...
Route 92 Medical today announced the commercial launch of the FreeClimb 88 catheter system comprising the FreeClimb 88 catheter and the Tenzing 8 delivery catheter—all designed to work with the Base Camp sheath.
The US Food and Drug Administration (FDA)...
Saluda Medical has announced the recent presentation of two abstracts analysing biomarker-based spinal cord stimulation (SCS) data at the 2024 American Society of Pain and Neuroscience (ASPN) annual conference (11–14 July, Miami, USA).
The abstracts—which were among 10 total...
Anaconda Biomed has announced that it has received conditional investigational device exemption (IDE) approval from the US Food and Drug Administration (FDA) to begin the ATHENA study of its ANA funnel catheter. This prospective, randomised, dual-arm, multicentre study will assess the...
Cerevasc has announced two new appointments to the company’s board of directors. Shlomi Nachman, former company group chairman of Cardiovascular and Specialty Solutions and Vision Groups within Johnson & Johnson’s Medical Devices sector, and Timothy Scannell, former president and...
Imperative Care has announced US Food and Drug Administration (FDA) 510(k) clearance of its Zoom 6Fr insert catheters, the company’s latest innovation in elevating stroke care and—as stated in an Imperative press release—the first insert catheters developed specifically for...
Boston Scientific Corporation has announced the presentation of positive five-year pooled results for the Intracept intraosseous nerve ablation system, measuring outcomes across three clinical trials in the treatment of vertebrogenic low back pain. The data were presented at the...
Mainstay Medical has announced that it has received regulatory approvals in the European Union, the UK and Australia of full-body magnetic resonance imaging (MRI) conditional labelling for the ReActiv8 restorative neurostimulation system.
As a result, all current and future ReActiv8...
Sensome has announced an exclusive distribution agreement in Japan with Cosmotec, an M3 Group company, for its smart clot-sensing guidewire used in mechanical thrombectomy. Cosmotec made an upfront investment in Sensome upon finalising the agreement, as noted in a...
A number of major players in the neurovascular device industry—including Medtronic, Microvention/Terumo and Penumbra—announced newly launched technologies throughout June. These updates, coupled with insights on recently published HEMERA-1 trial data, an exclusive interview with neurosurgeon Adnan Siddiqui, and a...
The Ottawa Hospital (TOH) in Ottawa, Canada has successfully adopted Vena Medical's Balloon Distal Access Catheter (BDAC) into its stroke treatment protocol. This follows a comprehensive evaluation through the Ontario Bioscience Innovation Organization’s (OBIO) Early Adopter Health Network (EAHN),...
Vesalio has launched a NeVa NET 4mm device to treat acute ischaemic stroke due to large vessel occlusion, a press release reports.
The company states that this introduction builds on the success of NeVa NET 5.5mm in international markets,...
Microvention, a wholly owned subsidiary of Terumo Corporation, has today announced the publication of data from SOFAST—a prospective, multicentre US study assessing the efficacy and safety of the 6Fr Sofia flow plus aspiration catheter as a first-line endovascular stroke...
Avicenna.AI has received Medical Device Regulation (MDR) certification for five of its algorithms from British Standards Institution (BSI) Medical Devices—a development that means the company's product portfolio is fully compliant with the European Union's (EU) MDR 2017/745, which is...
New data presented at the 2024 Vascular Annual Meeting (VAM; 19–22 June, Chicago, USA) have revealed poor overall rates of medical therapy adherence in moderate asymptomatic carotid stenosis patients—with smoking cessation representing a “ripe target” for improvement moving forward.
“The...
Following their initial presentation earlier this year, two randomised controlled trials (RCTs) indicating positive outcomes with middle meningeal artery (MMA) embolisation in chronic subdural haematoma (cSDH) patients were discussed in greater detail at the recent LINNC Paris meeting (3–5...
The American Academy of Neurology (AAN) and American Heart Association (AHA) have awarded the first-ever Ralph L Sacco Scholarships for Brain Health to two researchers, Patrick Devlin (University of Texas Health Science Center, Houston, USA) and Cyprien Rivier (Yale...
Evasc Neurovascular has announced the successful use of the Eclips Short Landing Zone device in treating all anterior communicating artery (ACOM) and middle cerebral artery (MCA) bifurcation aneurysms. The first successful case using this pioneering device was performed by...
“I think complication discussion is one of the most important parts of our job,” said Edoardo Boccardi (Niguarda Hospital, Milan, Italy), prefacing his presentation of a neurointerventional case at LINNC Paris 2024 (3–5 June, Paris, France). As part of...
The European Society of Minimally Invasive Neurological Therapy (ESMINT) has signed a memorandum of understanding (MOU) with the French Society of Neuroradiology (SFNR) in an effort to acknowledge their shared goals and interests.
The two societies have established a formal...
Zeto has revealed the winners of its 2024 Clinical Trial Sponsorship programme. This initiative, announced at the 2023 Society for Neuroscience Convention (11–15 November, Washington, D.C.), invited research teams to submit proposals for clinical trials using the Zeto electroencephalography...
Microvention, a wholly owned subsidiary of Terumo Corporation, announced today that the LVIS EVO intraluminal support device is now commercially available for the treatment of wide-neck intracranial aneurysms in the USA.
"I’ve really enjoyed getting to use and know EVO,”...
NeuroOne Medical Technologies Corporation has announced that the OneRF ablation system was recently used at a prestigious hospital located in Jacksonville, USA to successfully complete five ablations in one patient.
According to a company press release, the patient was suffering...
The use of robots in the autonomous treatment of stroke patients could widen access to time-sensitive emergency mechanical thrombectomy procedures, as evidenced by a recent paper from researchers at King’s College London (London, UK).
In the paper—now published online in...
Boston Scientific Corporation has obtained a CE mark for the Vercise neural navigator 5 software with STIMVIEW XT technology, which—when used as part of the Vercise Genus deep brain stimulation (DBS) systems—can provide clinicians with simple and actionable data...
A study examining outcomes between different carotid revascularisation procedures has concluded that transcarotid artery revascularisation (TCAR) and carotid endarterectomy (CEA) both represent a “reasonable choice” in severe chronic kidney disease (CKD) and haemodialysis patients—but transfemoral carotid artery stenting (TF-CAS)...
High stroke and death rates relating to carotid stenting in the Pacific Northwest of the USA may be driven by the selection of high-risk patients with less than 80% stenosis, and reducing the frequency of stenting in this high-risk...
Penumbra has announced the CE mark and European launch of BMX81 and BMX96—devices designed for the neurovascular management of ischaemic and haemorrhagic stroke. A company press release also notes that these technologies constitute Penumbra’s most advanced neuro access offerings.
This...
Boston Scientific has announced that it has entered into a definitive agreement to acquire Silk Road Medical, a medical device company involved in producing products to be deployed during transcarotid artery revascularisation (TCAR). The purchase price is US$27.50 per...
When it comes to the ongoing debate of carotid endarterectomy (CEA) versus transcarotid artery revascularisation (TCAR) in the treatment of carotid artery stenosis, operators should be comfortable and maintain experience with both of these procedures—and “collaborate as needed.” That...
The European Stroke Organisation (ESO) Executive Committee’s Thrombolysis Taskforce has provided “important updates” regarding the security of supply for Metalyse (tenecteplase) and Actilyse (alteplase) in the context of the European launch of Metalyse 25mg for acute ischaemic stroke treatment....
In a systematic review and meta-analysis of the current literature, deep brain stimulation (DBS) with a short pulse width has been shown to potentially induce more tremor reduction in essential tremor patients, but does not appear to offer a...
Siemens Healthineers and the World Stroke Organization (WSO) have announced a two-year partnership to develop the acute stroke workforce, and improve treatment and care for stroke.
Stroke is the second-leading cause of death and the third-leading cause of disability in...
Zeto has announced that its innovative, next-generation brain monitoring product, named the ONE, has received 510(k) clearance from the US Food and Drug Administration (FDA).
"Zeto ONE is a breakthrough EEG system, revolutionising many aspects of emergency EEG acquisition,” said...
Global conference coverage piqued NeuroNews readers’ interest through the month of May—initially with discussions at the Charing Cross (CX) International Symposium (23–25 April, London, UK) and, later, thanks to new trial data presented at this year’s European Stroke Organisation...
While he is a neurosurgeon by trade, Adnan Siddiqui (Buffalo, USA) has delved into an increasing number of domains throughout his career—not only through his interest in endovascular treatments and the neurosciences, but also via significant involvement in clinical...
Nalu Medical has revealed findings from a landmark clinical trial evaluating its Nalu peripheral nerve stimulation (PNS) system, utilising the company’s proprietary micro-implantable pulse generator (micro-IPG) to treat chronic pain patients.
Nalu’s COMFORT study is a post-market, multicentre randomised controlled...
In acknowledgement of their shared goals and interests, the European Society of Minimally Invasive Neurological Therapy (ESMINT) and the German Society of Neuroradiology (DGNR) announced today that they have formalised a collaboration to define joint actions, achieve the best possible...
Earlier today, Sensome announced positive results from its first-in-human CLOT OUT clinical trial evaluating the safety and performance of the company’s Clotild smart guidewire system used during mechanical thrombectomy treatments for ischaemic stroke. The results showed that the technology...
Medtronic has today announced the European launch of Artisse—a new intrasaccular device designed to treat intracranial aneurysms by conforming to the shape of the aneurysm. The launch coincides with interim data that examine the safety, efficacy and performance of...
In what has been described as the first study of its kind, researchers from the Keck School of Medicine at the University of Southern California (USC) in Los Angeles, USA and the California Institute of Technology (Caltech) recently designed...
This advertorial, intended for readers outside the USA only, is sponsored by Medtronic.
In light of the official European launch of the Artisse aneurysm embolisation system (Medtronic) at LINNC Paris 2024 (3–5 June, Paris, France), NeuroNews speaks to three of...
Following the recent publication in Stroke: Vascular and Interventional Neurology of results from HEMERA-1, a prospective, multicentre trial evaluating the safety of novel neuroprotective agent PP-007 (Prolong Pharmaceuticals) alongside mechanical thrombectomy in acute stroke patients, lead investigator Italo Linfante...
Intravenous thrombolysis (IVT) prior to a mechanical thrombectomy procedure appears to be less effective in ischaemic stroke patients with carotid-artery tandem lesions, as compared to in patients without tandem lesions, according to the findings of a MR CLEAN-NO IV...
Seven-year data from the Chinese CASSISS trial have, in the investigators’ view, provided “compelling evidence” that percutaneous transluminal angioplasty and stenting (PTAS) plus medical therapy does not confer additional benefits over medical therapy alone in patients with symptomatic, severe...
The use of a smartphone-based mobile application may be an effective method for improving medication adherence and risk-factor control among stroke survivors, and appears to be a feasible approach in low- and middle-income countries (LMICs). This is the salient...
This year’s European Stroke Organisation Conference (ESOC; 15–17 May, Basel, Switzerland) saw a plethora of data on intravenous tenecteplase—from studies spanning Australia, Canada, China, Europe, and beyond—presented for the first time. Fresh findings from the ATTENTION-IA, ORIGINAL, TASTE, TEMPO-2...
Ceretrieve has announced the successful results of the company's multicentre, single-arm study, showcasing the capabilities of its “state-of-the-art” aspiration catheter in stroke treatment.
The study—conducted across two centres—included 20 patients suffering from acute ischaemic stroke due to intracranial large vessel occlusion (LVO)...
Medtronic has today announced that Linnea Burman will succeed Dan Volz as its senior vice president (SVP) and president of its Neurovascular business—part of the company’s Neuroscience portfolio.
In her new capacity, Burman will be responsible for portfolio strategy, product...
New data from the C-GUARDIANS pivotal investigational device exemption (IDE) trial support consideration of carotid artery stenting (CAS) with the CGuard embolic prevention stent system (EPS; InspireMD) as a "frontline therapeutic option for appropriate patients being considered for carotid...
Spryte Medical has announced the publication of a first-in-human study of its neuro optical coherence tomography (nOCT) technology in the peer-reviewed journal Science Translational Medicine, in a paper entitled, “Volumetric microscopy of cerebral arteries with a miniaturised optical coherence tomography imaging...
This advertorial, intended for US readers only, is sponsored by Q’Apel Medical.
Hot on the heels of the device’s Food and Drug Administration (FDA) clearance and subsequent US launch, Jan-Karl Burkhardt (Penn Medicine, Philadelphia, USA) and Omar Tanweer (Baylor College...
A number of somewhat conflicting studies have been published over the past year regarding triage and transport protocols for stroke. In light of the most recent of these publications, NeuroNews speaks to Ashutosh Jadhav (Barrow Neurological Institute, Phoenix, USA)...
AiM Medical Robotics has announced a collaboration with Brigham and Women's Hospital (BWH; Boston, USA), and the Surgical Navigation and Robotics (SNR) Lab at Harvard, to validate its cutting-edge robot for deep brain stimulation (DBS) in Parkinson's disease patients. AiM recently entered into a clinical...
Three papers published in the journal Stroke have highlighted multidisciplinary care and global, collaborative efforts as “paramount” in the management of intracranial aneurysms, chronic subdural haematomas (cSDHs), and brain arteriovenous malformations (AVMs). These recommendations were led by the Aneurysm/AVM/cSDH...
Vesalio is set to welcome J D McCulloch as its chief financial officer (CFO) for overseeing all financial aspects of the business, and helping drive the company’s financial strategy and business development. According to a press release, he will...
XCath has announced the successful completion of a “first-of-its-kind” live telerobotic trial for stroke treatment, which took place between Abu Dhabi, United Arab Emirates (UAE) and Seoul, South Korea at Abu Dhabi Global Healthcare Week (ADGHW; 13–15 May, Abu Dhabi, UAE).
In...
Despite the study very narrowly failing to meet its prespecified primary endpoint, the SWITCH randomised controlled trial has shown a substantial treatment effect with decompressive craniectomy procedures in people with severe, deep supratentorial intracranial haemorrhage (ICH). These findings were...
Highlights:
ARISE I recommendations on the management of intracranial aneurysms, chronic subdural haematomas (cSDHs) and brain arteriovenous malformations (AVMs)
First European presentation of PERFORMANCE II trial data and subsequent discussions at the 2024 Charing Cross (CX) International Symposium (23–25...
Highlights:
ARISE I recommendations on the management of intracranial aneurysms, chronic subdural haematomas (cSDHs) and brain arteriovenous malformations (AVMs)
First European presentation of PERFORMANCE II trial data and subsequent discussions at the 2024 Charing Cross (CX) International Symposium (23–25...
MagVenture has announced a partnership with Magnus Medical that is intended to provide its industry-leading MagPro magnetic stimulation system to support an “exciting new chapter” in therapeutic transcranial magnetic stimulation (TMS) through Magnus' SAINT neuromodulation system.
A company press release notes that...
While the randomised controlled SELECT2 trial initially found that patients with large-core ischaemic stroke receive a greater benefit from thrombectomy compared to medical management, a secondary analysis of data from the study has now shown that the benefits of...
The latest data from the INTERACT trials—a series of studies evaluating intensive blood-pressure (BP) lowering in acute haemorrhagic stroke—point towards the importance of initiating BP reduction as early as possible in patients with intracranial haemorrhage (ICH), but also highlight...
The TENSION trial, conducted across 41 hospitals in Europe and Canada, has unveiled new insights into the long-term efficacy of endovascular mechanical thrombectomy in patients suffering from acute ischaemic stroke caused by large infarcts. Götz Thomalla (University Medical Center...
Brainomix has announced that results from what it claims is the largest prospective study of stroke artificial intelligence (AI) software were presented yesterday at the European Stroke Organisation Conference (ESOC; 15–17 May, Basel, Switzerland), showing that the implementation of...
TACTICS, a non-randomised intervention trial that aimed to optimise workflow and implement specialised imaging, has shown promise in improving access to endovascular therapy (EVT) for patients in regional and rural areas of Australia.
“While EVT has revolutionised stroke treatment, access...
Rapid Medical has announced what it claims is the first successful robotic thrombectomy, in Medellín, Colombia. Two patients were treated with the robotic Tigertriever—an endovascular thrombectomy device that adapts autonomously to the patient’s anatomy.
“Automating stroke procedures is a significant...
New research, presented today at the 10th European Stroke Organisation Conference (ESOC 2024; 15–17 May, Basel, Switzerland), has revealed that high-income individuals have a 32% lower risk of post-stroke mortality. Additionally, those with a higher level of education have...
Cerevasc announced recently that it has successfully completed the initial closing of a US$70 million Series B financing, which was jointly led by Bain Capital Life Sciences and existing investor Perceptive Xontogeny Venture Fund (PXV), with additional participation from other existing...
Hyperfine has announced that it has entered into agreements with three experienced and accomplished distributors to support commercial expansion plans of the Swoop system—the “first” US Food and Drug Administration (FDA)-cleared portable magnetic resonance (MR) brain imaging system—into European...
Route 92 Medical is recalling specific lots of its products containing the Tenzing 7 delivery catheters due to multiple instances of distal-tip separation at the proximal marker band. This recall has been identified by the US Food and Drug...
An international, multicentre study has confirmed the existence of the carryover or ‘echo’ effect—an interval before patients perceive the return of pain after their spinal cord stimulation (SCS) system has been deactivated—and also indicated a “remarkably high” degree of...
NeuroNews’ top 10 most popular stories of April 2024 include the European launch of a new aspiration catheter for acute ischaemic stroke treatment, a study evaluating transradial versus transfemoral access approaches in mechanical thrombectomy, and the long-awaited publication of...
RapidAI has announced that the US Food and Drug Administration (FDA) has granted 510(k) clearance for its AngioFlow by RapidAI solution. As per a company press release, this module delivers perfusion imaging analysis directly within the interventional suite to promote greater...
The recent, first-time European presentation of the PERFORMANCE II trial’s findings—delivered by Ralf Langhoff (Sankt Gertrauden-Krankenhaus, Berlin, Germany) at the 2024 Charing Cross (CX) International Symposium (23–25 April, London, UK)—led delegates to discuss the role of stenting in carotid...
Today, Penumbra announced the launch of its Midway 43 and Midway 62 delivery catheters, which are designed to provide ideal tracking and a stable platform to support the delivery of various embolisation therapies in the neurovasculature. This news came...
The latest product innovation by Nico Corporation, the Myriad Spectra system, has been described as a "game-changing advancement" by neurosurgeons with early experience using the device. That is according to a company press release, which also details that Myriad...
Scientia Vascular has announced the US Food and Drug Administration (FDA) clearance of two uniquely engineered catheters: the Plato 17, a dimethyl sulfoxide (DMSO)-compatible microcatheter, and the Socrates 38, an aspiration catheter engineered for ischaemic stroke.
The introduction of...
An initial evaluation of vagus nerve stimulation (VNS) in narcolepsy patients has linked this neuromodulation modality to a “significant improvement” in daytime sleepiness, leading researchers to aver that VNS could be a promising non-medical treatment option for this condition...
MindRhythm has announced that results from the pilot phase of its three-phase clinical study, EPISODE, have been published in Academic Emergency Medicine. While pilot EPISODE data have been presented in various academic society forums, this is the first official...
A study presented at the recent American Academy of Neurology (AAN) annual meeting (13–18 April, Denver, USA) has gone some way to elucidating how two factors—patient age, and connectivity of electrodes to the subiculum-retrosplenial cortex (SBC-RSC)—may impact the cognitive...
Route 92 Medical has today announced receipt of US Food and Drug Administration (FDA) 510(k) clearance for the FreeClimb 54 reperfusion system, comprised of the FreeClimb 54 aspiration catheter paired with a Tenzing 5 delivery catheter.
This new system...
The European Society of Minimally Invasive Neurological Therapy (ESMINT) has issued a call for experts in neurointerventions to work with notified bodies over the certification process of medical devices within the European Union (EU).
The society recently established a Medical...
Viz.ai has announced a collaboration with Nico Corporation to improve the lives of patients with intracranial haemorrhages (ICHs), leveraging the former’s artificial intelligence (AI)-powered disease detection and intelligent care coordination products, and the latter’s modern, minimally invasive interventional technologies...
Insightec has announced the CE-mark approval and European launch of Exablate Prime, which the company describes as a “significant enhancement” to its Exablate Neuro platform—a magnetic resonance imaging (MRI)-guided neurosurgery system that uses focused ultrasound to treat medication-refractory essential...
A retrospective analysis including data from close to 3,000 stroke patients has concluded that early changes in mechanical thrombectomy strategies may be associated with higher reperfusion rates and therefore “should be contemplated” following failed attempts with first-line standalone contact-aspiration...
Cerenovus, part of Johnson & Johnson MedTech, has today announced the launch of its Cereglide 71 aspiration catheter in Europe, an aspiration catheter equipped with TruCourse technology, indicated for the revascularisation of patients suffering from acute ischaemic stroke.
The...
Cognito Therapeutics has announced treatment results from OVERTURE II—an open-label extension (OLE) study of Spectris, the company’s potential disease-modifying therapy for the treatment of Alzheimer’s disease. The results in question were presented at the 2024 American Academy of Neurology...
The past three decades have seen a “notable rise” in the burden of haemorrhagic stroke across the USA and this, coupled with the increasing burden of stroke more generally, represents an “evolving and substantial public health challenge” for the...
The entirety of the results from the ENRICH trial evaluating the early surgical removal of intracranial haemorrhage (ICH) have been published in the New England Journal of Medicine (NEJM). As stated in a Nico Corporation press release, ENRICH demonstrated early...
How is innovation in stroke care guided by contemporary clinical trials? This was the question NeuroNews put to Atul Gupta, the Chief Medical Officer of Diagnosis & Treatment at Philips, who discussed what he sees as the recent trials...
SpineX has closed recruitment for the CONTINENCE clinical trial of its proprietary Scone device. The study began back in May 2022 and is evaluating the company’s spinal cord stimulation (SCS) technology in the treatment of neurogenic bladder patients.
Scone is...
Synchron has announced the launch of a community-centred brain-computer interface (BCI) registry to bring patients, carers and clinicians together to learn how BCI technology is being designed to provide benefit to people with limited mobility.
Synchron’s BCI technology—primarily seen in...
Researchers have found that electroconvulsive therapy (ECT)—whereby an electric current is passed through the brain of a patient under general anaesthesia to induce a brief seizure—can reduce the severity of mental illnesses.
A recent study, which was presented at the...
NOTE: This video is ONLY available to watch in selected countries and geographies
Edgar Samaniego (University of Iowa, Iowa City, USA) discusses his experiences to date with one of the latest technologies in the mechanical thrombectomy space—the CEREGLIDE™ 71...
XCath has announced that it presented at the recent Stroke Live Course (SLICE) Next Frontiers conference (3–4 April, virtual), hosted by Vincent Costalat (University Hospital of Montpellier, Montpellier, France), and Master and Fellow.
The event—broadcast live from the Montpellier Centre Hospitalier Universitaire...
Major pieces of industry news from a number of innovators in the neurovascular space populate NeuroNews’ top 10 articles of last month—including NeuroOne, Artiria, Arissa and Nanoflex Robotics. Data indicating the more long-term benefits of thrombectomy in patients with...
A study recently published online in the journal Interventional Neuroradiology has provided multicentre trial results that demonstrate the promise of using precise cyclic aspiration in the treatment of acute ischaemic stroke, as per a press release put out today by US...
Artificial intelligence (AI) may serve as a future tool for neurologists to help locate the part of the brain in which a stroke occurred, as per the findings of a new study. In the study, AI—more specifically, a large...
Silk Road Medical has announced the launch of its Enroute transcarotid neuroprotection system Plus (NPS Plus), which the company describes as a key component of its transcarotid artery revascularisation (TCAR) portfolio.
As per a Silk Road press release, this next-generation device builds...
The programme for the 2024 Charing Cross (CX) symposium (23–25 April, London, UK) will see the topics of acute stroke care, carotid disease and neurointerventional surgery return with renewed vigour, thanks in no small part to five separate debate...
An analysis involving some 300 patients with anterior-circulation acute ischaemic strokes caused by tandem lesions has determined a number of factors that may be predictive of good clinical outcomes at three months following an endovascular mechanical thrombectomy procedure. Said...
This advertorial, intended for readers outside the USA only, is sponsored by Medtronic.
In light of a recent publication detailing the safe and effective use of the Solitaire X 3mm (Medtronic) stent retriever in medium- and distal-vessel occlusion (MeVO/DVO) stroke,...
Data from a new study that maps out the levels at which adverse postoperative events decrease following transfemoral carotid artery stenting (TfCAS) based on depth of physician experience with the procedure represent an “absolute minimum threshold of learning”, according...
This advertorial is sponsored by Medtronic.
Late last year, on 24 November, a decade’s work from a passionate group of physicians bore fruit, with the Brazilian Ministry of Health adding mechanical thrombectomy for stroke to the list of procedures covered...
Viz.ai has announced a strategic collaboration with Medtronic to improve the coordination of cryptogenic stroke patient care between neurology and cardiology teams.
For stroke patients who are at risk of atrial fibrillation (AF) post-stroke and may need additional cardiac monitoring,...
Michihiro Tanaka, director of Neurosurgery and Neuroendovascular Surgery at Kameda Medical Center (Chiba, Japan), speaks to NeuroNews to discuss the factors that have shaped his career as a neurosurgeon, his tenure as World Federation of Interventional and Therapeutic Neuroradiology...
In stroke patients undergoing a mechanical thrombectomy procedure, access via the radial artery may be non-inferior to access through the femoral artery in terms of final recanalisation-related outcomes. However, reduced procedural delays associated with the latter mean transfemoral access...
Researchers have argued that “more needs to be done” for depressed stroke survivors in light of new findings showing that almost 60% of stroke survivors would experience depression within 18 years—a much higher estimation than previous studies, and one...
NeuroOne Medical Technologies has announced that it has initiated a limited commercial launch of its OneRF ablation system, which has US Food and Drug Administration (FDA) 510(k) clearance for creation of radiofrequency (RF) lesions in nervous tissue for functional neurosurgical...
After providing NeuroNews with an overview of the recent history of arteriovenous malformation (AVM) treatment in a previous video interview, Christophe Cognard (Toulouse University Hospital, Toulouse, France) summarises his own preferred approach to these cases, and takes a more...
Avicenna.AI announced today that it has received 510(k) clearance from the US Food and Drug Administration (FDA) for its CINA-ASPECTS and CINA-iPE products.
CINA-ASPECTS is an artificial intelligence (AI) tool for stroke severity assessment, automatically processing non-contrast computed tomography (NCCT)...
Recently, NeuroNews caught up with Christophe Cognard (Toulouse University Hospital, Toulouse, France) to discuss the current landscape of arteriovenous malformation (AVM) care. Cognard outlines the growing evidence and ongoing research that appear to contrast with seminal findings from ARUBA—a...
Medtronic has announced that the Patent Trial and Appeal Board (PTAB) of the US Patent and Trademark Office has affirmed the validity of claims in two of its patents in an ongoing patent infringement lawsuit filed by Medtronic against...
A meta-analysis published recently in the Journal of the Neurological Sciences has concluded that venous sinus stenting (VSS) appears to be a safe and effective treatment option in certain idiopathic intracranial hypertension (IIH) patients—specifically, those who do not respond...
Highlights:
The “major shift” likely to occur following presentation of three large-scale trials evaluating middle meningeal artery (MMA) embolisation for chronic subdural haematoma (SDH)
Numerous other studies presented for the first time at this year’s International Stroke Conference (ISC;...
Highlights:
The "major shift" likely to occur following presentation of three large-scale trials evaluating middle meningeal artery (MMA) embolisation for chronic subdural haematoma (SDH)
Numerous other studies presented for the first time at this year's International Stroke Conference (ISC;...
Arissa Medical has announced six-month digital subtraction angiography (DSA) follow-up of the first cohort of patients in its Syntra first-in-human (FIH) study—an early feasibility study evaluating the safety and efficacy of the company’s Syntra device for the treatment of...
Mainstay Medical has announced the publication of the five-year follow-up from its ReActiv8-B randomised, sham-controlled, double-blinded trial in Neuromodulation: Technology at the Neural Interface.
There were 126 patients who completed the five-year follow-up and—as per a Mainstay press release—the published...
Intracranial aneurysms are a largely underestimated condition, for which global awareness and clinical research are currently lacking—and these sentiments apply even more pertinently when it comes to hereditary brain aneurysms. For NeuroNews, Rebecca Middleton (Leicester, UK) discusses how her...
Hans-Henning Eckstein, the vascular surgeon who played a leading role in the SPACE and SPACE 2 randomised controlled trials on the treatment of carotid stenosis and founder of the Munich Vascular Conference (MAC), died on 24 February at the...
Axonics has announced that the Axonics R20 rechargeable sacral neuromodulation (SNM) system has received CE-mark approval.
Axonics expects to commence sales of the R20 to European customers in mid-April, as per a company press release. The R20 also received approval...
A large, single-centre analysis has found that, despite parity between the two procedures in terms of perioperative clinical outcomes, carotid endarterectomy (CEA) was associated with a reduced rate of late stroke/death compared to transcarotid artery revascularisation (TCAR).
Writing in...
Switzerland-based startup firm Nanoflex Robotics has announced that it recently installed its first remote-ready robotics system for neurovascular procedures at the Jacobs Institute (Buffalo, USA).
The Nanoflex Robotics system uses a compact magnetic field generator and a navigation control unit...
Our list of the most popular stories from last month is dominated by first-time data releases from the International Stroke Conference (ISC; 7–9 February, Phoenix, USA), with the red-hot topic of liquid embolic use in subdural haematoma (SDH) patients...
Apollo Hospitals announced today that one of its centres in New Delhi, India has become the first hospital in South Asia to introduce the ZAP-X gyroscopic radiosurgery platform (Zap Surgical), describing the event as a “significant milestone”.
The ZAP-X technology...
Nalu Medical has announced the closing of an incremental US$20 million in equity financing from new investor B Capital, bringing its total Series E round of equity investment to US$85 million. According to a press release, this funding will...
For ischaemic stroke patients, social factors like education, neighbourhood and employment may be linked to whether they receive treatment with intravenous, clot-busting drugs, according to a preliminary study that was released recently and is set to be presented at...
Medtronic recently announced that it has filed a complaint with the US International Trade Commission (ITC), along with a parallel action in US District Court for the District of Delaware, to block Axonics from “improperly importing and selling products”...
Silk Road Medical has announced the launch of its tapered Enroute transcarotid stent system to hospitals in the USA, expanding upon the company’s prior Enroute transcarotid stent system and offering additional configurations to better tailor the transcarotid artery revascularisation...
Artiria Medical has announced the successful closing of a Series A2 round worth US$6 million and the securing of a US$600,000 Fit Tech Growth loan.
The Series A2 investment round, led by 4FOX Ventures, was joined by the Wyss...
This year’s International Stroke Conference (ISC; 7–9 February, Phoenix, USA) hosted discussions on the current state of play in carotid stenosis treatment—and, most notably, advances that may erode the dominance of long-established carotid revascularisation procedures in the USA.
Session moderator...
Onward Medical announced recently that it has been awarded Breakthrough Device designation (BDD) by the US Food and Drug Administration (FDA) for the ARC-BCI system, which uses brain-computer interface (BCI) technology in conjunction with the company’s ARC-IM therapy to restore thought-driven...
In a guest article for NeuroNews, Adnan Mujanovic (Bern, Switzerland) discusses a relatively unknown but potentially significant factor in stroke patients experiencing poor clinical outcomes following a successful endovascular therapy (EVT) procedure—the ‘no-reflow’ phenomenon.
EVT has revolutionised the treatment for...
Royal Philips has announced major enhancements to its image-guided therapy system—Azurion—with the launch of its new Azurion neuro biplane system.
Featuring enhanced imaging and gantry positioning flexibility, this new angio suite system is designed to streamline neurovascular procedures and help...
One-year follow-up data from two randomised controlled trials (RCTs) evaluating mechanical thrombectomy in patients with ischaemic strokes caused by large-core infarct volumes have demonstrated the more long-term clinical benefits of the procedure—when coupled with standard medical management (MM).
Both trials—TESLA...
A subgroup analysis of the ASTER2 clinical trial has found that a first-line combined thrombectomy approach, which involves using contact aspiration and a stent retriever in tandem, may produce better reperfusion outcomes compared to use of a stent retriever...
Tivic Health Systems has announced that enrolment in its pilot clinical study of a proprietary approach to non-invasive vagus nerve stimulation (VNS) has been completed.
Tivic is testing a proprietary approach to more precisely influence vagus nerve signals, while enhancing...
The University of Cincinnati’s Center for Addiction Research and Spark Biomedical have jointly announced that they are conducting a clinical trial to help patients with opioid use disorder (OUD) and post-traumatic stress disorder (PTSD) stick with medication treatment while...
Route 92 Medical has today announced the completion of enrolment in the 250-patient SUMMIT MAX clinical trial evaluating the safety and effectiveness of its HiPoint 88 and HiPoint 70 reperfusion catheters as part of the Monopoint reperfusion system.
Route...
Combining brain stimulation with intense physical rehabilitation helped stroke survivors recover movement in their arms and hands, and maintain these improvements for one year, within a study presented at the International Stroke Conference (ISC; 7–9 February, Phoenix, USA).
“The recovery of arm...
NOTE: This video is ONLY available to watch in selected countries and geographies
Interventional neuroradiologists Vincent Costalat (University Hospital of Montpellier, Montpellier, France) and Marios Psychogios (University Hospital Basel, Basel, Switzerland) are currently focused on two very different matters...
Reteplase has demonstrated potential as an alternative to alteplase in patients requiring intravenous thrombolysis (IVT) to treat acute ischaemic stroke, as per the findings of the RAISE trial, which were presented by Yongjun Wang (Beijing Tiantan Hospital, Beijing, China)...
In an official statement, the Society of Neurolnterventional Surgery (SNIS) has acknowledged middle meningeal artery (MMA) embolisation as a beneficial adjunctive treatment for chronic subdural haematoma (SDH). This follows the presentation of new research at the recent International Stroke...
The use of middle meningeal artery (MMA) embolisation alongside standard care has been deemed superior to standard care alone for patients with symptomatic, non-acute subdural haematomas (SDHs), as per the findings of the MAGIC-MT randomised controlled trial (RCT). Ying...
Late-breaking findings from the TWIN2WIN trial—presented recently at the International Stroke Conference (ISC; 7–9 February, Phoenix, USA)—have demonstrated the potential benefits of performing mechanical thrombectomy procedures using two stent retrievers (SRs) simultaneously. The trial compared a first-line dual-SR strategy...
Viz.ai has announced receipt of US Food and Drug Administration (FDA) 510(k) clearance for its Viz Intracerebral Haemorrhage (ICH) Plus algorithm, which is intended to automate the process of identifying, labelling and quantifying the volume of segmentable brain structures...
RapidAI has announced the publication of TIMELESS—a randomised trial evaluating the use of tenecteplase in acute ischaemic stroke treatment—in the New England Journal of Medicine (NEJM), in addition to multiple other data from research studies unveiled at this year’s International...
Mainstay Medical has announced that the US Food and Drug Administration (FDA) has approved full-body magnetic resonance imaging (MRI) conditional labelling for the ReActiv8 restorative neurostimulation system—an implantable medical device designed to treat adults with intractable chronic low back...
Recently presented results from the STEM randomised controlled trial (RCT) have demonstrated improved outcomes with middle meningeal artery (MMA) embolisation plus standard management—as compared to standard management alone—in patients with chronic subdural haematoma (cSDH).
At the 2024 International Stroke...
Laying large vessel occlusion (LVO) ischaemic stroke patients flat with their heads at a zero-degree angle prior to a mechanical thrombectomy procedure has resulted in significant short-term improvements in neurological function, as compared to patients whose heads were elevated...
Sensome has announced enrolment of the first patients into a feasibility clinical study using the Clotild smart guidewire in peripheral artery disease (PAD). Clotild was designated a breakthrough medical device for use in brain arteries by the US Food and...
Mivi Neuroscience has announced the primary endpoint results of its EvaQ trial—a prospective, multicentre, global, single-arm, US Food and Drug Administration (FDA)-regulated investigational device exemption (IDE) study to evaluate the safety and effectiveness of the company’s Q revascularisation system for...
Middle meningeal artery (MMA) embolisation—the injection of a liquid embolic substance to block an artery feeding the brain’s dura—along with surgery for subacute or chronic subdural haematoma (SDH) has been found to reduce the risk of patients requiring repeat...
Cerenovus, part of Johnson & Johnson MedTech, has announced the launch of its Cereglide 71 device—a next-generation intermediate catheter with TruCourse technology indicated for the revascularisation of patients suffering from acute ischaemic stroke. The device is now commercially available...
Ischaemic stroke survivors who received care recommendations from an artificial intelligence (AI)-based system experienced fewer recurrent strokes and heart attacks, and a lower rate of vascular death, within three months—as compared to people whose stroke treatment was not guided...
The use of a relatively novel scoring system, referred to as Symptomatic carotid atheroma inflammation lumen-stenosis (SCAIL), has produced favourable predictive qualities versus the Oxford carotid stenosis tool (OCST) and Essen stroke risk score (ESRS). According to researchers, the...
Giving blood thinners in addition to clot-busting medications does not improve ischaemic stroke patients’ outcomes at 90 days, according to findings from the MOST trial, which were revealed today in a late-breaking science presentation at the International Stroke Conference (ISC; 7–9...
A new scientific statement from the American Heart Association (AHA) emphasises the need to boost patient and physician awareness of cerebral venous thrombosis (CVT), with a view to improving recognition of this condition and initiation of prompt medical treatment....
Boston Scientific Corporation announced today that the US Food and Drug Administration (FDA) has approved an expanded indication of the company’s WaveWriter spinal cord stimulation (SCS) systems for the treatment of chronic low back and leg pain in people...
A new guidance document from the UK National Institute of Health and Care Excellence (NICE) has endorsed National Health Service (NHS) deployment of two artificial intelligence (AI)-derived software technologies to support the review and reporting of computed tomography (CT)...
Carthera has announced the enrolment of the first patient in the SONOBIRD pivotal trial assessing its ultrasound-based Sonocloud medical device for the treatment of recurrent glioblastoma (rGBM). The trial aims to treat 560 patients across 40 sites in Europe and the USA,...
Brian Nahed (Boston, USA) outlines the latest advances in neurosurgery, and why it is important for those working in the field to keep up to date and continually hone their skills, in a guest article on NeuroNews.
Training and education...
Lumosa Therapeutics, in collaboration with CHI Memorial (Chattanooga, USA), has announced the initiation of multiple Phase 2 clinical trials for LT3001, which the company describes as a “groundbreaking” drug for treating acute stroke that combines clot-busting and nerve-protecting effects...
Endovascular brain-computer interface (BCI) technology firm Synchron has announced the acquisition of an equity stake in Acquandas—a leading technology provider specialising in state-of-the-art, high-precision components in healthcare and other industries.
As part of the transaction, Synchron chief executive officer (CEO) and...
Irish medical device firm Ceroflo announced today that it has raised €6.4 million in investment-round funding, which will be used to advance development of the company’s SubMax device—a novel stent intended to “revolutionise” intracranial atherosclerotic disease (ICAD) treatments. In...
A tribute to the late Conrad Yiu was NeuroNews’ most read story in January, indicating the impact he has had and will likely continue to have on the stroke care community. The long-awaited publication of final results from the...
Basking Biosciences has announced the close of US$55 million in financing, which will be used to accelerate clinical development of its novel thrombolytic therapy for acute stroke.
New investor ARCH Venture Partners led the round, with participation from additional new...
Medtronic has announced the first neurointerventional case in Europe with its Rist 6Fr radial access catheter, which recently received regulatory approval for use in European Union (EU) countries and other geographies accepting a CE mark.
According to Riitta Rautio (Turku...
A research team led by City University of Hong Kong (CityU; Kowloon, Hong Kong) neuroscientists recently discovered that low-dose ionising radiation (LDIR), such as X-ray irradiation, can reduce lesion size and reverse motor deficits associated with traumatic brain injury...
InspireMD announced today that it has received CE-mark recertification under the European Union’s (EU) new Medical Device Regulation (MDR) regulatory framework for its CGuard embolic prevention system (EPS), which is a carotid stent device intended to facilitate the prevention...
Abbott recently announced that it has received approval from the US Food and Drug Administration (FDA) to launch the Liberta RC deep brain stimulation (DBS) system—the “world's smallest” rechargeable DBS device with remote programming, according to the company—to treat...
A team of physicians, neuroscientists and engineers at Duke University (Durham, USA) have reported multiple new strategies that use deep brain stimulation (DBS) to improve the symptoms of Parkinson’s disease. By simultaneously targeting two key brain structures and using...
The closing weeks of 2023 saw fresh findings comparing general anaesthesia (GA) to sedation in stroke thrombectomy disclosed for the first time, with leading researcher Peng Roc Chen (UTHealth Houston, Houston, USA) presenting results from the SEGA trial at...
Thanh N Nguyen, professor of neurology, radiology and neurosurgery at the Boston University Chobanian and Avedisian School of Medicine in Boston, USA, has been elected president of the Society of Vascular and Interventional Neurology (SVIN). Nguyen is the first...
Leica Microsystems has launched an evolved version of its ARveo 8 digital visualisation microscope for neurosurgery. The ever-growing ecosystem, ARveo 8, enhances surgical visualisation through the application of a 3D view and augmented reality (AR) fluorescence, as stated in...
Physicians at The Ottawa Hospital (TOH) in Ottawa, Canada recently became the first in the world to use a new stroke technology, the MicroAngioscope (Vena Medical), in a patient procedure. Equipped with “the world’s smallest camera”, the device goes...
Nalu Medical presented interim data from the “landmark” COMFORT randomised controlled trial (RCT)—indicating long-term and holistic pain management outcomes with its peripheral nerve stimulation (PNS) system—at the recent North American Neuromodulation Society (NANS) annual meeting (18–21 January, Las Vegas,...
At this year’s North American Neuromodulation Society (NANS) annual meeting (18–21 January, Las Vegas, USA), Medtronic announced new data from two clinical trials demonstrating the benefits of its spinal cord stimulation (SCS) technologies in patients with chronic low back...
Cerevasc has announced that data from clinical studies in the USA and Argentina examining the use of its eShunt system to treat communicating hydrocephalus were presented at the recent ABC WIN Seminar (15–20 January, Val d’Isère, France).
Data from clinical studies of the...
As per an observational study published in the journal Neurology last year, female hormone therapy use may be associated with a higher risk of intracranial haemorrhage from cerebral cavernous malformations (CCMs)—raising questions about the safety of these therapies for...
The final publication of midterm results from the observational CARAS study suggest that cerebral ischaemic event (CIE) incidence in asymptomatic carotid stenosis patients “should not be underestimated”, so say authors Rodolfo Pini (University of Bologna, Italy) and colleagues, relaying...
Boston Scientific Corporation has announced positive one-year results from the SOLIS randomised controlled trial, demonstrating sustained pain relief using its WaveWriter Alpha spinal cord stimulation (SCS) systems for the treatment of non-surgical back pain (NSBP), presented at the recent...
Abbott has announced that the US Food and Drug Administration (FDA) has approved expanded magnetic resonance imaging (MRI) labelling for its dorsal root ganglion (DRG) stimulation therapy, the Proclaim DRG neurostimulation system, which allows patients to receive full-body MRI...
Arissa Medical has announced the enrolment of the first patients in its Syntra study—a first-in-human (FIH), early feasibility study evaluating the safety and efficacy of the company’s Syntra device for the treatment of wide-necked sidewall and wide-necked bifurcation cerebral...
A new study, published in the Journal of NeuroInterventional Surgery (JNIS) late last year, has assessed the safety of the latest iteration of the Pipeline Vantage embolisation device (Medtronic) in the treatment of unruptured intracranial aneurysm patients—ultimately producing “acceptable...
Medtronic has announced the US Food and Drug Administration (FDA) approval of its Percept RC deep brain stimulation (DBS) system.
The rechargeable neurostimulator is the latest innovation in the Medtronic Percept family, which includes the Percept PC neurostimulator, BrainSense technology...
Nevro Corporation has announced a series of data presentations supporting the use of the company's high-frequency (HFX) 10kHz spinal cord stimulation (SCS) therapy for patients with chronic pain—set to be presented at this week’s North American Neuromodulation Society (NANS)...
Saluda Medical has announced that its data will be presented at the upcoming North American Neuromodulation Society (NANS) annual meeting (18–21 January, Las Vegas, USA).
With the company’s three-year EVOKE study having demonstrated superior pain relief in its closed-loop arm...
SPR Therapeutics has announced that it is set to be featured prominently at the upcoming North American Neuromodulation Society (NANS) annual meeting (18–21 January, Las Vegas, USA). A total of 11 abstracts highlighting applications of the SPRINT peripheral nerve stimulation...
Boston Scientific Corporation has announced its clinical data that will be featured at the upcoming North American Neuromodulation Society (NANS) annual meeting (18–21 January, Las Vegas, USA). A total of 19 abstracts from the company’s chronic pain and deep...
Route 92 Medical has announced the company’s 100th global issued patent for its innovative neurovascular intervention product portfolio, as per a press release. The company offers a range of solutions for neurovascular interventional procedures, including its FreeClimb catheter systems...
Neuralace Medical has announced the US Food and Drug Administration (FDA) clearance of its “groundbreaking” Axon therapy for the treatment of chronic painful diabetic neuropathy (PDN). This “landmark approval” marks the first ever FDA clearance of a non-invasive, magnetic...
Carotid artery stenting (CAS) delivered via transradial artery access has demonstrated no increased risk of stroke, death, myocardial infarction, transient ischaemic attack, or access site complications, as compared to the more traditional transfemoral approach. That is the concluding finding...
In a recent study from the USA now published in the journal Neurology, Black people consistently had a higher rate of stroke than white people over a 22-year period. The same study also found that the average age of...
Extolling the benefits of evidence-based practice, timely surgical intervention and intensive medical therapy, Dominic PJ Howard (Oxford, UK) spoke at the recent Vascular Society of Great Britain and Ireland’s (VSGBI) annual scientific meeting (VSASM 2023; 22–24 November, Dublin, Ireland)...
Arissa Medical has announced the successful evaluation of the Syntra intrasaccular scaffold system within simulated use conditions under fluoroscopy using clinically relevant, in-vitro intracranial aneurysm models provided by the Jacobs Institute in Buffalo, USA.
The Syntra INR user study evaluated...
Mentice recently announced that Ankyras, the company’s clinical decision support application, has received 510(k) clearance from the US Food and Drug Administration (FDA). The approval of this product by the FDA demonstrates the safety and effectiveness of Ankyras, and...
Final results from the PROST randomised controlled trial (RCT) have been published in JAMA Neurology and—according to the study’s leading investigators—provide evidence that thrombectomy with the Preset stent retriever (Wallaby/Phenox) is a safe and effective option in large vessel...
In light of recent evidence indicating that thrombectomies with poor reperfusion may lead to inferior clinical outcomes versus medical management in ischaemic stroke, Adrien Guenego (Brussels, Belgium) assesses the need for a “fundamental change” over decision-making and how success...
Hyperfine has announced the launch of the artificial intelligence (AI)-powered eighth generation of its Swoop system software.
“The software update on the Swoop system has been most beneficial to our workflow,” said Jennifer Villa Frabizzio (Radiology Group of Abington, USA). “We...
A device labelled “the third way” to potentially treat intracranial aneurysms via an intrasaccular approach has demonstrated positive effectiveness and safety results at one year in a first-in-human (FIH) study, as per a presentation at the Barts Research and...
The recent Barts Research and Advanced Interventional Neuroradiology (BRAIN) conference (4–6 December 2023, London, UK) saw Tommy Andersson (Karolinska University Hospital, Stockholm, Sweden) put forward the case for post-thrombectomy rescue stenting in ischaemic strokes caused by challenging, neutrophil extracellular...
Phil White’s career as a physician and researcher has seen him play a role in numerous major stroke trials, and serve as an educator to many in the interventional neuroradiology (INR) space via the European Course in Minimally Invasive...
GE HealthCare has entered into an agreement to acquire MIM Software, a provider of artificial intelligence (AI)-enabled image analysis and workflow tools across multiple care areas, including oncology, urology, neurology, and cardiology.
GE HealthCare expects to leverage MIM Software’s imaging...
Axonics has announced that it has entered into a definitive agreement to be acquired by Boston Scientific Corporation for US$71 in cash per share, representing an equity value of approximately US$3.7 billion.
Axonics brings a complementary product portfolio to the...
SynerFuse has announced the appointment of Rohan Lall (M Health Fairview Neurosurgery, Princeton, USA) as the company’s chief medical officer. The appointment was effective on 2 January 2024.
“Dr Lall has been instrumental in SynerFuse progressing to where we are...
Rescue stent placement following a failed thrombectomy procedure has demonstrated “good outcomes” and a low risk of clinically significant bleeding in a multiethnic cohort of acute ischaemic stroke patients from the Middle East, Africa and Asia. Writing in the...
Evasc Neurovascular has announced new strategic growth initiatives, having recently achieved a milestone of 120 successful cerebral aneurysm cases with its innovative Eclips device. The Canada-based company is also expanding its European operations with the establishment of a new...
Multiple new pieces of major trial data presented at the Society of Vascular and Interventional Neurology (SVIN) annual meeting (16–18 November 2023, Miami, USA) feature across NeuroNews’ 10 most popular stories from December. Insights on intracranial aneurysm care—including a...
An international panel of clinical researchers has published a report in the journal Stroke in which they advocate “immediate change” regarding treatment protocols for intracranial haemorrhage (ICH), citing the fact that haemorrhagic stroke management “lags far behind” that seen...
NeuroPace has announced the completion of the patient enrolment goal in its NAUTILUS pivotal study for the treatment of idiopathic generalised epilepsy (IGE) “more than one quarter ahead of schedule”, according to a company press release.
“We are extremely proud...
In an editor's column published recently in the Journal of NeuroInterventional Surgery (JNIS), leading members of the Society of NeuroInterventional Surgery (SNIS) have argued that the entire body of research, including new evidence from two prospective clinical trials, “clearly confirms” that most patients...
Perfuze has announced US Food and Drug Administration (FDA) clearances for the Millipede 070 aspiration catheter and the second-generation of its Millipede 088 access catheter.
The first of these devices, the Millipede 070 aspiration catheter, is intended to remove blood...
Conrad Yiu, a pioneer and visionary in interventional ischaemic stroke therapy, passed away in the final weeks of 2023, succumbing to the very disease for which he so fervently sought to enable and advance treatment. In a guest piece for...
Researchers in The Netherlands have received a Horizon grant worth €10 million from the European Commission to accelerate development of a technology that could allow operators to assess the best treatment for a patient with a cerebral infarction or...
Oxford Heartbeat has announced that its ongoing clinical impact trial of PreSize Neurovascular—a CE mark-certified, “first of its kind” for decision-support software in the field that also featured on BBC Click earlier this year—has reached the halfway point in recruitment.
The trial, funded by...
Nicolab has announced that its computed tomography (CT) perfusion algorithm, which is integrated into the company’s StrokeViewer platform, has obtained 510(k) clearance from the US Food and Drug Administration (FDA). Nicolab’s StrokeViewer solution is also set to be deployed...
The US Securities and Exchange Commission (SEC) has today charged Laura Tyler Perryman—the former chief executive officer (CEO) and co-founder of Florida-based medical device startup Stimwave Technologies—with defrauding investors out of approximately US$41 million by making “false and misleading...
This advertorial is sponsored by Medtronic.
As part of the company’s ongoing commitment to offering physicians access to high-quality clinical data and, subsequently, enabling evidence-based practice to flourish, Medtronic has established a global registry—dubbed ‘INSPIRE-S’—producing real-world findings relating to the...
As per a recent statement from the North American Neuromodulation Society (NANS), the US state of Washington may be about to extend its insurance coverage policies relating to spinal cord stimulation (SCS) therapies.
Washington’s Health Technology Clinical Committee recently conducted...
Imperative Care has announced the initiation of a first-in-human (FIH) clinical study for its novel stent system designed to only require single antiplatelet therapy for patients undergoing stent-assisted treatment of wide-neck intracranial aneurysms.
The first three patients enrolled were successfully...
This advertorial is sponsored by Medtronic.
As the co-founder and chief executive officer of Chestnut Medical, Aaron Berez played a leading role in bringing flow diverters to market with the development of the Pipeline embolisation device (Medtronic) for intracranial aneurysm...
Researchers from the Medical University of South Carolina (MUSC) have partnered with US emergency medical services (EMS) to pilot test the first magnetic resonance imaging (MRI)-equipped ambulance in an effort to speed up stroke response. The researchers concluded a...
NeuroOne Medical Technologies Corporation has announced that it has received US Food and Drug Administration (FDA) 510(k) clearance to market its OneRF ablation system for creation of radiofrequency lesions in nervous tissue for functional neurosurgical procedures.
“When NeuroOne was founded, one...
Neuspera Medical recently announced it has completed patient enrolment and implant procedures for the SANS-UUI pivotal clinical trial of its Neuspera system—a discreet, minimally invasive implant designed to provide patients with personal control and relief from urinary urge incontinence...
BCV has announced that it has secured €6 million in a Series A round of financing led by Forepont Capital Partners, with other investors including NTI, MEDCO and existing French investors. This Series A funding brings the total amount...
Across October and November, our readers were drawn to everything from recent shifts in neurovascular device regulation, to “failures of the peer-review process” in intracranial aneurysm literature, to the latest major trial supporting thrombectomy for large-infarct ischaemic strokes. Among...
Rapid Medical has announced Japanese approval for its Tigertriever revascularisation device. With Pharmaceuticals and Medical Devices Agency (PMDA) approval, Tigertriever serves as “the first device to offer individualised solutions for mechanical thrombectomy”, a Rapid press release claims.
Kaneka Corporation has...
This advertorial is sponsored by Medtronic.
As a prospective, independently adjudicated registry boasting a highly comprehensive patient dataset, INSPIRE-A is a “very unique” phenomenon in the field of endovascular aneurysm care—and one that may be able to provide answers for...
Philips has announced that, on 29 November 2023, the WE-TRUST study enrolled its 100th patient, marking what the company describes as an “important milestone” in the target of enrolling more than 500 stroke patients by the end of 2024....
Highlights:
Physicians posit that equipoise likely remains between general anaesthesia and conscious sedation in endovascular therapy following the presentation of SEGA trial results at the Society of Vascular and Interventional Neurology (SVIN) annual meeting (16–18 November 2023, Miami, USA)
...
Highlights:
Physicians posit that equipoise likely remains between general anaesthesia and conscious sedation in endovascular therapy following the presentation of SEGA trial results at the Society of Vascular and Interventional Neurology (SVIN) annual meeting (16–18 November 2023, Miami, USA)
...
SpineX has announced that it is close to full recruitment of the patient cohort for a clinical trial of its proprietary SCONE device, recently passing the 80% mark. SCONE is an innovative device that treats urinary incontinence, allowing people...
Q’Apel Medical has launched a new-generation aspiration technology, the 072 Hippo aspiration system, which has been developed for patients suffering from a stroke due to a large vessel occlusion.
The recently US Food and Drug Administration (FDA)-cleared stroke system—comprised of...
Fresh data from the SOFAST study have indicated high rates of technical success and first-pass reperfusion with the Sofia 6Fr Flow Plus aspiration catheter (Microvention/Terumo), indicating that the device is both safe and effective in large vessel occlusion (LVO)...
Nevro Corporation has announced that it has acquired Vyrsa Technologies—a privately held medical technology company focused on a minimally invasive treatment option for patients suffering from chronic sacroiliac (SI) joint pain.
Under the terms of the transaction, which signed and...
A “historical milestone” for stroke patients in Brazil was achieved recently, with the country’s Ministry of Health (MOH) publishing Order 1.996/2023 on 24 November to add mechanical thrombectomy to the list of procedures covered by the Brazilian public health...
This advertorial, sponsored by Siemens Healthineers and intended for US readers only, is part of a series of articles on the emerging role for neurovascular office-based labs (OBLs).
Neurovascular diseases present formidable obstacles for both patients and healthcare providers. As...
Kaneka Corporation has acquired all shares of Japan Medical Device Technology and has made it a wholly owned subsidiary.
Kaneka manufactures and sells endovascular catheters, which are devices used in the treatment of cardiac, peripheral vascular and cerebrovascular diseases.
Kaneka is...
Nalu Medical has announced the publication of the spinal cord stimulation (SCS) nPower US clinical study in the Pain Physician Journal, reporting on clinical outcomes related to the use of the Nalu SCS system to treat patients suffering from chronic...
A comparative study recently demonstrated the promise held by PreSize Neurovascular (Oxford Heartbeat) software in consistently and accurately making predictions about flow-diverter placement in intracranial aneurysm treatments. However, according to lead study author Ansaar Rai (West Virginia University Rockefeller...
Intra-arterial tenecteplase has demonstrated potential as a safe and feasible adjunct to mechanical thrombectomy in patients with acute ischaemic stroke caused by a distal large vessel occlusion (LVO) who achieve “successful but incomplete” reperfusion, as per findings from the...
Theranica has announced the peer-reviewed publication of a comprehensive clinical study showing the preventive benefits of its remote electrical neuromodulation (REN) wearable, Nerivio, for adolescents suffering from migraine. The study—published in Frontiers in Pain Research—demonstrates that frequent use of...
In a guest piece for NeuroNews, Arūnė Simanavičienė (Kaunas, Lithuania) and Audrius Širvinskas (Vilnius, Lithuania) highlight the work being done by the Brain Aneurysm Foundation in Lithuania, and its attempts to boost awareness of the finer details of intracranial...
The multicentre, randomised SEGA trial has found that acute ischaemic stroke patients who receive endovascular therapy (EVT) under general anaesthesia experience better functional outcomes at 90 days compared to those who receive the procedure under conscious sedation.
These results—presented for...
Researchers from Germans Trias i Pujol Research Institute (IGTP; Badalona, Spain) have discovered that administering human apotransferrin to mice affected by intracranial haemorrhage (ICH) can mitigate the damaging effects of this severe type of stroke. Findings from an experimental...
Receiving intravenous tissue plasminogen activator (IV-tPA) in an ambulance-based mobile stroke unit (MSU) increases the likelihood of averting strokes and the odds of a patient achieving complete recovery compared with standard hospital emergency care, according to researchers at Weill...
Brainomix has heralded its continued US expansion with the launch of a full suite of US Food and Drug Administration (FDA)-cleared modules in its Brainomix 360 platform for stroke care.
The US launch—which included the company’s previously announced, FDA-cleared e-ASPECTS...
Nevro Corporation has announced the publication of new 24-month data from the SENZA-NSRBP multicentre randomised controlled trial (RCT) in the Journal of Neurosurgery: Spine. The published 24-month data detail outcomes for non-surgical refractory back pain (NSRBP) patients treated with Nevro's...
Route 92 Medical has announced it has raised more than US$31 million in a Series F financing round to accelerate the commercial adoption of a neurovascular intervention portfolio focused on acute ischaemic stroke. The oversubscribed capital raise was led...
Neurolutions and Kandu Health recently announced a strategic partnership intended to raise the standard of care for post-stroke recovery. Through this partnership, Kandu’s expert clinicians will support Neurolutions by providing clinical consultation and assessments of stroke survivors to determine...
Boston Scientific Corporation has announced the close of its acquisition of Relievant Medsystems—the company behind the US Food and Drug Administration (FDA)-cleared Intracept intraosseous nerve ablation system, which is used to treat a form of chronic low back pain...
The ATTEST-2 trial has found that tenecteplase was non-inferior to alteplase, the more established of the two thrombolytic agents, in suitable acute ischaemic stroke patients. Preliminary results from the study were presented by principal investigator Keith Muir (University of...
Rapid Medical has announced new data demonstrating “excellent” first-pass treatment success using the Tigertriever device in complex ischaemic stroke patients with underlying intracranial atherosclerotic disease (ICAD). The complication rates were also negligible, as reported at the ongoing Society of Vascular and...
Microvention, a wholly owned subsidiary of Terumo Corporation, is celebrating a decade of legacy innovation commemorating the anniversary of its Sofia and Sofia Flow Plus aspiration catheters, having performed more than half a million worldwide procedures across 170 countries,...
Route 92 Medical has announced new results from a multicentre clinical study evaluating the efficacy, safety and efficiency of the Tenzing 7 delivery catheter as a means for delivering therapeutic devices for mechanical thrombectomy in acute ischaemic stroke.
The results—now published in Stroke:...
A systematic review and meta-analysis of 1,356 studies and more than 410,000 patients have found that “methodological flaws and incomplete reporting” occur frequently in studies advocating the safety, effectiveness or durability of intracranial aneurysm treatments—forming a “potential public health...
The proliferation of new technologies and advancements in the neurosciences space has showed little sign of slowing in recent years and—as John Rolston (Boston, USA) avers in this guest piece for NeuroNews—patients with brain function diseases may well reap...
With a renewed focus on challenging cases, novel technologies and, overall, the most pressing issues in carotid treatments and acute stroke care, the 2024 Charing Cross (CX) Symposium (23–25 April, London, United Kingdom) intends to maximise audience participation throughout...
People who live in neighbourhoods with lower socioeconomic status are less likely to receive clot-busting medications or undergo mechanical thrombectomy procedures after they have a stroke compared to those living in neighbourhoods with a higher socioeconomic status. That is...
SpineX has reported in a press release that a publication titled, “A pilot study of the effect of transcutaneous spinal cord stimulation on micturition-related brain activity and lower urinary tract symptoms after stroke”, has been accepted by the Journal...
RapidAI announced today that it has received US Food and Drug Administration (FDA) clearance for Rapid SDH, its artificial intelligence (AI)-powered module for the detection and notification of suspected hemispheric acute and chronic subdural haematoma (SDH).
Together with Rapid ICH and Rapid Hyperdensity, both...
Rapid Medical has announced that the final patient has been enrolled in SUCCESS—a US Food and Drug Administration (FDA) post-market surveillance study assessing the safety and performance of the company's Comaneci embolisation assist device in the USA.
The final patient...
The principle of medical necessity “should drive all remote monitoring decisions” relating to spinal cord stimulation (SCS) technologies, according to recommendations recently published in Neuromodulation: Technology at the Neural Interface by a panel of pain management experts. The panel...
Surgical Information Sciences (SIS) has announced the commencement of its post-market VISION study evaluating visualisation of the subthalamic nucleus (STN) and globus pallidus internus (GPi) for deep brain stimulation (DBS) surgery in patients with Parkinson's disease.
This study aims to...
Perfuze has announced commencement of enrolment in its pivotal MARRS study—a multicentre trial set to evaluate the performance of aspiration thrombectomy with the company’s Millipede system for revascularisation in acute ischaemic stroke. The first patient was enrolled at Stony...
InspireMD recently presented 30-day results from the C-GUARDIANS US investigational device exemption (IDE) clinical trial evaluating its CGuard embolic prevention stent (EPS) system for stroke prevention at the annual Vascular Interventional Advances (VIVA) meeting (30 October–2 November 2023, Las...
New results from the TENSION study—presented recently at the 15th World Stroke Congress (WSC; 10–12 October, Toronto, Canada) by Götz Thomalla (University Medical Center Hamburg-Eppendorf, Hamburg, Germany)—have demonstrated improved functional outcomes and reduced mortality rates among stroke patients treated...
Contego Medical has announced the presentation of late-breaking clinical results from the PERFORMANCE II carotid stent trial at the annual Vascular Interventional Advances (VIVA) meeting (30 October–2 November 2023, Las Vegas, USA). PERFORMANCE II is a prospective, multicentre study...
Annalise.ai has announced the launch of Annalise Triage—an innovative software solution tailored specifically for the US market that the company claims will “transform the radiology field by empowering radiologists to efficiently triage studies and prioritise those with suspected critical...
A study demonstrating the successful deep-brain placement of a brain-computer interface (BCI) microchip into a living animal with no apparent neurological effects has been published in the journal Brain-Computer Interfaces, as per a press release from NICO Corporation.
The publication—led...
In a “notable departure” from prior iterations of the conference, this year’s Society of Vascular and Interventional Neurology (SVIN) annual meeting (16–18 November, Miami, USA) will place a “distinct emphasis” on innovation, focusing on the latest technologies within interventional...
There are multiple components of the PROST randomised controlled trial’s (RCT) design that set it apart from prior studies and make it somewhat unique in the stroke thrombectomy space. At this year’s European Society of Minimally Invasive Neurological Therapy...
Surmodics has announced the commercial launch of its most advanced hydrophilic medical device coating technology, the Preside hydrophilic coatings.
As per a company press release, Preside hydrophilic coatings complement Surmodics’ existing Serene hydrophilic coatings by providing customers with a unique,...
MindRhythm has announced that the US Food and Drug Administration (FDA) has awarded a Breakthrough Device designation to its Harmony headset embedded with HeadPulse technology.
“This designation highlights the position that Harmony is truly breakthrough, as it acknowledges the...
A secondary analysis of existing clinical trial data has indicated that new ischaemic brain lesions detected via diffusion-weighted magnetic resonance imaging (DW-MRI) following carotid artery revascularisation—either with carotid artery stenting (CAS) or carotid endarterectomy (CEA)—do not appear to have...
In a new case report, researchers at University of California Los Angeles (UCLA) Health have described “promising results” using repetitive transcranial magnetic stimulation (rTMS) in the management of post-stroke cerebellar ataxia—a debilitating condition marked by impaired coordination and balance.
Ataxia...
Recently published data from two large randomised controlled trials (RCTs) have indicated there may be minimal benefits—or even negative effects—associated with bypassing local or primary stroke centres (PSCs) and transporting patients straight to thrombectomy-capable comprehensive stroke centres (CSCs). However,...
Cordance Medical has announced that its device, NeuroAccess, has been granted Breakthrough Device designation by the US Food and Drug Administration (FDA), meaning the company will receive prioritised review and accelerated interaction with the regulator.
The NeuroAccess device is engineered...
Ahead of World Stroke Day 2023, on 29 October, physicians from the Get Ahead of Stroke campaign are highlighting the fact that, while prevalence of stroke in the USA is declining in adults aged 75 years and older, it...
EOSolutions Corporation has announced that the US Food and Drug Administration (FDA) has cleared its Thinline introducer sheath—an approval that swiftly follows the successful launch of the company’s “revolutionary” Dr Banner balloon guide catheter (BGC) in the USA.
The Thinline...
Cognito Therapeutics has announced that continued active treatment with the company’s gamma sensory stimulation technology in the Phase 2 OVERTURE open label extension (OLE) study demonstrated durability and concordance of clinical and magnetic resonance imaging (MRI) benefits over 18...
Digital health company Butterfly Network and deep tech research firm Forest Neurotech announced yesterday that they have entered into a five-year co-development agreement to further the development of next-generation brain-computer interfaces (BCIs) using Butterfly’s semiconductor-based Ultrasound-on-Chip technology.
The agreement includes...
While the latest thrombectomy techniques, thrombolytic drug candidates and even neuroprotective agents are the source of much discussion in today’s neurovascular space, there is also significant room for improvement within another step along the stroke care pathway: patient triage....
Researchers at the UK Dementia Research Institute (DRI) have developed a new form of deep brain stimulation (DBS) that does not require surgery and could provide an alternative treatment option for brain diseases like Alzheimer’s.
The technology—based on temporal interference...
A specialised ‘brain-wave cap’, designed by researchers in The Netherlands, may be able to diagnose stroke patients while they are in an ambulance—thus allowing them to receive appropriate treatments more quickly.
"Our research shows that the brain-wave cap can recognise...
Robocath has today announced the results of its CARE clinical trial focusing on robotic carotid stenting—the first phase of a research programme launched in July 2021 by Robocath and Rennes University Hospital (Rennes, France), which, in the long term,...
SynerFuse has announced that it has completed enrolment in its proof-of-concept study to evaluate the safety and tolerability of the Electric Transforaminal Lumbar Interbody Fusion (e-TLIF) procedure integrating spinal fusion with direct nerve stimulation, which is designed to treat...
The third Stroke Recovery and Rehabilitation Roundtable—an initiative of the International Stroke Recovery and Rehabilitation Alliance (ISRRA)—has made a series of key recommendations about managing fatigue, measuring mobility, harnessing non-invasive brain stimulation technologies, and improving how trials are designed,...
The existing body of evidence supporting artificial intelligence (AI) and the autonomous navigation of endovascular procedures is “inadequate”, despite the theoretical benefits held by this “promising” concept.
This is among the concluding messages delivered by Thomas Booth (Kings College Hospital,...
Administering 10Hz cerebellar repetitive transcranial magnetic stimulation (rTMS) offers a “promising”, non-invasive treatment option in patients experiencing dysphagia following a subacute infratentorial stroke, as per the findings of a recent randomised controlled trial (RCT).
Writing in the journal Brain Stimulation,...
Anaconda Biomed has announced that the European Patent Office has granted the company a European patent for “A device and a thrombectomy apparatus for extraction of thrombus from a blood vessel”, published as patent number EP 3866708 B1 on...
Imperative Care recently announced the publication of clinical data in the journal Interventional Neuroradiology (INR) detailing the use of its Zoom aspiration catheters in patients with large and medium vessel occlusion stroke.
Data from an independent study evaluating real-world experiences...
Athersys has announced that the independent data safety monitoring board (DSMB) has completed a preplanned interim analysis of the company’s ongoing, phase three MASTERS-2 pivotal clinical trial evaluating MultiStem (invimestrocel) for the treatment of moderate-to-severe acute ischaemic stroke. The...
Discussions at this year’s European Society of Minimally Invasive Neurological Therapy (ESMINT) congress (4–6 September, Marseille, France) revealed the extent of the disparities between the current regulatory systems in Europe and the USA, with experts and attendees outlining how “the...
The Nautilus system (Endostream Medical)—a self-conforming intrasaccular flow diverter intended for the treatment of intracranial aneurysms—heralds the “next evolution” in these types of neurovascular devices.
That is according to J Mocco (Mount Sinai, New York, USA), who spoke to...
Boston Scientific has announced that the US Food and Drug Administration (FDA) has approved an expanded indication of the WaveWriter Alpha spinal cord stimulator (SCS) systems for the treatment of painful diabetic peripheral neuropathy (DPN), a complication of diabetes...
Brainomix and Nanoflex Robotics have announced today that they have been awarded a grant via the ‘UK—Switzerland Bilateral: Collaborative R&D ’ programme, under which the companies will work together to jointly develop an integrated remote diagnosis and treatment platform...
While sex disparities regarding the outcomes of carotid revascularisation have “long been a concern”, new prospective data published in the Journal of Vascular Surgery (JVS) indicate that no such disparity exists between male and female patients treated with transcarotid...
NeuraSignal has announced the publication of positive results from the BUBL clinical study supporting the safety and superior performance of its NovaGuide intelligent ultrasound system in detecting right-to-left shunt (RLS)—often due to a patent foramen ovale (PFO)—in patients with...
Royal Philips and the World Stroke Organization (WSO) have announced the signing of a two-year partnership aimed at improving access to high-quality stroke care.
Building on their shared commitment to delivering improvements in stroke prevention, treatment, rehabilitation and support, Philips...
Hyperfine has announced US Food and Drug Administration (FDA) clearance of updated software for its portable magnetic resonance brain imaging technology, the Swoop system.
Built on a “robust” artificial intelligence (AI) foundation, the latest software brings image-quality enhancements to...
Between now and 2050—unless “urgent action is taken”—the number of people who die from stroke globally is estimated to increase by 50%, to 9.7 million deaths per year, with annual costs as high as US$2.3 trillion also a possibility....
Roger Malcolm Greenhalgh, the surgeon internationally renowned for his unparalleled contribution to vascular education, training and research, died peacefully on 6th October, aged 82. At the time of his death, he was emeritus Professor of Surgery at Imperial College...
Contego Medical has announced enrolment of the first patient in the prospective, multicentre PERFORMANCE III trial aimed at further evaluating the safety and effectiveness of the Neuroguard integrated embolic protection (IEP) direct system—a carotid stent system designed for direct transcarotid...
Exclusive interviews with multiple pioneering figures in the US neurovascular field earmark NeuroNews’ latest top 10, as do results from two ongoing studies attempting to elucidate mechanical thrombectomy and its place alongside other therapies in acute ischaemic stroke. A...
Biotronik Neuro has announced that results from the BENEFIT-02 trial—the “first of its kind” to clinically evaluate a multiphase stimulation paradigm—support the effectiveness of RESONANCE multiphase stimulation used in the company’s Prospera spinal cord stimulation (SCS) system for the...
A study recently published in the journal Neurology investigated whether there are discrepancies in the prognosis of subarachnoid haemorrhage (SAH) patients between the university hospital districts in Finland—and has revealed “surprising” regional differences, according to lead author Aleksanteri Asikainen (University...
Medtronic has shared that Paolo Di Vincenzo will join the company as president of its neuromodulation business, effective 30 October 2023. In this role, Di Vincenzo will be responsible for the overall strategic direction of the Medtronic neuromodulation business...
The North American Neuromodulation Society (NANS) has led a multi-society response to the Washington State Health Care Authority (WSHCA) following its review of the current evidence on spinal cord stimulation (SCS).
As per a NANS press release, the state of...
Transradial access, whereby the vasculature is navigated to via the radial artery in the wrist, has been a topic of much debate in the neurovascular space over the past few years. Despite demonstrating promising advantages and being advocated for...
A new study has shed fresh light on the potential connection between pre-existing heart issues and symptoms of ‘long-COVID’. According to researchers from New York University (NYU) Langone Health in New York City, USA, being infected with the pandemic...
This advertorial, intended for US readers only, is sponsored by CERENOVUS.
“Going distally with guide catheters is more routine nowadays,” says Violiza Inoa (Memphis, USA), discussing what she sees as a relatively recent shift in the way many physicians choose...
A young neurosurgeon and researcher from Buffalo, USA has been awarded US$150,000 via the Congress of Neurological Surgeons (CNS) Foundation/Cerebrovascular (CV) Young Investigator Grant to study the reasons why women develop a higher rate of cerebral aneurysms compared to...
Remote teleproctoring has demonstrated promising results in providing hands-on mechanical thrombectomy training and overcoming wartime migration restrictions in Ukraine, according to initial experiences published recently in the journal Interventional Neuroradiology.
“Teleproctoring brings together specialists who are engaged in INR all around the...
Highlights:
New data that "refute" the seminal ARUBA trial's conclusions on interventional treatments for arteriovenous malformations (AVMs) as well as several other highlights from this year's Society of NeuroInterventional Surgery (SNIS) annual meeting (31 July–4 August, San Diego, USA)
...
Highlights:
New data that "refute" the seminal ARUBA trial's conclusions on interventional treatments for arteriovenous malformations (AVMs) as well as several other highlights from this year's Society of NeuroInterventional Surgery (SNIS) annual meeting (31 July–4 August, San Diego, USA)
...
“The possibility to restore mobility to patients could have tremendous benefits,” says Mitchell Elkind, chief clinical science officer of the American Heart Association (AHA), and a tenured professor of neurology and epidemiology at Columbia University (New York City, USA),...
Cerevasc has announced that data from clinical studies examining the use of its eShunt system to treat elderly patients with normal-pressure hydrocephalus, and patients with communicating hydrocephalus following treatment for a ruptured cerebral aneurysm, were recently presented at the Congress...
Saluda Medical has announced that the US Food and Drug Administration (FDA) has approved magnetic resonance imaging (MRI) conditional labelling for its Evoke system, which the company claims is “the first and only” precision, dose-control spinal cord stimulation (SCS)...
Onward Medical has today announced the successful first-in-human implant of its ARC-IM stimulator intended to restore upper-extremity function after spinal cord injury (SCI). The implanted patient also received a wireless brain-computer interface (BCI) designed to initiate thought-driven movement when...
The Brain Aneurysm Foundation (BAF) has announced the recipients of its 2023 research grants, providing support to academic researchers studying the underlying biology of aneurysms or developing new treatment methods.
This year's grantees include leading academic researchers from across the USA and Canada whose...
New data from an analysis of patients who would have been eligible for the ARUBA trial—which previously indicated medical management is likely favourable over intervention in unruptured arteriovenous malformation (AVM) treatment—have produced results contradicting this seminal study, and look...
Data from the US Vascular Quality Initiative (VQI) have indicated that younger patients (aged ≤55 years) who undergo a carotid endarterectomy (CEA) procedure face an increased likelihood of carotid disease recurrence and late neurological events, as compared to their older...
Cerevasc has announced that the US Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) supplement to permit the expansion of a study of its eShunt system in patients with normal-pressure hydrocephalus (NPH) to additional study...
Vesalio has announced the recent presentation of key findings from the CLEAR study—a prospective, multicentre, open-label, single-arm, US Food and Drug Administration (FDA)-regulated investigational device exemption (IDE) trial evaluating the safety and effectiveness of the company’s Neva thrombectomy device,...
Given the potentially devastating consequences that can occur if an ischaemic stroke or acute intracranial aneurysm procedure goes wrong, an interventional neuroradiologist’s practice is inherently pressurised and extraordinarily demanding—even relative to the average physician. To gain insights on how...
Nevro Corporation has announced the publication of new data validating the health economic benefits of 10kHz therapy, the company’s proprietary, high-frequency spinal cord stimulation (SCS) therapy, in both painful diabetic neuropathy (PDN) and non-surgical refractory back pain (NSRBP). These...
Microvention, a wholly owned subsidiary of Terumo Corporation, announced today that the Sofia EX 5Fr 115cm intracranial support catheter received US Food and Drug Administration (FDA) 510(k) clearance on 15 September 2023 for use in transradial access in addition...
Sheba Medical Center in Tel Aviv, Israel has revealed the results from a “groundbreaking” study in the International Journal of Emergency Medicine, validating an artificial intelligence (AI) algorithm developed by Aidoc for intracerebral haemorrhage (ICH) detection.
The study demonstrated that machine...
To help “close the gap between knowledge and action”, the American Stroke Association (ASA) is launching a culturally relevant Spanish-language campaign named ‘Juntos Contra el Derrame Cerebral’ to raise awareness among Spanish-dominant audiences around the use and understanding of...
Motif Neurotech, a company developing minimally invasive bioelectronics for mental health conditions, has announced new research published to the preprint server Medrxiv that demonstrates the use of a millimetre-sized brain stimulator—the prototype Motif DOT microstimulator—in a human subject.
The study was a...
Route 92 Medical has announced the appointment of Jonathan Kennedy to the role of chief financial officer. In this role, Kennedy will be responsible for overseeing all financial management for the company, reporting directly to CEO and founder Tony...
Boston Scientific Corporation has today announced it has entered into a definitive agreement to acquire Relievant Medsystems—a privately held medical technology company that has developed and commercialised the Intracept intraosseous nerve ablation system to treat a form of chronic...
Cerevasc has today announced that findings from a clinical study examining the use of its eShunt system to treat communicating hydrocephalus were recently presented at the 2023 European Society of Minimally Invasive Neurological Therapy (ESMINT) congress (4–6 September, Marseille,...
Theranica has announced the results of a study, recently published in the journal Pain Management, suggesting the rapid impact of Nerivio—the first and only migraine ‘neuroband’, according to the company—in reducing numbers of migraine days.
A previous study had already...
The Congress of Neurological Surgeons (CNS) Foundation has launched its Pathway to Neurosurgery programme, an initiative dedicated to alleviating healthcare disparities by encouraging high school students from underrepresented groups to pursue a career in neurosurgery or medicine.
"This unique programme...
The Brain Aneurysm Foundation (BAF) has announced the launch of ‘Stop the Pop’—a new campaign intended to increase awareness of the prevalence and impact of brain aneurysms, and the need for ongoing investment to fund new innovations, screening, and...
Several presentations and news stories from this year’s Society of NeuroInterventional Surgery (SNIS) annual meeting (31 July–4 August, San Diego, USA) ended up among our most-read articles in August. Additionally, exclusive insights on intracranial aneurysm treatments—offered by a globally...
Synchron has announced completion of patient enrolment in the USA-based COMMAND trial assessing the company’s endovascular brain-computer interface (BCI) technology.
“Giving patients the option to receive a BCI device without the need for open brain surgery could open up a...
There are likely to be minimal differences in clinical outcomes between acute stroke patients presenting directly to endovascular treatment centres who undergo mechanical thrombectomy alone, and those who receive intravenous thrombolysis (IVT) plus thrombectomy. That is according to a...
Two separate systematic reviews and meta-analyses—both published recently in Neuromodulation: Technology at the Neural Interface—have concluded that intrathecal drug delivery (IDD) systems are effective in the management of cancer-related pain, with one report also finding an average reduction in...
When it comes to advising young physicians on how to navigate the more commercial, industry-entwined commitments that their career will most likely bring further down the line, there are few better-placed physicians than Ajay Wakhloo (Burlington, USA)—an interventional neuroradiologist-turned-inventor...
This advertorial, intended for readers outside the USA only, is sponsored by Penumbra.
Much of the clinical success that can be achieved with aspiration-based mechanical thrombectomy is dependent on the characteristics and features of the specific device being used. In...
This advertorial is sponsored by Medtronic.
Alberto Nania (National Health Service Lothian, Edinburgh, UK) speaks to NeuroNews to outline how, despite the rapid proliferation of new technologies and clinical data in the interventional neuroradiology (INR) space over the past...
Female representation in the neurointerventional world may be growing, but Johanna Fifi (Mount Sinai, New York, USA) and Anne-Christine Januel (Toulouse University Hospital, Toulouse, France) believe much more work can—and will—be done to carry this even further in the...
Endovascular therapy (EVT) treatments that achieve poor reperfusion have been found to result in inferior clinical outcomes compared to best medical management (BMM) in large vessel occlusion (LVO) acute ischaemic stroke patients.
That is according to a substudy of the...
Rapid Medical has announced Chinese National Medical Product Administration (NMPA) approval for its adjustable Tigertriever revascularisation device, making it the first device to offer patient-specific solutions for removing blood clots from the brain to advance the treatment of ischaemic...
Having initially sought out a career in plastic surgery, Ameer Hassan (Harlingen, USA) switched gears to interventional neurology in 2005—a change of heart he attributes to his “greatest mentor”—and never looked back. In addition to being triple board-certified in...
Mainstay Medical has announced the completion of enrolment in its RESTORE randomised clinical study of ReActiv8 for the treatment of intractable chronic low back pain. The study is designed to provide a direct comparison to optimised medical management for...
A novel brain stimulation technique called high-definition transcranial infraslow pink noise stimulation (HD-tIPNS) was recently evaluated in a placebo-controlled pilot study, and found to be both safe and feasible in the treatment of chronic tinnitus.
However, writing in the journal...
Brain Navi has announced the demonstration of NaoTrac, a neurosurgical navigation robot, and KrystoLens, a single-use neuro-endoscope, at two upcoming conferences: the Congress of Neurological Surgeons (CNS) annual meeting (9–13 September, Washington DC, USA) and the European Association of Neurosurgical Societies...
Nevro Corporation recently announced the publication of 24-month data from the SENZA painful diabetic neuropathy (PDN) randomised controlled trial (RCT)—the largest RCT to evaluate spinal cord stimulation (SCS) as a PDN treatment, the company claims—in Diabetes Research and Clinical Practice.
Published...
Protembis has announced the appointment of J Mocco (Icahn School of Medicine at Mount Sinai, New York, USA) as an independent member of its board of directors.
Mocco will offer insights into the strategic direction of the company as well...
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has designated three new approved bodies to increase the country’s capacity to certify medical devices.
TÜV SÜD, Intertek, and TÜV Rheinland UK join the four current UK approved bodies, almost doubling...
Mahesh Jayaraman, an interventional neuroradiologist at Rhode Island Hospital in Providence, USA—who has led national efforts to improve stroke systems of care in the USA—has been named the 2023 president of the Society of NeuroInterventional Surgery (SNIS), a scientific...
Medtronic has received CE-mark approval for its Inceptiv closed-loop rechargeable spinal cord stimulator in the treatment of chronic pain.
Inceptiv is the first Medtronic spinal cord stimulation (SCS) device to offer a closed-loop feature that senses each person's unique biological...
NOTE: This video is ONLY available to watch in selected countries and geographies
Much of the clinical success that can be achieved with aspiration-based mechanical thrombectomy is dependent on the characteristics and features of the specific device being used....
A case series conducted by Courtney Ellerbusch (Centura Home Health, Colorado, USA) on multiple sclerosis (MS) patients has found quantitative improvements in strength, spasticity, and range of motion, over a series of 18 treatments with Neubie direct-current neuromuscular electrical...
A collaborative study published in the journal Brain Stimulation has shown that targeted electrical stimulation in epilepsy patients with traumatic brain injury (TBI) can improve memory—more specifically, the recalling of words—by an average of 19%.
Led by Michael Jacob Kahana...
Laurent Pierot’s (Reims University Hospitals, Reims, France) long career in the treatment of intracranial aneurysms predates not only what many consider to be the advent of the interventional neuroradiology (INR) specialty, the ISAT trial, but also the introduction of...
The phenomenon of missing outcome data (MOD) within stroke registries of mechanical thrombectomy cases “is not a rare event and does not occur completely at random”. That is a key concluding message from research carried out and recently published...
Massachusetts patients experiencing stroke could soon have access to refined treatment, triage and transport protocols based on a provision in the US state’s new budget. According to a press release from the Society of NeuroInterventional Surgery (SNIS), the provision...
Nurami Medical, a medical device startup company, has received 510(k) clearance from the US Food and Drug Administration (FDA) for its electrospun nanofibre-based product, ArtiFascia Dura Substitute. US sales of this resorbable dural repair graft will begin in the upcoming...
Hubly Surgical has announced the results from the first peer-reviewed study comparing the safety and efficacy of its recently US Food and Drug Administration (FDA)-cleared portable cranial access drill with smart auto-stop to a well-established, non-portable neurosurgical perforator.
The...
Enspire DBS Therapy has announced the publication of the results of the EDEN trial—an early feasibility study led by Cleveland Clinic (Cleveland, USA) researchers assessing electrical stimulation of the dentate nucleus for upper-extremity hemiparesis due to ischaemic stroke—in Nature Medicine.
The EDEN...
BlueWind Medical has announced that the US Food and Drug Administration (FDA) has granted a de novo marketing request for the Revi system—a “transformative” tibial neuromodulation therapy for the treatment of the symptoms of urgency incontinence alone or in...
Kandu Health has announced preliminary outcomes from the first 40 stroke survivors served by its novel stroke recovery programme, which intends to support stroke patients returning to community settings after hospital discharge.
Preliminary data from the first 40 stroke survivors...
A new study led by researchers from the University of Chicago Medicine (Chicago, USA) has revealed that nearly 75% of acute stroke patients wait more than two hours to be transferred to a comprehensive stroke centre (CSC)—a treatment delay that creates...
Hyperfine has announced completed enrolment for HOPE PMR—a multicentre, observational pilot study assessing portable magnetic resonance imaging (MRI) in children with neurological injury, using hydrocephalus as an index condition.
With the aim of exploring a safer, more accessible solution for...
Flow Neuroscience, the creator of the Flow transcranial direct current stimulation (tDCS) headset for at-home, non-invasive brain stimulation to treat depression, has announced the results of its US Food and Drug Administration (FDA) pivotal clinical trial. The results show...
Imperative Care has announced a new organisational structure designed to accelerate the company’s growth across its businesses. As per an Imperative press release, this new business architecture connects a “continuum of stroke and vascular care” for patients, from onset...
NeuroNews’ 10 most popular stories from July reveal a huge amount of interest in the treatment of stroke patients with medium vessel occlusions (MeVOs)—with the role of mechanical thrombectomy being examined via expert opinion and published research alike. Key...
Saluda Medical has announced the publication of new health economic data in the Clinical Journal of Pain that provides “the strongest ever economic case” for the use of its Evoke closed-loop spinal cord stimulation (SCS) with physiologic SmartLoop technology over open-loop SCS therapy,...
More stroke patients are benefitting from life-changing treatment thanks to Brainomix's e-Stroke artificial intelligence (AI) platform, according to a recent report from the Oxford Academic Health Science Network (AHSN).
Brainomix's e-Stroke imaging technology uses AI to automatically process computed tomography...
A study presented at last week’s Society of NeuroInterventional Surgery (SNIS) annual meeting (31 July–4 August 2023, San Diego, USA) noted that mechanical thrombectomy—in addition to its usage in adults with large vessel occlusion (LVO) stroke—is also safe and...
Using a ‘care hotel’ model, which discharges patients to a specialty hospital hotel after smaller surgeries, can lower costs and shorten patients’ time in the hospital following some elective neuroendovascular interventions. That is according to a study presented recently...
Enspire DBS Therapy recently announced that it has raised US$17.6 million of committed capital in a Series B financing led by existing investor Cleveland Clinic Innovations. Also participating in the round were JobsOhio Growth Capital Fund and an undisclosed investor.
The company...
Anuncia Medical has announced the successful first implant of the company's US Food and Drug Administration (FDA)-cleared ReFlow mini flusher device.
Performed on by neurosurgeon Samuel Cheshier (Intermountain Primary Children's Hospital, Salt Lake City, USA), the patient previously required at least 11...
Imperative Care has announced late-breaking data from the Neurovascular Quality Initiative-Quality Outcome Database (NVQI-QOD) evaluating its Zoom stroke solution, which were presented at the Society of NeuroInterventional Surgery (SNIS) annual meeting (31 July–4 August 2023, San Diego, USA) by...
Kernel has unveiled its Flow2 system, which the company claims will give researchers and clinicians “unprecedented access” to robust, functional magnetic resonance imaging (fMRI)-like neuroimaging in a quick and user-friendly headset—making precision neuromedicine “more accessible than ever before”.
Flow2 incorporates...
During a late-breaking abstract session at this year’s Society of NeuroInterventional Surgery (SNIS) annual meeting (31 July–4 August, San Diego, USA), researchers discussed a smartphone application that can reliably, autonomously recognise patients’ physical signs of stroke thanks to the...
Contrary to the results of a seminal study in the field, a recent analysis presented at the Society of NeuroInterventional Surgery (SNIS) annual meeting (31 July–4 August, San Diego, USA) indicates that surgical approaches—including embolisation, microsurgery and radiosurgery—for treating...
Viz.ai has announced the presentation of three new abstracts that demonstrate the real-world impact of the Viz neuro suite at this week’s Society of NeuroInterventional Surgery (SNIS) annual meeting (31 July–4 August, San Diego, USA). These independent studies demonstrate...
A study presented yesterday at the Society of NeuroInterventional Surgery (SNIS) annual meeting (31 July–4 August, San Diego, USA) indicates that it may be possible to use a less invasive technique to identify the gene mutations responsible for some...
EOSolutions has announced the US Food and Drug Administration (FDA) 510(k) submission, through a design consulting firm, of the Thinline 8Fr sheath—a vascular access solution designed to complement the “remarkable features” of the company’s Dr Banner balloon guide catheter (BGC).
Together,...
Imperative Care has announced multiple new pieces of data from studies evaluating its Zoom stroke solution, presented at the ongoing Society of NeuroInterventional Surgery (SNIS) annual meeting (31 July–4 August, San Diego, USA).
“We are pleased to see the results...
Aidoc has announced the launch of its “revolutionary” Full Brain solution, which the company claims will significantly expand the anatomy analysed by artificial intelligence (AI) to identify suspected strokes, allowing for identification and care coordination of patients with medium...
Research presented at the ongoing Society of NeuroInterventional Surgery (SNIS) annual meeting (31 July–4 August, San Diego, USA) has shown that different types of stent-retriever tips may result in improved patient outcomes when performing a mechanical thrombectomy to treat...
Microvention, a wholly owned subsidiary of Terumo Corporation, has announced the publication of five-year follow-up data from the WEB-IT trial and the addition of two sizes to its Woven EndoBridge (WEB) aneurysm embolisation system.
With these now-published five-year clinical trial data,...
A study presented on the first day of the 2023 Society of NeuroInterventional Surgery (SNIS) annual meeting (31 July–4 August, San Diego, USA) has found that US rates of endovascular stroke thrombectomy are projected to increase “dramatically” based on...
This advertorial, sponsored by Siemens Healthineers, is intended for US readers only.
A neurosurgical clinic in Raleigh, USA recently opened an office-based lab (OBL)—specifically, the country’s first office-based endovascular neuro practice supported by a fixed biplane angiography system from Siemens...
Administering antiplatelet medication within 24 hours of a mechanical thrombectomy procedure may help stroke patients recover more successfully and prevent high-risk individuals from experiencing additional strokes, according to a study presented yesterday at the Society of NeuroInterventional Surgery (SNIS)...
Route 92 Medical has today announced the publication of a retrospective, first-in-human study featuring its FreeClimb 70 reperfusion system in the journal Interventional Neuroradiology. The study, conducted across five US centres and one international site, reports “impressive” M1 first-pass...
A novel approach to vagus nerve stimulation (VNS) may enable successful post-stroke recovery without the need for “invasive and often-uninsured” traditional VNS therapies.
A paper published in the journal Neurorehabilitation and Neural Repair by Medical University of South Carolina (MUSC) researchers...
Mainstay Medical recently announced the publication of three-year clinical data from the post-market clinical follow-up (PMCF) study of 33 ReActiv8 patients at five medical centres across the UK. ReActiv8 is an implantable medical device designed to treat adults with...
Anuncia Medical has announced the successful US commercial launch of the ReFlow mini flusher—a second-generation device for the treatment of hydrocephalus. According to a company press release, neurosurgeons in the USA and, soon, internationally will now have a new...
In a guest piece for NeuroNews, Thomas Devlin (Chattanooga, USA) and Michelle Luffey advise the community on how best to navigate the transition from primary stroke centres (PSCs) to comprehensive stroke centres (CSCs) and, in doing so, provide stroke...
Nicolab and Titan Neuroscience Research Australia have announced the formal signing of a Memorandum of Understanding (MOU) between the two organisations. The MOU outlines the establishment of a collaborative partnership aimed at leveraging their respective resources and expertise.
This MOU...
Hubly Surgical has successfully closed its Series seed funding round at an oversubscribed US$3 million. As per a company announcement, this investment comes on the heels of a recent US Food and Drug Administration (FDA) clearance for the Hubly Drill—a patented...
Nalu Medical, a company that has miniaturised neurostimulation implants for the management of chronic intractable pain for both peripheral nerve stimulation (PNS) and spinal cord stimulation (SCS) indications, presented new data from several studies at the recent American Society...
Imperative Care has announced US Food and Drug Administration (FDA) 510(k) clearance of its Zoom 88 large distal platform (LDP) support, a portfolio expansion of the company’s original Zoom 88 LDP.
In a press release, Imperative claims to have pioneered...
RapidAI today announced US$75 million in Series C funding led by Vista Credit Partners, a subsidiary of Vista Equity Partners and strategic financing partner focused on the enterprise software, data and technology markets.
A press release details that the funding aims to...
Arsenal Medical has today announced enrolment of the first patient treated with the company’s investigational NeoCast embolic biomaterial for neurovascular conditions.
The patient was successfully embolised as part of the NeoCast first-in-human clinical trial—an open-label, multicentre study evaluating the early...
iVascular has announced that the SEMTIC study, evaluating the safety and efficacy of its comprehensive stroke thrombectomy treatment, is one step closer to providing its first outcome data, with more than 50% of patients having now been enrolled.
The primary...
When utilised as a first-line technique for medium vessel occlusion (MeVO) stroke, aspiration and stent-retriever thrombectomy have demonstrated “no significant difference” in imaging-related or clinical outcomes. That is according to a multicentre, propensity score-matched analysis including more than 400...
Insightec has announced US Food and Drug Administration (FDA) approval of the five-year study endpoint for what it claims is the largest prospective, long-term follow-up study of unilateral magnetic resonance-guided focused ultrasound (MRgFUS) surgery, or ‘thalamotomy’, for essential tremor...
Magnus Medical has announced that the first participants have been treated in the Open Label Optimisation (OLO) clinical trial evaluating the effectiveness of the company’s neuromodulation system with SAINT technology for the treatment of major depressive disorder (MDD).
“SAINT therapy...
Experts in Germany are working on an ‘intelligent suit’ with which they hope to significantly improve rehabilitation after a serious spinal cord injury. This artificial intelligence (AI)-supported solution will be developed over the next three years by researchers from...
Researchers in Germany have developed a new deep learning model for detecting stroke lesions, claiming that—by leveraging rich geometric information to segment brain stroke lesion images—the proposed approach may be able to outperform other, more widely used neural network...
Neurolief has announced positive results from a planned interim analysis of the ongoing, randomised controlled MOOD pivotal trial, which is studying Relivion DP—a novel neuromodulation therapy for the treatment of major depressive disorder (MDD).
At a meeting of the study's...
Rapid Medical has announced new clinical data demonstrating the “significant advantages” of its novel Comaneci embolisation assist device over established techniques to treat ruptured wide-neck intracranial aneurysms.
A recent meta-analysis published in World Neurosurgery found that Comaneci is associated with...
The concluding findings of a systematic review and meta-analysis published in the journal Neurosurgery indicate that flow-diverter performance in posterior communicating artery (PComA) aneurysms is “comparable” to the outcomes observed in other supraclinoid aneurysm subtypes.
Authors Santiago Ortega-Gutierrez (University of...
Cognito Therapeutics has announced “robust, lobe-specific” changes in white matter volume and myelination in Alzheimer’s disease patients following six months of non-invasive gamma stimulation therapy using its at-home wearable device.
The company presented new imaging data at the 2023 Alzheimer’s...
The neuromodulation space has proliferated significantly over the past few years, and one area in which this is most notable is with the expansion of spinal cord stimulation (SCS)—not only in terms of technological advancements, but also regarding the...
Royal Philips has today announced enrolment of the first patients in both the USA and France into the large-scale WE-TRUST study—a multicentre, prospective randomised controlled trial assessing whether a direct-to-angio-suite (DTAS) workflow improves outcomes for early time-window stroke patients...
Despite having worse stroke symptoms and living within comparable distances to comprehensive stroke centres (CSCs), women with large vessel occlusion (LVO) acute ischaemic stroke are less likely to be routed to these types of centres compared to men, according...
The two prevailing techniques used during surgical treatments of traumatic acute subdural haematomas (SDHs)—craniotomy and decompressive craniectomy—have demonstrated broadly similar efficacy outcomes in a randomised controlled trial (RCT). However, reporting their findings in the New England Journal of Medicine...
Evren Technologies has announced the launch of its Phoenix 100 system, a “state-of-the-art” transcutaneous auricular vagus nerve stimulator (taVNS) research tool.
The Phoenix 100 system is intended to solve longstanding challenges faced by researchers in the realm of VNS, as—according to a...
A US centre has achieved a steep drop in infection rates among its neurosurgery patients over a two-year period thanks to the implementation of a multidisciplinary quality and process improvement initiative—as per a recent presentation at the Association for...
Stryker has commercially launched its Q guidance system with cranial guidance software to provide surgeons with an image-based planning and intraoperative guidance system that assists in positioning instruments and identifying patient anatomy during cranial surgery.
The software can be used...
Engineers at Rice University (Houston, USA) have created nanoelectrodes that are minimally invasive and exceptionally flexible—and, as such, have the potential to function as an implanted platform, enabling long-term, high-resolution neurostimulation therapy.
As per a statement from Rice University, traditional,...
Hyperfine, the company that created the Swoop system—which it claims is the world’s first US Food and Drug Administration (FDA)-cleared portable magnetic resonance (MR) brain imaging system—has today announced the commencement of the ACTION PMR study.
To support its acute stroke care...
With multiple large clinical trials currently underway to assess thrombectomy treatments in patients with medium vessel occlusion (MeVO) stroke, Johanna Ospel (Calgary, Canada) takes a look at the possibility of endovascular therapy (EVT) becoming the standard of care for...
ZAP Surgical Systems has announced that the company has received National Medical Products Administration (NMPA) approval in China for its ZAP-X gyroscopic radiosurgery platform.
ZAP-X was previously granted NMPA’s Chinese Medical Device Evaluation (CMDE) green pathway, an accelerated path for...
Zeta Surgical has successfully treated its first patient using the Zeta cranial navigation system as part of a first-in-human trial at the National Neuroscience Institute (NNI) in Singapore.
The clinical trial at NNI aims to evaluate the safety, efficacy and feasibility of...
Append Medical has raised US$4.35 million as part of an extended series A round, which will be used to support the company's first-in-human trials of Appligator.
Investors include participants from the first tranche of the series A round, as well as new investors,...
The results of a clinical trial have shown that a drug commonly used for patients with bleeding disorders has the potential to lessen the side-effects of blood-thinning drugs in stroke patients.
Researchers from the University of Nottingham (Nottingham, UK) and...
Highly targeted electrical stimulation to the brain has shown promise as a treatment option for acute ischaemic stroke, according to a pilot study led by University of California Los Angeles (UCLA) Health researchers in Los Angeles, USA.
The study is the first...
In addition to a number of key study presentations from the European Stroke Organisation Conference (ESOC; 24–26 May, Munich, Germany), NeuroNews’ most popular stories from June include pain physicians’ response to a recent review of spinal cord stimulation (SCS)...
MindRhythm, in partnership with Wayne State University School of Medicine (Detroit, USA), recently announced that the first patient has been enrolled in the pivotal portion of its EPISODE-VS study—which is designed to validate that use of the company’s proprietary...
Researchers at the RIKEN Center for Brain Science (CBS) in Wako, Japan have discovered a set of related mutations that lead to intracranial aneurysms. The mutations all appear to act on the same biological signalling pathway, and—writing in the...
Theranica has announced the results of a study recently published in the journal Headache demonstrating the safety of its Nerivio device—a novel remote electrical neuromodulation (REN) wearable—as a drug-free treatment for pregnant women with migraine.
The study found no statistically...
Neuroprotective agents and steerable microcatheter technologies were among a number of potential new interventional neuroradiology (INR) frontiers showcased and discussed at this year’s LINNC Paris Course (5–7 June 2023, Paris, France)—with faculty member Ricardo Hanel (University of Florida, Jacksonville,...
SynerFuse has announced that—for the first time in the world, it claims—a solo spine surgeon has performed the SynerFuse procedure in a two-level spinal fusion patient.
Rohan Lall (M Health Fairview, Minneapolis, USA) performed the procedure and implanted a neurostimulator...
Just two months after announcing what it claims is the “world's first positive surgical trial” in haemorrhagic stroke, NICO Corporation is awarding a US$200,000 investigator-initiated study grant with the goal of building on conclusions from the ENRICH study and...
Microvention, a wholly owned subsidiary of Terumo, has announced that the ERIC retrieval device is now commercially available in the USA for ischaemic stroke treatment, having received 510(k) clearance from the US Food and Drug Administration (FDA) on 31 March 2022.
"The...
A new study from Keck Medicine at the University of Southern California (USC; Los Angeles, USA) has uncovered “significant racial disparities” in the diagnosis, treatment and outcomes of peripheral artery disease (PAD) among Black and white patients in the USA.
“We discovered that Black...
InspireMD today announced that it has completed enrolment of its ongoing C-Guardians US Investigational Device Exemption (IDE) clinical trial, designed to support potential US marketing approval of its CGuard Prime embolic prevention stent (EPS) system.
The C-Guardians clinical trial is...
Expert groups from the USA and China have separately introduced new guidelines relating to the management of aneurysmal subarachnoid haemorrhage (aSAH). The updated guidelines—spearheaded by the American Heart Association/American Stroke Association (AHA/ASA)—are intended to provide “patient-centric recommendations for clinicians...
LivaNova has announced that the 150th bipolar depression patient has been randomised in its RECOVER clinical study—a prospective, multicentre, double-blinded randomised controlled trial investigating the safety and effectiveness of the company’s vagus nerve stimulation (VNS) therapy system as an...
As president of the Society of NeuroInterventional Surgery (SNIS), endovascular neurosurgeon J Mocco (Icahn School of Medicine at Mount Sinai, New York, USA) has aspired to take the baton from his predecessors and carry forward their work in improving...
Alessandro Gregio (University of Bologna, Bologna, Italy) recently presented midterm results from the Carotid asymptomatic stenosis observational study during the first of two Society of Vascular Surgery-Vascular and Endovascular Surgery Society (SVS-VESS) scientific sessions on the opening day of...
As per a press release from AptaTargets, JAMA Neurology has published positive results from APRIL—a Phase 1b/2a clinical trial evaluating the safety and efficacy of the neuroprotective drug ApTOLL in combination with endovascular therapy (EVT) in patients with acute...
Pain physicians have urged the Cochrane Library to retract and revise a recent review of spinal cord stimulation (SCS) in the treatment of low back pain, citing “striking errors” across the publication’s methodology, executions and conclusions.
Writing in the Cochrane...
Sensome and Asahi Intecc have today announced a collaboration to develop the next-generation Clotild smart guidewire, with Asahi Intecc taking on the manufacturing role for this artificial intelligence (AI)-powered device intended for the treatment of acute ischaemic stroke.
As a...
Transient ischaemic attacks (TIAs) encountered with incomplete neurovascular imaging in emergency departments (EDs) have been associated with higher odds of subsequent stroke within 90 days, as per a publication in the American Journal of Roentgenology (AJR).
“Increased access to urgent neurovascular...
Imperative Care recently announced the appointment of Kirsten Carroll as the new CEO of Kandu Health—a digital health startup with the aim of improving quality of life for people affected by stroke. The company has also announced the successful enrolment...
A prospective study has demonstrated that carotid intervention can improve mood in depressed patients with advanced carotid disease, in addition to enabling cognitive improvements irrespective of baseline depression.
These findings were presented at the Vascular Annual Meeting (VAM; 14–17 June,...
A durability study that looks at reintervention risk among patients treated with carotid endarterectomy (CEA) versus carotid artery stenting (CAS) procedures established that CEA demonstrated the lowest risk up to six months after surgery. A subgroup analysis between stenting...
Findings that consider the incidence of carotid stent fractures and their impact on stent durability were elucidated by Neeta Karani (Bronson Healthcare, Kalamazoo, USA) during a plenary session at this week's Vascular Annual Meeting (VAM; 14–17 June 2023, National...
A study presented recently at the Vascular Annual Meeting (VAM; 14–17 June, National Harbor, USA) has found that the long-term outcomes of transcarotid artery revascularisation (TCAR) are “not significantly affected” by prior head and neck radiation. Owing to substantially...
Earlier this year, researchers debuted single-centre experiences indicating that intravascular lithotripsy (IVL) may be able to expand transcarotid artery revascularisation (TCAR) into patients with traditionally prohibitive calcific disease. With a multicentre case series now further suggesting IVL’s utility, but...
Royal Philips has today announced the results of a health economics analysis published in the Journal of NeuroInterventional Surgery (JNIS) that show an “innovative approach” to the stroke care pathway—referred to as direct-to-angio suite (DTAS)—can reduce costs by an average of €2,848...
A multicentre study presented at the recent European Stroke Organisation Conference (ESOC; 24–26 May, Munich, Germany) has found that vision recovery and an increased likelihood of early neurological improvement are among the potential benefits endovascular therapy (EVT) can offer...
A new study conducted by scientists at Louisiana State University (LSU) Health New Orleans Neuroscience Center of Excellence (New Orleans, USA) reports that the additive neuroprotection of a combination of two omega-3 fatty acid-derived signalling molecules is more effective...
By identifying plasma proteomic determinants of incident cardioembolic and non-cardioembolic ischaemic stroke, researchers in the USA have found a novel protein believed to be associated with stroke risk in patients with left atrial dysfunction.
Detailing findings from the Cardiovascular Health...
Imperative Care has announced the publication of early clinical data in the Journal of NeuroInterventional Surgery (JNIS) from a single-centre evaluation of the Zoom RDL radial access system.
This independent, retrospective evaluation of Zoom RDL in 29 patients—who underwent neurointerventional procedures from...
Precision Neuroscience Corporation has announced that the first in-human procedures in a pilot clinical study of its neural implant system have been successfully completed. In partnership with West Virginia University Rockefeller Neuroscience Institute (WVU RNI; Morgantown, USA), this study...
Presenting first-time data from large multicentre European studies at this year's Leipzig Interventional Course (LINC 2023; 6–9 June, Leipzig, Germany), Arne Schwindt (St Franziskus Hospital Münster, Münster, Germany) and Ralf Langhoff (Sankt Gertrauden Hospital, Berlin, Germany) delivered results that...
The US Food and Drug Administration (FDA) has released draft guidance with updated recommendations for good clinical practices (GCPs) aimed at modernising the design and conduct of clinical trials.
In a statement, the regulator said that the updates are intended...
Neuralace Medical has announced the upcoming clinical study presentation of the SEAT randomised controlled trial (RCT), which is assessing the safety and efficacy of its Axon therapy, at the American Society of Pain and Neuroscience (ASPN) conference (13–16 July, Miami, USA).
Leonardo...
While the exact location of atherosclerotic plaque ruptures—a common cause of myocardial infarction (MI) and stroke—has previously been unknown, researchers at Lund University (Lund, Sweden) have now managed to successfully map this phenomenon. In addition, the team has identified...
While a handful of our highlights from the European Stroke Organisation Conference (ESOC; 24–26 May, Munich, Germany) unsurprisingly feature in NeuroNews’ most-read stories through the month, key industry updates and a closer look at how ChatGPT (Open AI) may...
The MAGNA meta-analysis of individual patient data (IPD) has provided “strong, generalisable evidence” on the clinically meaningful benefits of endovascular therapy (EVT) in ischaemic stroke patients with a large-core infarct volume. Late-breaking findings from MAGNA were presented by Amrou...
At a time when many of Europe’s medical technology markets are effectively going backwards due to complications created by the EU Medical Device Regulation (MDR), corresponding sectors in the USA are receiving an inevitable boost. Alongside the US Food...
Anuncia Medical has announced that an article highlighting its US Food and Drug Administration (FDA)-cleared and CE-marked ReFlow ventricular system (Gen 1) with hydrocephalus shunts in patients suffering from chronic shunt occlusions has been published in Pediatric Neurosurgery.
Two years prior...
Nalu Medical has announced the first patient enrolment in the COMFORT-2 randomised controlled trial (RCT), which will assess the company’s peripheral nerve stimulation (PNS) technologies. Together with COMFORT-1, COMFORT-2 is designed to enrol the largest cohort of RCT subjects...
New data from the VECTOR randomised controlled trial—presented at the European Stroke Organisation Conference (ESOC; 24–26 May, Munich, Germany)—have indicated that a mechanical thrombectomy in which a stent retriever is deployed alongside contact aspiration, a 'combined technique', is not...
Highlights:
Positive results with the Woven EndoBridge (WEB; Microvention/Terumo Corporation) device—presented for the first time at the LINNC Americas Seminar (16–17 March, Miami, USA)—indicate its utility across a range of intracranial aneurysm types
Our very own editor-in-chief, Philip M...
Highlights:
Positive results with the Woven EndoBridge (WEB; Microvention/Terumo Corporation) device—presented for the first time at the LINNC Americas Seminar (16–17 March, Miami, USA)—indicate its utility across a range of intracranial aneurysm types
Our very own editor-in-chief, Philip M...
The results of the TESLA trial were recently presented at the European Stroke Organisation Conference (ESOC; 24–26 May, Munich, Germany), demonstrating a “strong suggestion” across several domains that endovascular therapy (EVT) can provide benefits over best medical management (BMM)...
Penumbra has announced the US Food and Drug Administration (FDA) clearance and launch of Lightning Bolt 7, which the company claims is the most advanced and powerful arterial thrombectomy system on the market.
Lightning Bolt 7 introduces a new method...
Adept Medical has announced the launch of the Head Immobiliser—a radiolucent support for a range of interventional radiology (IR) and neuroradiology procedures. Now commercially available, the positioning device can help mitigate the costs of retakes, from reducing the amount...
Following the presentation of new trials assessing intracranial haemorrhage (ICH) treatment approaches, INTERACT3 and ENRICH, Craig Anderson (The George Institute for Global Health, Sydney, Australia)—who delivered first-time data from the former of the two studies—posited that, “maybe, the time...
Stryker has announced that Early Product Surveillance (EPS) cases utilising its Q guidance system with cranial guidance software are underway. The technology provides surgeons with image-based planning and an intraoperative guidance system designed to support cranial surgeries, a company press...
A collaboration analysing several major clinical trials has found that endovascular therapy (EVT) plus intravenous thrombolysis (IVT) is likely to be superior to EVT alone—also known as direct EVT—in the majority of ischaemic stroke patients, but that one of...
Nicolab has been awarded a prestigious three-year contract to supply stroke workflow software and advanced artificial intelligence (AI) diagnostics for the Victorian Stroke Telemedicine (VST) service in Viewbank, Australia.
The VST service—a virtual platform that connects healthcare professionals across multiple...
EOSolutions Corporation has announced the introduction of the Dr Banner balloon guide catheter (BGC), which boasts “unmatched features” for neurovascular procedures. As per a company press release, the device was developed in collaboration with InNeuroCo, and sets “new benchmarks”...
Supplying healthcare providers with performance feedback can significantly reduce the time between an ischaemic stroke patient arriving at a hospital and them subsequently receiving endovascular therapy (EVT), according to the findings of a clinical trial presented at last week’s...
Onward Medical has announced a recent publication in Nature showing that a wireless brain-computer interface (BCI) can use patients’ thoughts to modulate ARC therapy. Researchers reported that, when paired with the company’s ARC therapy, an implanted BCI allowed an...
Positive results from a clinical trial involving a novel therapeutic procedure known as sonolysis—deployed during a carotid endarterectomy (CEA)—were presented at the recent European Stroke Organisation Conference (ESOC; 24–26 May, Munich, Germany).
“The randomised clinical trial confirmed the results of...
NeuroOne Medical Technologies has announced the first clinical case using the Evo stereoelectroencephalography (sEEG) electrode in robotic neurosurgery.
Performed by William Bingaman at Cleveland Clinic in Cleveland, USA, the procedure was the first to utilise NeuroOne’s Evo sEEG electrode—exclusively marketed in the...
A retrospective study from China has concluded that the Pipeline Flex embolisation device (Medtronic) is safe and effective in the treatment of complex intracranial aneurysms. Reporting their results in Nature: Scientific Reports, Shun-Qiang Chen (Henan Provincial People's Hospital, Zhengzhou,...
Artiria Medical, a Swiss neurovascular company, has announced that its real-time, deflectable guidewire has been granted 510(k) clearance by the US Food and Drug Administration (FDA).
This milestone opens a “new pathway” to a “more advanced and effective approach”...
Interim results from the ECST-2 randomised controlled trial (RCT) have shown no evidence that carotid stenosis patients with a low-to-intermediate stroke risk, treated with optimised medical therapy, will benefit from additional carotid revascularisation via carotid endarterectomy (CEA) or carotid...
Results from the TIMELESS trial represent “fantastic news” on the safety of intravenous tenecteplase in selected late-window stroke patients, despite the drug failing to meet its prespecified primary and secondary efficacy endpoints.
That is according to Gregory Albers (Stanford...
While patients treated via a structured ambulatory post-stroke care programme (SANO) in a recent cluster-randomised study experienced better control of their cardiovascular risk factors compared to a control group, this did not translate into any significant reduction in recurrent...
In an attempt to promote more consistent and higher quality research in the field of small vessel disease (SVD), international experts have published the second iteration of the Standards for Reporting Vascular Changes on Neuroimaging (STRIVE-2)—an update to the...
As per results from the RESIST study, remote ischaemic conditioning (RIC)—while not being associated with any major safety issues—has failed to improve functional outcomes in patients with acute ischaemic stroke.
These findings were presented today at the European Stroke Organisation...
An international clinical trial presented today at the European Stroke Organisation Conference (ESOC; 24–26 May, Munich, Germany) has demonstrated that—in people with ischaemic stroke and atrial fibrillation—anticoagulation can safely be started earlier than current guidelines recommend.
"Our study finally brings...
A team of researchers from Denmark have developed a new artificial intelligence (AI) framework to address the number of strokes that go unrecognised by human emergency call handlers. The framework outperformed emergency call handlers in recognising stroke for both...
The Woven EndoBridge (WEB) 17 device (Microvention/Terumo Corporation) has demonstrated positive efficacy and safety outcomes in the prospective, multicentre CLEVER study, indicating its utility for intrasaccular embolisation across ruptured and unruptured intracranial aneurysms. Twelve-month results from the study were...
A new randomised controlled trial (RCT)—the “largest ever” of its kind in the major depressive disorder (MDD) space—will attempt to provide a “thorough understanding” of how treatment-resistant patients respond to vagus nerve stimulation (VNS) therapy.
Details of the RECOVER trial...
Both open and endovascular surgical approaches are likely to produce improved outcomes compared to ligation in the treatment of ruptured extracranial carotid artery aneurysms. This was the salient point delivered by Maarit Venermo (Helsinki University Hospital, Helsinki, Finland) at the...
An analysis published in the Journal of Neurosurgery, which assessed ChatGPT’s (OpenAI) performance on a surrogate for neurosurgical board-style questions, has found that the natural language processing (NLP) algorithm was able to significantly outperform medical students and was only...
Abbott has announced that the US Food and Drug Administration (FDA) has approved its spinal cord stimulation (SCS) devices for the treatment of chronic back pain in people who have not had or are not eligible to receive back...
‘Upstream’ causes of health inequities related to stroke—such as structural racism and conditions of the places where people live, learn, work and play—have not been studied well, according to a recent American Heart Association (AHA) scientific statement. The statement,...
RapidAI announced recently that its combined haemorrhagic solution—Rapid ICH (intracranial haemorrhage) and Rapid Hyperdensity—has been selected as the “Best New Imaging Solution” in the seventh annual MedTech Breakthrough Awards, which attracted more than 4,000 nominations from over 17 countries this...
Magnus Medical has shared promising results from a clinical trial published in the Proceedings of the National Academy of Sciences indicating that treatment with SAINT neuromodulation reverses abnormal brain signalling by changing the direction of brain signal flow in people with...
A nationwide cohort study of over 9,000 patients shows that the “controversial” practice of arteriotomy closure for carotid endarterectomy (CEA) is associated with an increased risk of ipsilateral stroke and “should be avoided”. Instead, authors Magnus Jonsson (Karolinska University...
As per a recently published retrospective chart review, the removal of sacral neuromodulation (SNM) devices in the office setting, under local anaesthesia, is a safe, well-tolerated and effective procedure.
Reporting their findings in the journal Urology, Sarah Martin and Howard...
Carthera has announced the publication in The Lancet Oncology of results from a Phase 1 clinical trial carried out by scientists at Northwestern University Feinberg School of Medicine (Chicago, USA). In the trial, they used the SonoCloud-9 implantable ultrasound...
Endovascular therapy (EVT) has been deemed safe and effective in patients with ischaemic stroke caused by an anterior circulation large-vessel occlusion (LVO) who present 6–24 hours from onset, or last seen well, who were selected on the basis of...
Abbott has announced that the US Food and Drug Administration (FDA) has approved expanded magnetic resonance imaging (MRI) labelling for its Eterna spinal cord stimulation (SCS) system to include new leads that are MR conditional—meaning people with chronic pain...
Earlier this week, the European Academy of Neurology (EAN) announced the launch of the Brain Health Mission, a collaborative initiative that aims to address the global crisis of brain disorders and present solutions.
The mission brings together governments, healthcare providers,...
“Overall, we just need better tools” was one of the salient points delivered by Jane Khalife (Cooper University Health Care, Camden, USA) in a talk at the LINNC Americas Seminar (16–17 March, Miami, USA) focusing on stroke cases with...
Hubly Surgical has received 510(k) clearance from the US Food and Drug Administration (FDA) to market its Hubly Drill, which the company describes as an innovative medical technology developed with the goal of making burr-hole procedures safer and more efficient in...
The Get Ahead of Stroke campaign is launching Survive Stroke Week from 15–21 May—an observance aimed at increasing awareness of stroke symptoms and the importance of calling 911 right away.
The longer a stroke patient’s treatment is delayed, the greater...
This advertorial is sponsored by CERENOVUS.
The EMBOTRAP® family of revascularisation devices (CERENOVUS) is innovative within the stent retriever space due to its differentiated design based on a wealth of clot-science research. As a physician currently using EMBOTRAP in mechanical...
Cerevasc has announced that data on its minimally invasive central nervous system (CNS) delivery system will be presented for the first time at the American Society of Gene and Cell Therapy annual meeting (16–20 May 2023, Los Angeles, USA).
The...
Brian Fiani (Livonia, USA) and Ryan Jarrah (Rochester, USA) take a look at the neurosurgical implications of one of the hottest topics permeating not only the medical industry, but virtually all of society, right now—the natural language processing (NLP)...
A systematic review and analysis published in the journal Interventional Neuroradiology has examined how far along “the right path” management paradigms for persistent primitive trigeminal artery (PPTA) aneurysms currently are—ultimately concluding that, while endovascular techniques in this area are successful, “meticulous”...
ConcertAI's TeraRecon has announced the release of Neuro Suite, its artificial intelligence (AI)-driven clinical suite, which the company claims is purpose-built for disease triage, differential diagnostic insights, and care activation in many neurological disease states—such as neuro-oncology, dementia, multiple...
MIVI Neuroscience has announced that it has completed enrolment in the EVAQ clinical trial to assess the safety and effectiveness of the Q revascularisation system for the treatment of acute ischaemic stroke.
The EVAQ trial has enrolled 121 patients at 17...
“The time has definitely come to look at the evidence, and redo these studies,” posited Alun Davies (Imperial College London, London, UK), putting forward his argument that the NASCET and ECST clinical trials “need to be reconducted” at this...
The Heart and Stroke Foundation, Brain Canada, and the Canadian Stroke Consortium, have announced the recipients of the 2022 Stroke Clinical Research Catalyst grants. The purpose of this programme, as per a joint press release, is to increase the capacity for clinical stroke...
A number of potentially contentious issues caught the eye of our readers in April—including how best to define 'success' in stroke thrombectomy; efforts to expand the range of specialties capable of performing these procedures; and question marks over the...
NeuroOne Medical Technologies has announced the commercial launch of the Evo stereoelectroencephalography (sEEG) electrode product line in the USA.
Zimmer Biomet holds exclusive worldwide distribution rights to NeuroOne’s Evo Cortical and sEEG product lines, and the Evo product line is expected...
Researchers at the Feinstein Institutes for Medical Research (Manhasset, USA) have received a US$3.4 million grant from Wellcome to study repetitive transcranial magnetic stimulation (rTMS) and its effects—potentially opening the door for a new, non-pharmacological way to treat major mental health disorders like schizophrenia...
Stryker announced today that it has completed the acquisition of Cerus Endovascular—a medical device company engaged in the design and development of neurointerventional devices for the treatment of intracranial aneurysms.
Cerus’ CE-marked products, including the Contour neurovascular system and the...
New research has indicated that Mexican Americans have worse outcomes after a stroke than non-Hispanic white Americans.
A recent study, which looked at whether the language Mexican American people speak is linked to how well they recover after a stroke,...
Cerenovus has announced that the new Cerepak detachable coils are now commercially available in the USA, and that the first patient cases have been performed. Cerepak is the latest innovation to join the company’s haemorrhagic stroke portfolio.
The Cerepak detachable...
More than half of all stroke survivors may develop cognitive impairment within a year after their stroke, and one in three are at risk for developing dementia within five years. That is according to a new American Heart Association (AHA) scientific statement...
Having taken place via a virtual format in 2021, and as a hybrid meeting last year, the 2023 European Stroke Organisation Conference (ESOC; 24–26 May, Munich, Germany) is set to return to a more traditional, fully on-site setup. Robin...
SynerFuse has announced that Michael Park (University of Minnesota, Minneapolis, USA)—principal investigator for the company’s investigational device exemption (IDE) proof-of-concept study—presented data from the study’s first eight patients at the 10th annual Minnesota Neuromodulation Symposium (20–21 April, Minneapolis, USA).
"This presentation showcased the...
A debate between two prominent carotid interventionists—Peter Schneider (University of California San Francisco, San Francisco, USA) and Domenico Valenti (King's College London, London, UK)—on the Wednesday of the Charing Cross (CX) symposium (25–27 April 2023, London, UK) revealed that...
Penumbra recently announced the launch of the latest addition to its RED family of catheter devices for mechanical thrombectomy, the RED 43 reperfusion catheter.
According to the company, this device is intended to take distal aspiration “to the next level”...
NICO Corporation has announced initial positive results from the completed ENRICH trial at the 2023 American Association of Neurological Surgeons (AANS) annual scientific meeting (21–24 April, Los Angeles, USA). ENRICH was designed to evaluate the safety, efficacy, and economic outcomes...
Route 92 Medical has today announced receipt of 510(k) clearance from the US Food and Drug Administration (FDA) for its FreeClimb 70 reperfusion system, which includes the FreeClimb 70 aspiration catheter along with the Tenzing 7 delivery catheter.
The FreeClimb...
Biotronik has announced US Food and Drug Administration (FDA) approval for Prospera—a new spinal cord stimulation (SCS) system. The system features RESONANCE, which the company claims is the first and only multiphase stimulation paradigm, paired with Embrace One, which...
Cercare Medical has announced it will be bringing its neurovascular clinical workflows into ConcertAI's TeraRecon Eureka clinical artificial intelligence (AI) platform as part of a new partnership.
The platform is intended to provide clinicians with state-of-the-art AI and deep learning technologies, delivering...
NICO Corporation has announced that the results from the completed ENRICH trial will be presented at the annual American Association of Neurological Surgeons (AANS) meeting (21–24 April 2023, Los Angeles, USA).
The ENRICH results were accepted as a late-breaker and...
RapidAI announced today that it has received US Food and Drug Administration (FDA) 510(k) clearance for Rapid non-contrast computed tomography (NCCT) Stroke, which is intended to support faster treatment and transfer decisions in stroke care.
A company press release describes this...
A new set of guidelines intended to standardise and expand stroke thrombectomy training have been published simultaneously in Europe, in the journal Advances in Interventional Cardiology, and in the USA, in Cardiovascular Revascularization Medicine.
The World Federation for Interventional Stroke...
Theranica recently had the results from a real-world analysis of Nerivio for acute treatment of migraine in adolescents published in the journal Pediatric Neurology. The study demonstrates the ease of use, safety and efficacy of Nerivio—the company’s remote electrical neuromodulation...
A “landmark” paper published in The Lancet Neurology by leaders of the Parkinson's Progression Markers Initiative (PPMI)—a study sponsored by The Michael J Fox Foundation (MJFF) for Parkinson's Research—confirms what the charity describes as “the most significant breakthrough yet” in the...
Jason Pope (Santa Rosa, USA) discusses closed-loop spinal cord stimulation (SCS) and its potential to provide sustained, holistic outcomes for chronic pain patients. In addition to describing these theoretical benefits and the mechanisms of action by which they can...
Lithotripsy may hold the key to enabling more carotid artery disease patients who require calcification treatment to undergo stent placement via a transcarotid artery revascularisation (TCAR) procedure, as per single-centre experiences presented at the recent Society for Clinical Vascular...
Adept Medical has launched the Adducted Arm Scoop—an improved solution for supporting the adducted arms of supine patients during image-guided procedures.
Adept’s new, “extremely durable” Adducted Arm Scoops are purpose-designed, providing security and comfort on narrow imaging tables, as per...
This week, three companies developing novel neuromodulation technologies for use in the treatment of various neurological disorders have each separately announced the receipt of significant financing rounds intended to boost their respective brain stimulation therapies.
Saluda Medical has announced the...
Moderate- to high-quality evidence suggests that specific neuromodulation modalities can provide effective treatments in patients undergoing stroke rehabilitation. As per a systematic review and meta-analysis, these therapeutic approaches are able to improve upper-limb motor function in both acute/subacute and...
Annalise.ai has received US Food and Drug Administration (FDA) 510(k) clearances covering an additional seven findings as part of the company's innovative artificial intelligence (AI)-assisted triage and notification solutions. The clearances, which include a suite of time-sensitive stroke findings...
A recent data presentation has revealed reduced risk of stroke and mortality among transcarotid artery revascularisation (TCAR) patients who receive dual antiplatelet therapy (DAPT), at discharge, as compared to other drug regimens. Researchers believe these findings underscore the importance...
Reach Neuro has been granted a Breakthrough Device designation by the US Food and Drug Administration (FDA) for its Avantis platform, which uses small electrical impulses delivered to the spinal cord to help restore shoulder, arm and hand movement...
Intravenous tenecteplase was associated with a higher rate of intracranial haemorrhage (ICH), as compared to alteplase, in a recent analysis of real-world data from acute ischaemic stroke patients who did not undergo a thrombectomy procedure.
Navpreet Bains (University of Missouri,...
The peer-reviewed journal Pain and Therapy recently published a new study, titled "Reduced pain and improved function following short-term use of non-invasive BioWave high-frequency peripheral nerve stimulation for pain management", authored by Alaa Abd-Elsayed (University of Wisconsin School of Medicine and...
While a number of companies in the neurovascular space have become increasingly focused on the ‘first-pass effect’ in mechanical thrombectomy treatments, many major clinical trials assessing the safety and efficacy of the technique still favour a ‘rule-of-three’ paradigm. And—although...
A nationwide study drawing on data from Swedish patients has indicated that—while the majority of ruptured intracranial aneurysm patients treated with microsurgery experienced favourable outcomes—intraoperative adverse events were associated with an increased risk of unfavourable outcomes.
Writing in the Journal...
A new probe that performs two types of spectroscopy could make deep brain stimulation (DBS) procedures safer and improve success rates by helping doctors more accurately navigate instruments inside the brain in patients with advanced Parkinson’s disease.
The research team...
A unique case presentation at this year’s LINNC Americas Seminar (16–17 March, Miami, USA) saw Rafael de Oliveira Sillero (University of Texas Southwestern Medical Center, Dallas, USA) outline how he treated a child with ischaemic stroke at his centre,...
Astrocyte Pharmaceuticals has announced the initiation of a Phase 1b study of its lead cerebroprotective candidate, AST-004, as an extended infusion in healthy volunteers. This adaptive-design clinical study will be conducted over the next four-to-six months at the QPS...
The Catholic Health Initiatives (CHI) Memorial Stroke and Neuroscience Center has announced its participation in the national research study, BUBL, stating that it was “instrumental” in developing the technology involved—a novel solution intended to better detect a specific cause...
A randomised controlled trial (RCT) involving more than 200 patients has indicated that stent-assisted coiling (SAC) is not superior to coiling alone in unruptured intracranial aneurysm cases with a high risk of recurrence.
Reporting results from the STAT trial in...
In addition to the US approval of a unique neurovascular device, discussions around female physicians in the neurointerventional space; pushback against the European Union’s (EU) recent decision to reclassify non-invasive brain stimulation technologies; and a study elucidating disparities in...
A recently published Cochrane review has concluded that the clinical benefits of spinal cord stimulation (SCS) do not outweigh the risks and costs associated with the approach in patients with low back pain—leading researchers to claim that “there is...
Highlights:
The 2023 International Stroke Conference (ISC; 8–10 February, Dallas, USA) is punctuated by new data on neuroprotective medications in ischaemic stroke, sparking tempered optimism from delegates
Other late-breaking highlights from ISC 2023 include findings on tenecteplase’s utility versus...
Highlights:
The 2023 International Stroke Conference (ISC; 8–10 February, Dallas, USA) is punctuated by new data on neuroprotective medications in ischaemic stroke, sparking tempered optimism from delegates
Other late-breaking highlights from ISC 2023 include findings on tenecteplase's utility versus...
The opening statements and presentation of evidence are set for 10am PST today in a lawsuit involving claims that a medical doctor and his corporation retaliated against a former employee, Yamin Shwe, after she refused to be concurrently on-call...
The charity Chest, Heart and Stroke Scotland (CHSS) has voiced support for the Scottish government’s decision to reinstate “vital” funding of thrombectomy services across the country, stating that a “whirlwind two-week campaign” centred around its Thrombectomy for All petition...
Dual antiplatelet therapy (DAPT) has demonstrated improved clinical outcomes, including reduced in-hospital stroke and mortality risks, compared to other medication regimens in carotid artery disease patients who undergo stent placement via a transcarotid artery revascularisation (TCAR) procedure.
This is the...
Q'Apel Medical has been granted a CE mark under the European Medical Device Regulation (MDR) for Walrus, its balloon guide catheter (BGC) product used in the treatment of patients suffering an acute ischaemic stroke.
The Walrus BGC has been...
As medical accolades go, performing the world’s first robot-assisted neurointerventional procedure—a feat that Vitor Mendes Pereira and his team achieved back in 2019—is something any physician would be proud of. But, as a professor of Surgery and Medical Imaging...
Cerevasc has named neurosurgeon Adel Malek as its new chief medical officer. This appointment will allow the company to further accelerate the development and clinical strategy of the eShunt system—a minimally invasive device designed to treat communicating hydrocephalus—according to a press...
A new study found no difference in perioperative outcomes and incidence of adverse events at follow-up after transcarotid artery revascularisation (TCAR) between academic and non-teaching community institutions. Presented at the 2023 winter annual meeting of the Vascular and Endovascular...
The Brain Aneurysm Foundation (BAF), a leading global research and advocacy organisation committed to improving treatment and care for brain aneurysms, has announced the addition of Carolina Maier—vice president of Clinical Affairs at RapidAI—to its board of directors.
“We are beyond thrilled...
Alongside his colleagues at the Barts Health NHS Trust, Levansri Makalanda (London, UK) was responsible for setting up the second ever 24/7 mechanical thrombectomy service for ischaemic stroke in the UK. He recently spoke to NeuroNews to outline how...
A recent addition to Europe’s flow diversion market—the Derivo 2 embolisation device (DED2; Acandis)—has demonstrated promise in a small-scale, multicentre study, providing a safe and effective treatment for both ruptured and unruptured intracranial aneurysms.
Writing in Interventional Neuroradiology, study authors...
Athersys has announced planned amendments to its MASTERS-2 clinical trial protocol following a Type B meeting with the US Food and Drug Administration (FDA). Held on 21 March, the meeting addressed Athersys’ proposed modifications that seek to establish primary...
Brainomix has today announced that its 360 e-ASPECTS tool for stroke has received US Food and Drug Administration (FDA) clearance, enabling the company to deploy its cutting-edge artificial intelligence (AI) imaging platform to stroke centres in the USA.
With deployments...
Synchron has announced that the COMMAND trial assessing its endovascular brain-computer interface (BCI) technology is commencing enrolment at Gates Vascular Institute, a Kaleida Health facility and teaching affiliate of the Jacobs School of Medicine and Biomedical Sciences at the...
In the latter stages of 2022, the Society of NeuroInterventional Surgery (SNIS) released a position statement advocating pregnancy and parental leave policies in neurointerventional surgery, stating a belief that physicians “should not have to choose” between a fulfilling family...
A total of £10 million has been awarded to the Medicines and Healthcare products Regulatory Agency (MHRA)—an executive agency of the UK Department of Health and Social Care (DHSC)—to help bring innovative new medicines and medical technologies to UK...
ObvioHealth and Mi-Helper have announced a partnership to conduct a decentralised clinical trial with a small, non-invasive neuromodulation device for the treatment of migraines. The randomised controlled trial will be fully remote, enabling data capture from home—the setting in which...
NeuroOne Medical Technologies has announced the successful completion of an initial animal implant of its novel, thin-film paddle leads for spinal cord stimulation (SCS). The devices are intended for the treatment of patients with chronic back pain due to...
MindRhythm, in partnership with Wayne State University School of Medicine (Detroit, USA), has announced the first publication of results from its EPISODE-PS trial in the journal Stroke: Vascular and Interventional Neurology.
The EPISODE-PS trial was designed to evaluate the use...
A dystonia patient in Turkey who had been having uncontrollable involuntary contractions in her legs and arms for the past five years recently underwent brain pacemaker surgery—while awake and watching cartoons. The surgery was performed within the Medical Park Hospitals...
Scientia Vascular has announced the US Food and Drug Administration (FDA) 510(k) clearance of the Aristotle Colossus macrowire. The company claims that this device is the only 0.035-inch macrowire currently indicated for neurovascular intracranial use.
Like its predecessors—the Aristotle 18...
Carthera, which develops the Sonocloud—an ultrasound-based medical device used to treat a wide range of brain diseases—has announced today the completion of an end-of-Phase 2 meeting with the US Food and Drug Administration (FDA).
The company presented preclinical and clinical...
The European Society for Brain Stimulation (ESBS) has said it “strongly opposes” the European Union’s (EU) recent decision to reclassify non-invasive brain stimulation (NIBS) technologies as Class III medical devices.
In what ESBS members describe as a “sudden and unwelcome”...
With Brain Awareness Week (13–19 March) approaching, the Get Ahead of Stroke campaign has announced it is debuting new online resources for emergency medical service (EMS) providers, enabling them to assist stroke patients with greater efficiency and ease.
As a...
Distal embolic protection using a filter has been associated with improved transfemoral carotid artery stenting (tfCAS) outcomes in terms of in-hospital stroke and death risks—underpinning current Society for Vascular Surgery (SVS) guidelines recommending routine use of distal embolic protection...
The Society of Vascular and Interventional Neurology (SVIN) has released its first global analysis of access to mechanical thrombectomy for the treatment of large vessel occlusion (LVO) stroke. Findings from MT-GLASS—a study conducted as part of the SVIN Mission...
Neuromod Devices has announced that the US Food and Drug Administration (FDA) has granted de novo approval to Lenire—the first bimodal neuromodulation device of its kind to be approved by the FDA for the treatment of tinnitus, according to a company...
Nevro Corporation announced today that it has now initiated the full US market launch of its HFX iQ spinal cord stimulation (SCS) system, following the completion of a successful limited market release.
"This is an exciting time in spinal cord...
The European Union’s (EU) Council of Ministers has today adopted a resolution to extend the deadline for the certification of medical devices under the Medical Devices Regulation (MDR).
Producers of medical devices will have until 31 December 2027 for higher-risk...
A team from the University of Oklahoma (Norman, USA) has embarked on a five-year research project with the intention of designing a device that can be customised to better treat brain aneurysms.
For the project, researchers are set to use...
Children's Minnesota (Minneapolis, USA) has claimed, in a press release, to have become the first health system in North America to open a paediatric hybrid intraoperative magnetic resonance imaging (iMRI) suite equipped with both moving-scanner and moving-patient MRI technology in the same surgical...
Mainstay Medical has announced the publication of a paper, titled “Effect of Restorative Neurostimulation on Major Drivers of Chronic Low Back Pain Economic Impact", in the journal Neurosurgery. The paper contains a review of patients from the pivotal ReActiv8-B...
Spinal cord stimulation (SCS) therapy has been shown to trigger instant improvements in arm and hand mobility, enabling people affected by moderate-to-severe stroke to perform daily activities more easily, as reported in Nature Medicine by researchers from the University...
Physicians in the USA have published details of—to their knowledge—the “first reported use” of the Indigo aspiration system (Penumbra) to treat cerebral venous sinus thrombosis (CVST) via endovascular thrombectomy. The treated patient underwent successful partial recanalisation of the superior...
Altering the porosity of coiling in the treatment of cerebral aneurysms has been found to have a greater impact on maximum oscillatory shear index (OSI) among male patients, as compared to their female counterparts. This is the key concluding...
Stroke research was the flavour of the month throughout February on NeuroNews, with highlights from the International Stroke Conference (ISC; 8–10 February, Dallas, USA) featuring heavily in our most-read stories. Promising findings on the benefits of neuroprotection in ischaemic...
Theranica has announced that its drug-free Nerivio prescription wearable recently received US Food and Drug Administration (FDA) clearance as a dual-use acute and preventive treatment for migraine with or without aura in people 12 years of age or older....
NovaSignal has today announced the donation of a NovaGuide 2 intelligent ultrasound system to the Jacobs Institute in Buffalo, USA in order to advance stroke research, and use real-time neuromonitoring to detect and help prevent intraprocedural cardiovascular and neurovascular complications...
Researchers at the Feinstein Institutes for Medical Research (Manhasset, USA) are microscopically mapping more than 100,000 individual fibres that make up the vagus nerve to determine how they are anatomically connected, and which bodily functions they control, and recently...
Route 92 Medical has today announced the issuance of the company’s 80th global patent for its Monopoint operating platform. Route 92 claims this is “the only neurointervention platform” designed to streamline the delivery of large- and super-bore catheters for...
High-frequency spinal cord stimulation (HF-SCS) for treating chronic refractory low back pain (CRLBP) may be associated with a significant decrease in total healthcare costs, offsetting device acquisition costs within 27 months, according to a recent analysis published in Neuromodulation:...
Methinks has announced receipt of a CE mark for its artificial intelligence (AI)-based medical imaging software, Methinks Stroke Suite, following a milestone year of development progress enabling commercialisation in Europe and assisting in emergency settings for the benefit of acute stroke...
A study intended to examine the impact of different weather conditions and modes of transport on mechanical thrombectomies in stroke patients has found a link between higher temperatures and improved outcomes—whereas daily drizzle was associated with poorer post-thrombectomy outcomes.
As...
The opening day of the 2023 International Stroke Conference (ISC; 8–10 February, Dallas, USA) saw the presentation of findings from an animal-model study that assessed multiple promising neuroprotective agents—with one of these candidates, an intravenous, uric acid infusion, exceeding...
Cognito Therapeutics has announced the first patient enrolment in its US pivotal study, HOPE, which is designed to demonstrate the safety and efficacy of the company’s proprietary, non-invasive stimulation device—CogTx-001—in patients with Alzheimer’s disease.
The HOPE study for Alzheimer’s disease is...
Vesalio has announced the successful initial use of its NeVa VS device in the USA for the treatment of post-aneurysmal subarachnoid haemorrhage (aSAH) cerebral vasospasm.
"We are excited to be the first centre to use the NeVa VS device in...
Incepto, a distributor and co-creator of artificial intelligence (AI) solutions applied to medical imaging, has signed a partnership with Avicenna.AI to enrich its platform with new solutions for neurovascular pathologies like stroke.
All of Avicenna’s AI solutions are CE...
The initial findings from a recent randomised controlled trial (RCT) do not support the addition of extracranial to intracranial (EC-IC) bypass surgery to the current medical management of patients with symptomatic internal carotid artery (ICA) or middle cerebral artery...
CVRx has announced the preliminary topline results of the BEAT-HF (Baroreflex activation therapy for heart failure) postmarket clinical trial.
The BEAT-HF postmarket phase of the multicentre, prospective, randomised controlled trial assessed 323 patients suffering from heart failure with reduced ejection...
A randomised trial has found mechanical thrombectomy procedures performed within 24 hours of symptom onset to be more effective than standard medical care in treating acute ischaemic strokes caused by anterior circulation large vessel occlusions (LVOs) with a large...
Brainomix has announced its involvement in a new study sponsored by the University of Liverpool (Liverpool, UK) focused on post-stroke atrial fibrillation (AF). Sites with existing clinical deployments of Brainomix's e-Stroke platform will utilise the artificial intelligence (AI) system...
The favourable trend toward gender parity that has been seen within neurology faculty over the past decade “has not translated” to the leadership of stroke-related clinical trials, as per a recent analysis published in the journal Stroke.
“The results of...
Viz.ai has announced a collaboration with BIOS Clinical Trials Coordinating Center (BIOS CTTC) at Johns Hopkins University (Baltimore, USA) to expedite patient enrolment for the National Institutes of Health (NIH)-funded BEACH study, which is assessing a novel treatment for...
Mechanical thrombectomy appears to be a safe and technically feasible treatment option for ischaemic strokes caused by primary isolated anterior cerebral artery (ACA) occlusions in more distal locations. The procedure—which is more traditionally used in large vessel occlusions (LVOs)...
Among Chinese patients with minor, non-disabling stroke presenting <4.5 hours from symptom onset, dual antiplatelet therapy (DAPT) has been found to be non-inferior to intravenous thrombolysis (IVT) with alteplase regarding 90-day functional outcomes.
Thanh N Nguyen (Boston University Chobanian and...
This advertorial is sponsored by CERENOVUS.
Following the recent addition of the EMBOGUARD balloon guide catheter (BGC) to the CERENOVUS STROKE SOLUTIONSi portfolio of devices, Demetrius K Lopes (Chicago, USA) discusses the significance of this latest tool when it comes...
A randomised, triple-blinded clinical trial involving 35 women has found that active transcranial direct current stimulation (tDCS)—delivered at an intensity of 2mA and across a total of 10 sessions—may be an effective treatment option for patients with fibromyalgia.
This finding...
Rhaeos has announced the successful closing of US$10.5 million in Series A funding, led by the Steele Foundation for Hope, bringing the company’s total funding to more than US$18 million. Other round participants include follow-on investors, Creative Ventures and Lateral Capital.
This funding...
On day two of the Pan Arab Interventional Radiology Society annual meeting (PAIRS; 11–14 February, Dubai, UAE), Riad Salem (Northwestern University, Chicago, USA) took to the podium to give insight into a new frontier in interventional oncology (IO)—yttrium 90...
Athersys, the company developing MultiStem (invimestrocel) cell therapy for critical care indications, announced recently that it has been granted a clinical Type B meeting with the US Food and Drug Administration (FDA).
The company was previously granted Regenerative Medicine Advanced Therapy...
Hospital institutions in Mexico will have access to a single, comprehensive set of stroke certification services through a new collaboration between the Mexican stroke association, Asociación Mexicana de Enfermedad Vascular Cerebral AC (AMEVASC), and the American Stroke Association (ASA).
The ASA, a division of...
Perfuze has secured its first product clearance from the US Food and Drug Administration (FDA) for the company’s Millipede 088 access catheter. The first US clinical procedures with Millipede 088 were successfully performed by physicians at Stony Brook University...
MindMaze has announced the US and EU launch of Izar, which it describes as a “first-of-its-kind”, US Food and Drug Administration (FDA)-listed and CE-marked smart peripheral for patients with impairment in hand motor function.
Izar is designed to fill a...
Ischaemic stroke patients treated with a clot-busting medication and/or mechanical thrombectomy who also received butylphthalide—a novel medication initially compounded from celery seed—experienced milder neurological symptoms with better functioning at three months post-stroke, as compared to stroke patients who had...
IRRAS has announced the publication of the first comparative study detailing the use of the company's novel IRRAflow system. This study, which was conducted under the guidance of Adnan Siddiqui (University of Buffalo, New York, USA) and colleagues, is published in the...
New data on intravenous tenecteplase indicate that it can achieve comparable efficacy and safety to alteplase in treating stroke—and, as such, may be used as an alternative to alteplase for acute ischaemic stroke patients within 4.5 hours of symptom...
A new smartphone application called FAST.AI (Neuronics Medical) may help people who are having a stroke—or their family and caregivers—to recognise common stroke symptoms in real time, prompting them to seek medical care and receive urgent treatment.
FAST.AI is a fully automated...
Phenox, a Wallaby Medical company, has today announced the presentation of the primary results of the PROST (Preset for occlusive stroke treatment) randomised clinical trial at the International Stroke Conference (ISC; 8–10 February 2023, Dallas, USA).
The PROST trial was...
EndoStream Medical has announced that the first patient has been enrolled in the TORNADO-US clinical study in the USA, which will evaluate the Nautilus intrasaccular system in the treatment of cerebral aneurysms.
The patient was treated at Mount Sinai Hospital in New...
An international clinical study has found that patients experiencing a ‘large’ stroke—characterised by a greater infarct-core volume on imaging—had a dramatically better recovery after receiving an endovascular mechanical thrombectomy plus standard medical management than those who received standard medical...
New data pointing to the possible advantages held by several drug products in treating acute ischaemic stroke were delivered at the recent International Stroke Conference (ISC; 8–10 February, Dallas, USA), including novel alternatives to conventional intravenous thrombolytics. Multiple companies...
The administration of medications to lower systolic blood pressure in acute ischaemic stroke patients who have undergone a successful mechanical thrombectomy procedure—also known as endovascular therapy (EVT)—"should be customised", owing to possible safety concerns and only marginal benefits associated...
Hyperfine has announced the presentation of new stroke patient follow-up data regarding the use of the Swoop system—which it claims is the world’s first US Food and Drug Administration (FDA)-cleared portable magnetic resonance imaging (MRI) system—at the 2023 International Stroke...
A study of two widely used cardiovascular medications—cilostazol and isosorbide mononitrate—in more than 350 patients has confirmed that both were well-tolerated and safe for patients experiencing a stroke caused by a clot in a small blood vessel deep in...
Phenox, a Wallaby Medical company, has announced the US Food and Drug Administration (FDA) 510(k) clearance of its Preset thrombectomy device for the treatment of acute ischaemic stroke.
The Preset product family, which has been available in Europe for more...
In a study presented yesterday at the International Stroke Conference (ISC; 8–10 February, Dallas, USA), irregular heart rhythms were detected in roughly one in five people who survived an ischaemic stroke due to atherosclerosis and were continuously monitored for...
Viz.ai and TeleSpecialists have announced new data presented at the 2023 International Stroke Conference (ISC; 8–10 February, Dallas, USA) from the VALIDATE study, which demonstrated that hospital utilisation of Viz’s artificial intelligence (AI)-powered care coordination platform was associated with...
ApTOLL, a neuroprotectant medication intended to shield the brain from tissue damage, has been linked to reduced death and disability when used alongside standard treatments to restore blood flow in ischaemic stroke patients. That is according to preliminary late-breaking...
Avicenna.AI announced today that it has secured a Series A funding round, bringing aggregated investment in the company close to US$10 million. The round was backed by existing investors Innovacom and CEMAG Invest, according to an Avicenna.AI press release.
The...
Imperative Care has announced the formation of digital health startup Kandu Health as an independent company, with the aim of “changing the course of stroke recovery and post-acute care”.
Kandu is set to offer remote clinical support from Kandu Navigators, who...
Intravenous thrombolysis (IVT) prior to a mechanical thrombectomy procedure could result in better functional outcomes than thrombectomy alone in stroke patients with M2 occlusions, as per a retrospective analysis derived from the Endovascular Treatment in Ischemic Stroke (ETIS) registry.
Outlining...
A new American Heart Association (AHA) scientific statement provides guidance on staffing, leadership and resource requirements for hospital stroke centres, with the intention of reducing variability and improving quality of care at stroke centres across the USA.
The statement...
A national study conducted by researchers in the Czech Republic has found that, while stroke admissions in the country declined during the first year of the COVID-19 pandemic, this was not related to the incidence of the virus.
The study’s...
The external validity—in other words, the transferability to real-world clinical practice—of contemporary randomised controlled trials (RCTs) investigating carotid artery stenosis interventions “varies considerably”, as per a recent analysis published in the European Journal of Vascular and Endovascular Surgery (EJVES)...
JMIR Publications has announced the expansion of its journal portfolio with JMIR Neurotechnology (JNT)—an open-access, peer-reviewed journal focused on the intersection between clinical neuroscience and technology to prevent, diagnose, and treat neurological disorders.
Neurosurgeon Pieter Kubben (Maastricht University Medical Center, Maastricht,...
Spinal cord stimulation (SCS) therapies targeting the dorsal column “may be considered” within the multimodal treatment plans typically required by cancer patients, but it is “unclear” which types of cancer-related pain are likely to respond to these therapies. That...
LivaNova has launched SenTiva DUO—an implantable pulse generator (IPG) with a dual-pin header intended to provide vagus nerve stimulation (VNS) therapy for patients with drug-resistant epilepsy.
The dual-pin header distinguishes this latest IPG from the original SenTiva device, which is...
A meta-analysis of recent basilar artery occlusion trials—including ATTENTION and BAOCHE—has further indicated the potential benefits held by endovascular therapy (EVT) in treating posterior-circulation large vessel occlusion (PC-LVO) stroke.
Writing in the Journal of NeuroInterventional Surgery (JNIS), authors Jeremy Heit...
The latest and greatest in neurointerventional technologies feature among NeuroNews’ most read stories from January, including a direct intravascular imaging tool; a new, stroke-specific transradial access system; and two recent introductions to global neurovascular catheter markets. The potential held...
At Stryker, we invest in clinical trials and registries to advance stroke care. In this video, Markus Möhlenbruch discusses the most significant studies that have demonstrated the safety and efficacy of Trevo Retrievers over the last decade. You can count on...
Basking Biosciences has announced that it will be presenting three oral presentations and two moderated posters concerning the company’s novel drug candidate—a reversible thrombolytic agent for ischaemic stroke—at the 2023 International Stroke Conference (ISC; 8–10 February, Dallas, USA).
“Current drug...
Axonics has announced that the US Food and Drug Administration has approved the company’s fourth-generation rechargeable sacral neuromodulation (SNM) system—a technology intended to provide patients suffering from overactive bladder and/or faecal incontinence with long-lived, easy to use, safe and...
A systematic review and meta-analysis have demonstrated “convincing evidence” that sex differences exist in carotid atherosclerosis, with all types of plaque features—including those relating to size, composition, and morphology—found to be either larger or more common in men than...
Esteemed neurologist Ralph Sacco passed away at the age of 65 earlier this month, and a number of prominent neurology and stroke societies have since paid tribute to him and his achievements in the field.
Sacco’s obituary in the journal...
Combination spinal cord stimulation (SCS) therapy with Boston Scientific’s WaveWriter system has demonstrated superior outcomes to conventional medical management (CMM) in chronic pain patients with no prior back surgery, as per randomised controlled trial (RCT) data presented recently at...
A systematic review of interventional acute ischaemic stroke treatments in Latin American countries has found that mechanical thrombectomy usage in these regions is “comparable to international levels”. Writing in the Journal of Stroke and Cerebrovascular Diseases, Alejandro Gonzalez-Aquines (University...
Infinity Neuro announced today that its Inspira aspiration catheters have received CE-mark approval and are now commercially available in Europe.
This is the first offering from Infinity—a company that plans to launch a full range of products for the treatment of...
Abbott has announced that the US Food and Drug Administration (FDA) has approved its Proclaim XR spinal cord stimulation (SCS) system to treat painful diabetic peripheral neuropathy (DPN)—a debilitating complication of diabetes.
The Proclaim XR SCS system can provide relief...
A double-blinded randomised controlled trial (RCT) has shown that transcutaneous auricular vagus nerve stimulation (taVNS) can improve cognitive performance in patients with mild cognitive impairment (MCI), offering evidence that this “inexpensive, effective and innovative” technique could be recommended to...
The CELLO II balloon guide catheter (Fuji Systems Corporation) has received 510(k) premarket approval from the US Food and Drug Administration (FDA), and can now be marketed in the USA and other FDA-regulated territories for peripheral and neurovascular indications.
Having...
Blackford—an artificial intelligence (AI) imaging platform and solutions provider—is set to form a strategic partnership with Brainomix to bring the latter’s comprehensive e-Stroke solution to the Blackford Platform, making advanced stroke care available to more institutions around the world.
"Timely...
Researchers have explored the therapeutic outcomes of patients with brain arteriovenous malformations (AVMs) in mainland China and produced early findings indicating that microsurgery is the “dominant” strategy for this indication, and treatment protocols based around disease severity are the...
A study conducted by Michigan Medicine (Ann Arbor, USA) researchers suggests that hospitals without the highest stroke care designation may be missing strokes that occur after transcatheter aortic valve implantation (TAVI)—a common, minimally invasive procedure whereby a patient’s thickened...
Recently published data from the ENCHANTED2/MT study have shed new light on the safety and efficacy of more intensive versus less intensive blood pressure lowering after mechanical thrombectomy procedures in large vessel occlusion (LVO) stroke patients.
The key finding from...
A multi-year clinical trial at the University of Texas Medical Branch (UTMB; Galveston, USA) and Medical University of South Carolina (MUSC; Charleston, USA) will examine the use of a wearable device designed to stimulate nerves near the ear and...
MedRhythms has announced that the company's pivotal trial for MR-001, a novel digital intervention being developed to treat gait deficits in chronic stroke, was successfully completed and met its primary endpoint of improvement in gait speed.
The multi-site randomised controlled...
Basecamp Vascular (BCV) has announced the appointment of Thierry Col as its new CEO, effective 1 February 2023.
He succeeds interventional neuroradiologist Raphaël Blanc (Foundation Rothschild Hospital, Paris, France), the company’s co-founder and president, who has held this role since the...
This advertorial is sponsored by Philips.
Time is of the essence when treating a patient who has just experienced a stroke. Every minute counts, and minimising the number of minutes a stroke is left untreated could be the difference for...
Stroke symptoms that disappear in under an hour—often referred to as a transient ischaemic attack (TIA)—need emergency assessment to help prevent a full stroke, according to a new American Heart Association (AHA) scientific statement published today in the association’s...
The Squid liquid embolic agent (Balt) has been deemed safe and effective in treating high-grade dural arteriovenous fistulas (DAVFs), and serves to expand the armamentarium for neurointerventionists treating DAVFs and other intracranial vascular malformations.
Markus Möhlenbruch (Heidelberg University Hospital, Heidelberg,...
Saluda Medical has announced that late-breaking data from the "landmark" EVOKE clinical trial was presented at the recent North American Neuromodulation Society (NANS) annual meeting (12–15 January 2023, Las Vegas, USA). The data presented constitute “the longest follow-up evidence...
A newly published meta-analysis of individual patient data has found that older patients with symptomatic carotid disease are likely to benefit as much from timely intervention as younger patients. Speaking to Vascular News in light of this key finding,...
An international study conducted by Leonard Yeo (National University Hospital, Singapore) and colleagues has found that the presence of atrial fibrillation does not modify the treatment effect of bridging intravenous thrombolysis (IVT) in ischaemic stroke patients undergoing a thrombectomy...
Abbott presented new data in more than 30 presentations and posters at the North American Neuromodulation Society (NANS) annual meeting (12–15 January 2023, Las Vegas, USA), highlighting how neuromodulation can help people suffering from chronic pain and movement disorders,...
A study by the Neiman Health Policy Institute (Reston, USA) has found that the costs of an ischaemic stroke episode increased by 4.9% from 2012 to 2019, with the main driver of this being changes in treatments—such as endovascular...
Neuralace Medical has announced the commencement of and first patient enrolments in its AT-PDN (Axon therapy and painful diabetic neuropathy) study.
The multicentre AT-PDN study has a targeted enrolment of 80 patients and will be led by Lora Brown (TruWell Health, St...
The “renaissance” of neuro- and cerebroprotective paradigms, coupled with “the advent of new ideas”—such as the concept of ‘transient neuroprotection’ to preserve the penumbra—appears to offer promise in interventional stroke care. This was arguably the prevailing message offered by...
Gentuity has today announced the first human use of the Vis-M high-frequency optical coherence tomography (HF-OCT) imaging system and probe. As per a company press release, this represents a “significant technological advance for the field of neurointervention”, making high-resolution...
A systematic review and meta-analysis of the “scarce” existing literature has adjudged flow diversion with a coated stent plus single antiplatelet therapy (SAPT) to be “feasible” in the treatment of ruptured intracranial aneurysms, despite thromboembolic complications occurring in a...
Athersys, the company developing MultiStem (invimestrocel)—an off-the-shelf stem cell treatment intended for critical care indications, including acute ischaemic stroke, trauma and other inflammatory conditions—has provided an update regarding two ongoing clinical trials with this product.
The MASTERS-2 trial is attempting to...
Medtronic has announced that it will highlight clinical and preclinical research relating to sensing-enabled spinal cord stimulation (SCS) therapy at the North American Neuromodulation Society (NANS) annual meeting (12–15 January 2023, Las Vegas, USA).
In addition, Medtronic and its partners...
A career in clinical research is perhaps a less formulaic and well-trodden path than the one into medicine itself, typically requiring relatively young and inexperienced clinicians to show initiative, commitment and a great deal of patience. According to Diederik...
Synchron has announced that the medical journal JAMA Neurology has published peer-reviewed, long-term safety results from a clinical study in four patients with severe paralysis implanted with the company’s first-generation Stentrode neuroprosthesis device. The study found that it is...
Fluidx Medical has released information regarding the success of the IMPASS Embolic Device in in vivo research related to middle meningeal artery (MMA) embolisations that can be used to treat chronic subdural haematomas (CSDH) on the surface of the...
A recent update on the DISTAL randomised controlled trial (RCT)—which was delivered at the Barts Research and Advanced Interventional Neuroradiology (BRAIN) conference (5–8 December 2022, London, UK)—saw attendees discuss the study’s strengths, and how far it could go towards...
Justin Zenanko, the CEO of SynerFuse, announced today that—in what the company says is a world-first—a solo spine surgeon has performed the “groundbreaking” SynerFuse procedure.
Rohan Lall (M Health Fairview, Minneapolis, USA) simultaneously performed both a spinal fixation procedure and...
Nalu Medical—a company working on miniaturised neurostimulation implants for the management of chronic intractable pain via both spinal cord stimulation (SCS) and peripheral nerve stimulation (PNS) indications—has announced the publication of two key studies in Neuromodulation: Technology at the Neural...
The final weeks of 2022 saw the global burden of stroke gain a great deal of attention from NeuroNews’ online audience, including discussions around improving access to thrombectomy treatments in the UK. Established techniques and novel technologies alike feature...
Researchers from India have developed a patient-specific mathematical model to examine and elucidate the parameters—including shape and size—that influence aneurysm rupture risks prior to surgical intervention.
Predicting the rupture of cerebral aneurysms is crucial for medical prevention and treatment, as...
Nevro Corporation has announced that two abstracts for clinical trials relating to painful diabetic neuropathy (PDN) and non-surgical back pain (NSBP) treatments have been accepted as podium presentations at the upcoming North American Neuromodulation Society (NANS) annual meeting (12–15...
A new study funded by the Heart and Stroke Foundation has revealed that annual stroke occurrence rates in Canada have increased to 108,707—roughly one every five minutes. This highlights the need for strong stroke care, treatment and recovery systems across the country, as...
Imperative Care announced today that the US Food and Drug Administration (FDA) has finalised 510(k) clearance of its Zoom RDL radial access system—the company’s latest innovation in elevating stroke care and the “first radial access platform developed specifically for...
Abbott has announced the US Food and Drug Administration (FDA) approval of the company's Eterna spinal cord stimulation (SCS) system, which it claims is the smallest implantable, rechargeable spinal cord stimulator currently available on the market for the treatment...
Insightec recently announced it has received an additional US Food and Drug Administration (FDA) approval for treatment of essential tremor using its Exablate Neuro platform.
Essential tremor commonly affects both sides of the body, and this new FDA approval will...
A patient’s race may influence the recommendations they receive for the surgical removal of brain tumours, as per a recent, registry-based cohort analysis published in The Lancet by University of Minnesota Medical School (Minneapolis, USA) researchers.
According to the analysis,...
A team including researchers from the USA, Germany and Canada has found that stimulating a specific network in the brain of Alzheimer’s disease patients can reduce their symptoms, recently publishing these findings in Nature Communications. The researchers hope their...
The thrombolysis taskforce of the European Stroke Organisation (ESO) executive committee has provided an update on current shortages of alteplase and tenecteplase, detailing outcomes from a recent meeting with Boehringer Ingelheim (BI)—the company that markets both drugs in Europe—and...
Saluda Medical has announced plans for a limited commercial release of its Evoke spinal cord stimulation (SCS) system in the USA, with a full commercial release expected in 2023.
The Evoke system is the first and only US Food and Drug...
Through her many years as a consultant neuroradiologist at the North Bristol NHS Trust (Bristol, UK), as well as organising the European Course in Minimally Invasive Neurological Therapy (ECMINT) and making leading contributions to the UK Neurointerventional Group, Shelley...
A transmural approach for accessing the perivascular tissues of the cervical carotid artery has been deemed safe following initial evaluations in a swine model.
Geoffrey Colby, Wi Jin Kim and Milan Samarage (all University of California Los Angeles , Los...
The utilisation of 3D printing to make drug-eluting stents may currently be in its infancy, but the advantages it carries—such as the ability to develop patient-specific devices and tailored drug-release profiles, and evaluate different materials and designs via computational...
Closed-loop evoked-interference deep brain stimulation (DBS) has been shown to be potentially utilisable in characterising the role of oscillatory dynamics in Parkinson’s disease and other brain conditions—indicating that this DBS modality could play a role in developing personalised neuromodulation...
Sonorous NV has announced the treatment of the first patients in North America with the BossStent device, which is designed to treat patients with symptomatic cerebral venous diseases.
As per a Sonorous press release, the single-use, implantable device acts as...
Stryker recently opened its Neurovascular (NV) lab—a “state-of-the-art” laboratory designed to accelerate stroke-related innovation in the Asia-Pacific region. Located within the Stryker Global Technology Center (SGTC) at International Park in Gurgaon, India, the Keystone Suite will enable collaboration between...
This educational supplement has been sponsored by MicroVention.
Since its inception in 1997, MicroVention has gradually expanded its offerings from cerebral aneurysms to include several other areas in neuroendovascular care—with ischaemic stroke being a key area of focus over the...
Permanent intracranial stenting offers a feasible, safe ‘bailout’ option following a failed mechanical thrombectomy procedure. This was the concluding message delivered recently by Sarah Power (Beaumont Hospital, Dublin, Ireland)—who highlighted stenting’s association with improved successful recanalisation rates (thrombolysis in...
Highlights:
With the UK Stroke Association continuing its push to make thrombectomy treatments more widely accessible, NeuroNews speaks to Sanjeev Nayak (Stoke-on-Trent, UK), Dileep Yavagal (Coral Gables, USA) and Michihiro Tanaka (Kamogawa, Japan) to gain global perspectives
"So, you...
Highlights:
With the UK Stroke Association continuing its push to make thrombectomy treatments more widely accessible, NeuroNews speaks to Sanjeev Nayak (Stoke-on-Trent, UK), Dileep Yavagal (Coral Gables, USA) and Michihiro Tanaka (Kamogawa, Japan) to gain global perspectives
"So, you...
Medtronic Neurovascular has announced a new partnership with Avail Medsystems, creating the Medtronic Remote Connectivity Program (Medtronic RCP) in the process.
The goal of this collaboration is to enable real-time connectivity with peers, thought leaders, and other industry experts, according...
Corindus has been rebranded to Siemens Healthineers Endovascular Robotics and will sit as a dedicated business within the Advanced Therapies area of Siemens Healthineers, the company has announced.
This brand unification is the final step of the company integration process...
Despite their clear significance in pain management, gender differences relating to the ways patients respond to neuromodulation therapies are relatively poorly understood and underpinned by a limited amount of definitive data. Beatrice Bretherton (Leeds, UK) discusses this existing evidence...
Axonics has announced that Health Canada has approved the company’s fourth-generation rechargeable sacral neuromodulation system as a treatment for bladder and bowel dysfunction.
The newly approved Axonics R20 neurostimulator is labelled for a functional life in the body of at least...
IRRAS has announced that it recently received regulatory clearance from the US Food and Drug Administration (FDA) to activate all of the functionality on the next-generation control unit for its flagship product, IRRAflow—which it claims is the world's first...
Eight winners have been exclusively invited to join Phase 2 of the Neuromod Prize, a US$9.8 million competition to accelerate the development of targeted neuromodulation therapies. With the competition, the National Institutes of Health (NIH) hopes to “bridge the...
Europe’s health commissioner, Stella Kyriakides, has announced that proposals to extend the transition period for the implementation of the European Union’s (EU) Medical Device Regulation (MDR) will be put forward in early 2023.
Kyriakides informed health ministers from the EU’s...
NeuroOne Medical Technologies has announced that it has successfully completed a feasibility study with its OneRF ablation system—a developing technology that utilises existing implanted stereoelectroencephalography (sEEG) diagnostic electrodes for brain tissue lesioning.
The study evaluated the company's new radiofrequency (RF)...
Key announcements from a number of the neurovascular market's leading companies generated interest from NeuroNews' online readers last month, including updates from the recent Society of Vascular and Interventional Neurology (SVIN) annual meeting (16–19 November 2022, Los Angeles, USA)....
Renowned pain management expert and clinical professor of anaesthesiology Timothy Deer (West Virginia University, Charleston, USA) is set to receive the inaugural Presidential Merit Award from the North American Neuromodulation Society (NANS).
This award—which is a new introduction for 2023—has...
A study published in Neurology has found that the burden of ischaemic stroke in young adults “continues to increase” across low-socio-demographic index (SDI) regions, such as North Africa and the Middle East, and Southeast Asia. As such, the study’s...
“We are entering an era where true scientific evidence from IONM is guiding technology and our clinical practice.” This was one of the salient messages delivered by Steven Falowski (Argires Marotti Neurosurgical Associates of Lancaster, Lancaster, USA) at...
Health charities and National Health Service (NHS) clinicians have united in a call for the Scottish government to reverse a cut to the funding of stroke thrombectomy treatments.
More than 150 stroke clinicians have backed a call from charities Chest,...
A wealth of new data confirming the beneficial role mechanical thrombectomy can play in the treatment of acute ischaemic stroke came to light through the 2010s, but global healthcare systems are still fighting to make these procedures available for...
NOTE: This video is ONLY available to watch in selected countries and geographies
Principal investigators Urs Fischer (University Hospital of Basel, Basel, Switzerland) and Jan Gralla (University Hospital of Bern, Bern, Switzerland) provide insights on the results from SWIFT-DIRECT—a...
A prospective study has demonstrated the potential feasibility, applicability and accuracy held by artificial intelligence (AI) in the detection of carotid artery disease on greyscale static duplex ultrasound imaging. This is the conclusion reached by Ali Kordzadeh (Faculty of...
Wise, a company that develops next-generation implantable electrodes for neuromonitoring, neuromodulation and brain-machine interfacing applications, has announced the US Food and Drug Administration (FDA) clearance of its Wise Cortical Strip (WCS)—a single-use medical device intended to be used on the...
LuSeed Vascular has announced that Robert Stern, an experienced medical device executive and investor, has been nominated as the vice chairman of the company’s board of directors.
Stern currently serves as an advisor to several medical device companies and...
The Society of NeuroInterventional Surgery (SNIS) has released a position statement advocating pregnancy and parental leave policies in neurointerventional surgery, also voicing support for a physician’s ambition to have a family, as well as start, develop and maintain a...
NeuroPace has announced that the first patient with Lennox-Gastaut syndrome (LGS)—a particularly severe form of childhood-onset epilepsy characterised by cognitive dysfunction and frequent seizures—was recently treated in its feasibility investigational device exemption (IDE) study.
The study will see the company’s...
Viz.ai has announced a partnership with Cercare Medical that will incorporate the latter’s Cercare Perfusion—a fully-automated, simple-to-use, patient-specific perfusion software—into the Viz artificial intelligence (AI) platform.
In a press release, Viz.ai states that it is broadening its imaging features and...
Neurologica, a subsidiary of Samsung Electronics, has announced that its head-to-toe trauma imaging solution—the BodyTom 64 point-of-care mobile computed tomography (CT) scanner—has received 510(k) clearance from the US Food and Drug Administration (FDA) for commercial use in the USA.
Based on...
Two neurosurgeons from Tufts Medical Center in Boston, USA have been honoured with the 2022 Innovation Award at this year’s Society of Vascular and Interventional Neurology (SVIN) annual meeting (16–19 November, Los Angeles, USA) for their work on an...
The Swiss Federal Assembly has voted in favour of accepting medical devices with US Food and Drug Administration (FDA) marketing authorisation in Switzerland.
A motion for ‘more freedom of action in the procurement of medical products for supply of the...
The ongoing annual meeting of the Radiological Society of North America (RSNA; 27 November–1 December 2022, Chicago, USA) has seen a plethora of new research findings presented relating to various brain conditions—including attention-deficit/hyperactivity disorder (ADHD) in children, migraine-related brain...
Following the presentation of first-in-human cases with the GECKO system at the 2022 European Society of Minimally Invasive Neurological Therapy (ESMINT) congress (7–9 September, Nice, France), Basecamp Vascular (BCV) CEO and co-founder Raphaël Blanc (Foundation Rothschild Hospital, Paris, France)...
